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SUMMARY 
 
 
Wounds are one of the most common reasons for patients of all ages requiring health 
care 
[1,2]
. It is well known that neglected wounds may lead to installation of multiple 
disabilities with negative impact on patients’ daily activities [3]. Delayed healing, 
infections and wound dehiscence can cause a transformation of acute wounds in chronic 
wounds, which from an economic point of view is important, due to increased cost of 
healthcare. Chronic wounds are estimated to affect 433,000 Australians and to cost the 
health system $2.6 billion a year 
[4]
. In USA, the health care cost associated with wound 
management and treatment has reached $20 billion a year 
[5]
. Wounds are a major 
therapeutic problem and burden on the healthcare system. This is due to the increase in 
aged population, and the rising incidence of obesity and diabetes all of which delay the 
healing of wounds and lead to the development of chronic wounds. These debilitating 
wounds cause significant morbidity and mortality and are an escalating burden to the 
health care system.  
 
Developing new methodologies to improve wound healing is of significant importance 
and the use of low level light radiation with optimal parameters as a means to promote 
wound healing would lead to changes in clinical practice. Applications of light therapy 
can offer a possibility of more economical and effective non-invasive therapies for 
tissue healing, presently considered refractory to conventional treatments. Promoting 
XIX 
 
the rate of healing would reduce both the likelihood and effect of secondary 
complications. There is substantial evidence that the application of electromagnetic 
radiation (EMR) in visible (VIS) and infra-red (IR) light ranges can result in 
physiologically beneficial biological effects in soft tissue repair 
[6-9]
.  
 
This project has two arms: 
1. First study aims to investigate and experimentally evaluate the effects of applied 
electromagnetic radiation in the range of visible light on biological activity of 
Collagenase enzyme, a key molecule playing a central role in wound healing 
process.  
2. In the second study, a novel bioactive peptide is computationally designed to mimic 
the activity of the native antimicrobial peptide Azurocidin. The antimicrobial 
properties of this novel peptide are experimentally evaluated on different types of 
bacteria. 
 
In Study 1, the collagenase enzyme was selected as a model system for computational 
analysis and determination of its activation frequency. The activation 
frequency/wavelength range (450-460nm) of collagenase was computationally 
determined using RRM. To validate the computational predictions, collagenase protein 
samples were irradiated by monochromatic visible light in a frequency range predicted 
computationally by the RRM. The kinetics of the irradiated collagenase was measured 
XX 
 
by continuous monitoring of the collagen (substrate of collagenase) absorption at 340 
nm. The experimental findings are presented and discussed in Chapter 5.  
 
In Study 2, the native antimicrobial peptide Azurocidin was selected as a model system 
for its computational analysis and de novo design of a synthetic peptide analogue. Using 
the RRM approach, the synthetic Azurocidin peptide analogue (Azu-RRM) was 
designed to mimic the anti-microbial activity of the selected native Azurocidin peptide. 
A control synthetic Azurocidin peptide (Azc-RRM) is also designed to lack 
anti-microbial activity. The anti-microbial activities of the designed synthetic peptide 
analogues Azu-RRM and Azc-RRM are experimentally evaluated on selected 
Gram-positive and Gram-negative bacteria. In addition, the experimental evaluation of 
the synthetic Azu-RRM and Azc-RRM analogues is conducted to compare their 
activities with the biological activity of the native Azurocidin protein. These 
experiments are performed using the selected Gram-positive bacterium Staphylococcus 
aureus (ATCC25923). The results are presented and discussed in Chapter 5. 
 
The experimental findings obtained within Studies 1 and 2 reveal that application of 
visible light irradiation and synthetic peptide therapy provide an evidence-based 
approach towards development of novel treatment modalities for wound healing. 
 
1 
 
Chapter1  
 
 
Introduction 
 
Wound healing is a complex and dynamic process of replacing devitalized and missing 
cellular structures and tissue layers. The wound-healing process consists of four highly 
integrated and overlapping phases: hemostasis, inflammation, proliferation, and tissue 
remodeling 
[10]
. The events of each phase must occur in a precise and regulated manner. 
Interruptions, aberrancies, or prolongation in the process can lead to delayed wound 
healing or a formation of non-healing/chronic wound. Multiple factors can lead to 
impaired wound healing. In general terms, the factors that influence repair can be 
categorized into local and systemic. Local factors are those that directly influence the 
characteristics of the wound itself (such as oxygenation, infections etc), while systemic 
factors are the overall health or disease state of an individual that affect his or her ability 
to heal. Many of these factors are related, and the systemic factors act through the local 
effects affecting wound healing
 [11]
. 
 
Up to date, the research on treating local factors for chronic wound healing is more 
focused on:  
1. Stimulation of cell growth;  
2. Wound bed preparation; and  
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3. Anti-infection treatment.  
 
Wound bed preparation involves debridement and managing exudates 
[12]
. Debridement 
is the process of removing necrotic tissue to diminish infection and promote healing. It 
is an essential component of any plan to prepare the chronic wound bed for healing 
[13]
. 
There are several debridement methods applied in clinics, such as surgical debridement; 
enzymatic debridement; mechanical debridement; and autolytic debridement 
[14]
. 
Enzymatic debridement may be used as the primary technique for debridement in 
certain cases, when a surgical debridement is not feasible owing the bleeding disorders 
or other complications 
[15]
. In enzymatic debridement process, the collagenase shows 
more selectivity on denatured collagen in devitalized tissue. This selectivity is 
beneficial as it keeps the vital tissue and growth factors crucial to wound healing 
[16]
. 
 
This research project is focused on improvement of wound bed preparation and 
development of a novel anti-infection treatment for wound healing promotion. In 
particular, this project comprises two major research studies: 
 Study 1: The application of external electromagnetic radiation (EMR) of the 
computationally determined frequency that can modulate the biological activity 
of Collagenase enzyme (a key player in wound repair process) and thus, promote 
the process of enzymatic debridement for a better wound bed preparation that 
can lead to enhanced wound healing; and  
 Study 2: Investigation of the antimicrobial activity of a novel computationally 
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designed synthetic peptide analogue that emulates the function of a native 
antimicrobial peptide Azurocidin. This study evaluates the antimicrobial 
efficacy of the novel anti-infection agent against the selected Gram-positive and 
Gram-negative bacteria in vitro. 
 
There are studies showing that applied electromagnetic radiation (EMR) in the visible 
light range can effect protein and cellular activity
 [17-19]
. It was also reported that the 
protein activity can be modified by the electromagnetic radiation within the specific 
frequency range which could be computationally predicted with using the Resonant 
Recognition Model (RRM) 
[20-22]
. In Study 1, the selected model system, Collagenase 
enzyme, was computationally analyzed using the RRM approach. The activation 
frequency/wavelength range of Collagenase enzymes was computationally determined 
to be 450–460 nm. The Collagenase enzyme was irradiated by monochromatic visible 
light in a wavelength range of 400– 900nm (that includes the computationally predicted 
wavelengths). The kinetics of the irradiated Collagenase was monitored and compared 
with the kinetics of non-irradiated enzyme sample. The obtained results revealed that 
enzymatic activity of collagenase is modulated by exposures to visible light radiation 
with the maximum effect observed at the wavelengths determined computationally (456 
nm), thus confirming that applied EMR can be used to produce the desired alterations in 
selected proteins. By modulating the biological activity of collagenase enzyme, it 
becomes possible to improve collagenase debridement and hence, enhance would bed 
preparation stage of wound healing process.  
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Presently, antibiotics are the common anti-infection drugs applied in clinic. However, 
the rising antibiotics’ resistance is a major problem that limits current use of traditional 
antibiotics for treatment of various infections. Hence, there is a growing need to find 
alternative drugs that can eradicate the antibiotics resistance arising from their excessive 
applications 
[23]
. Antimicrobial peptides (AMP) are found in virtually all life forms 
where they work as a first line of defense against invading pathogens. These AMP are 
one of the innate immunity actors which were conserved along evolution 
[24,25]
. In recent 
years, one of the natural antimicrobial peptides “Azurocidin” has been found to have 
various antimicrobial, antiviral, and immunomodulatory properties 
[26-29]
. Azurocidin is 
found in neutrophils. Neutrophils are the most abundant (40% to 75%) type of white 
blood cells in mammals and form an essential part of the innate immune system 
[30-32]
. 
 
Study 2 is focused on development of a novel anti-infection agent. The antimicrobial 
activity of the synthetic bioactive peptide, computationally designed by the RRM, and 
mimicking the activity of Azurocidin protein is evaluated on the selected Gram-positive 
and Gram-negative bacteria. The antimicrobial activity of the synthetic peptide 
analogue, Azu-RRM, is compared to the native antimicrobial peptide Azurocidin (Azu) 
and evaluated against the Gram-positive bacterium Staphylococcus aureus 
(ATCC25923), the Gram-negative bacterium E. coli (ATCC25922) and the ampicillin 
resistant bacterium strain Staphylococcus aureus344. The experimental findings showed 
that novel Azu-RRM peptide affected the growth of both Staphylococcus aureus ATCC 
25923, 344 and E. coli 25922. The activity of Azu-RRM peptide against Staphylococcus 
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aureus ATCC 25923, and penicillin resistant Staphylococcus aureus 344 and E. coli 
ATCC 25922 was shown to be dose- and time-dependent. The results clearly indicate 
that synthetic Azu-RRM shows a potent antimicrobial activity and can potentially 
present a new alternative therapeutic compound to control bacterial infections. 
 
1.2 Aims of the research project 
In essence, this project aims to test two hypotheses as shown in Figure 1: 
1. Electromagnetic radiation of the computationally determined frequency can 
modulate the enzymatic activity and thus, promote a wound healing process. 
2. The computationally designed synthetic peptide can exhibit an antimicrobial 
activity and thus, promote wound healing process. 
 
1.3 Research Questions 
 
- Is it possible to apply EMR of certain parameters that will induce biological 
effects on the selected protein activity? 
- If there is a biological effect, can we modulate enzymatic activity using EMR 
with a specific frequency (increase or inhibit the enzymatic activity)?  
- Can we design a synthetic peptide analogue which can emulate the native 
antimicrobial peptide?  
- How the selected bacterium will respond to the treatment by the synthetic 
peptide analogue? 
6 
 
 
 
Figure 1.1. Flow chart of the project 
 
1.4 Thesis Outline 
 
This thesis contains seven chapters. 
Chapter 1 presents a general introduction describing the overall aim and objectives of 
the project.  
Chapter 2 presents a literature review of relevant published literature of interest for this 
project. It covers general aspects of wound healing, anti-infection, wound bed 
preparation, the effects of electromagnetic radiation on proteins and cells.  
Chapter 3 presents the biological effects electromagnetic radiation and its therapeutic 
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applications  
Chapter 4 presents the materials and methods used in this project. The concepts and 
possible applications of the Resonant Recognition Model (RRM) are also presented. 
The computational analysis of the selected protein examples (Collagenase enzyme and 
Azurocidin antimicrobial protein) carried out within the project is described. 
Chapter 5 presents the experimental studies conducted in this project. One study is the 
experimental evaluation of the effects of applied electromagnetic radiation (EMR) in the 
visible light range on biological activity of Collagenase enzyme. The second study is 
the investigations of the antimicrobial activity of the synthetic, computationally 
designed Azurocidin peptide analogue on growth and proliferation of selected 
pathogenic bacteria. 
Chapter 6 outlines the conclusion drawn from the experimental results of the project, 
and presents and discusses the findings in the light of the research questions set for this 
project. 
Chapter 7 provides the recommendations for a further research. 
Chapters of this thesis are concluded by a list of references used in the project. 
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Chapter2  
 
 
Literature Review 
 
2.1 Wound healing: Overview 
 
Wound healing is an intricate process whereby the skin repairs itself after injury 
[33]
. It’s 
classically comprises hemostasis, inflammation, proliferation, and remodeling 
[34]
. 
Chronic wounds do not follow the same orderly progression toward healing as acute 
wounds but are trapped in a phase of inflammation 
[35]
. Chronic wound represents 
necrotic tissue, corrupt matrix, hypoxia, high bacterial burden and senescent cells within 
the wound bed. Up to date, the research on chronic wound healing is mostly focused on 
(i) stimulation of cell growth; (ii). anti-infection; and (iii) wound bed preparation 
[36-38]
.  
 
Recent advances in molecular and cellular biology have greatly expanded general 
understanding on the biological process involved in wound healing and tissue 
regeneration. The interactive process of wound healing comprise of soluble mediators, 
blood cells, extracellular matrix and parenchymal cells. Four distinct phases of wound 
healing are discussed below in greater details.  
 
 
2.1.1 Phases of wound healing 
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Hemostasis Phase: 
Wound disrupts normal tissue integrity, leading to division of blood vessels and direct 
exposure of extracellular matrix (ECM) to platelets. This result in platelets to adhere to 
the site of injury, become activated, and aggregate. Under the influence of adenosine 
diphosphate (ADP) leaking from damaged tissues, the platelets aggregate and adhere to 
the exposed collagen. They also secrete factors, which interact with and stimulate the 
intrinsic clotting cascade through the production of thrombin, which in turn initiates the 
formation of fibrin from fibrinogen. The fibrin mesh strengthens the platelet aggregate 
into a stable hemostatic plug. Finally platelets also secrete cytokines such as 
platelet-derived growth factor (PDGF), which is recognized as one of the first factors 
secreted in initiating subsequent steps. Hemostasis occurs within minutes of the initial 
injury unless there are underlying clotting disorders
 [39,40]
.  
 
Inflammation Phase:  
During the inflammation phase, bacteria and cell debris are phagocytosed and removed 
from the wound by white blood cells. The inflammatory response causes the blood 
vessels to become leaky releasing plasma and polymorphonuclear leukocytes (PMNs, 
neutrophils) into the surrounding tissue. The neutrophils phagocytize debris and 
microorganisms and provide the first line of defense against infection.  They are aided 
by local mast cells. As fibrin is broken down as part of this clean-up the degradation 
products attract the next cell involved. Macrophages are able to phagocytize bacteria 
and provide a second line of defense. They also secrete a variety of chemotactic and 
10 
 
growth factors such as fibroblast growth factor (FGF), epidermal growth factor (EGF), 
transforming growth factor beta (TGF) and interleukin-1 (IL-1) which appears to direct 
the next stage 
[41,42]
. 
 
Proliferative Phase: 
During this phase, the wound site is being cleared of debris. Fibroblasts and endothelial 
cells are infiltrating the healing wound. The fibroblasts grow and form a new, 
provisional extracellular matrix (ECM) by excreting collagen and fibronectin resulting 
in matrix synthesis, granulation tissue formation and remodeling. Endothelial cells 
participate in formation of new capillaries resulting in angiogenesis. Concurrently, 
re-epithelialization of the epidermis occurs, whereby epithelial cells proliferate and 
"crawl" atop the wound bed, covering the new tissue. In the final stage of 
epithelializtion, contracture occurs as the keratinocytes differentiate to form the 
protective outer layer or stratum corneum. All wounds undergo some degree of wound 
contraction and area of wound will be decreased. Myofibroblasts have been postulated 
as being major cell responsible for contraction. Typically this cell contains alpha 
smooth actin in thick bundles called stress fibers 
[43,44]
. 
 
Remodeling Phase: 
During remodeling, collagen is remodeled and realigned along tension lines. Collagen is 
broken down by matrix metallipoproteinases (MMPs) and net wound collagen is result 
of a balance between collagenolysis and collagen synthesis. There is a shift towards 
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collagen synthesis and eventually re-establishment of extracellular matrix composed of 
a relatively extracellular collagen rich scar. Scar remodelling continues for several 
months post injury, gradually resulting in a mature, avascular and acellular scar 
[45]
. 
 
Wound healing classically comprises four phases mentioned above. It is critical to 
acknowledge that wound healing is not linear and often wounds can progress both 
forwards and backwards through these phases depending on intrinsic and extrinsic 
forces within a particular patient. This process is fragile and susceptible to interruption 
or failure that can cause the formation of non-healing chronic wounds. Among the 
factors that may contribute are diabetes, venous or arterial disease, infection, and 
metabolic deficiencies of old age 
[46]
. 
 
2.1.2 Classification of wounds 
(Classification is with respect to healing of wounds that can be classified as either acute 
or chronic). 
Acute wound: they heal in a predictable manner and time frame. The process results in a 
well-healed wound with a few complications if any. 
Chronic wound: wounds that have failed to proceed through the orderly process that 
produces satisfactory anatomic and functional integrity
 [47,48]
. 
 
2.1.3 Chronic wound 
Chronic wounds do not follow the same orderly progression toward healing as acute 
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wounds but are trapped in a phase of inflammation. Chronic wound represents necrotic 
tissue, corrupt matrix, hypoxia, high bacterial burden and senescent cells within the 
wound bed 
[35]
. 
 
2.1.4 Features of chronic wounds [49] 
Clinical 
   ● Presence of necrotic and unhealthy tissue 
   ● Lack of adequate blood supply 
   ● Absence of healthy granulation tissue 
   ● Lack of re-epithelization 
● Recurrent wound breakdown due to superficial bridging  
Molecular and biochemical changes 
Elevated levels of: 
 ● Inflammatory cytokines 
 ● Collagenolytic activity – elevated levels of Matrix metalloproteinases (MMP-1, 
MMP-8, and MMP-13) 
 ● Gelatinases – MMP-2,and MMP-9 
 ● Stromelysins – MMP-3,MMP-10, and MMP-11 
 ● Serine proteases 
Diminished level of: 
 ● Tissue inbitor of metalloproteinases (TIMPs) 
 ● α1-protease inhibitor 
13 
 
 ● α2-macroglobulin 
Significant degradation of: 
 ● Fibronectin 
 ● Vitronectin 
 ● Tenascin 
 
Cellular features 
 ● Low mitotic activity 
 ● Altered cellular phenotype 
 ● Presence of senescent cells 
 ● Decreased growth factor activity 
 
Microbiology 
 ● High levels of bacterial content 
 ● Presence of more than one bacterial strain 
 ● Presence of multi-drug resistant organisms 
 ● Presence of biofilms 
 
Long-term complications 
 ● Sinus or fistula formation 
 ● Involvement of the bone leading to osteomyelitis 
 ● Contractures and deformity in surrounding joints 
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 ● Malignant change 
 ● Systemic amyloidosis 
 ● Calcification  
 
2.1.5 Wound bed preparation 
 
Wound bed preparation focuses on all of the critical components, including debridement, 
bacterial balance, and management of exudates and takes into account the overall health 
status of the patient and how this may impinge upon the wound healing process. It is the 
management of a wound to accelerate endogenous healing or to facilitate the 
effectiveness of other therapeutic measures
 [13,15]
.  
It involves: 
• An ongoing debridement phase 
• Management of exudates 
• Resolution of bacterial imbalance 
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2.1.6 Necrotic tissue and its accumulation in chronic wounds 
Necrotic tissue is a dead tissue, which usually results from an inadequate local blood 
supply. Necrotic tissue contains dead cells and debris that are a consequence of the 
fragmentation of dying cells. Necrotic tissue changes color from red to brown or 
black/purple, as it becomes more dehydrated. Finally, the tissue goes from a black, dry, 
thick, and leathery structure known as eschar. This can be seen in a wide variety of 
wound types, including burns and all types of chronic wounds. In contrast, slough is a 
yellow fibrinous tissue that consists of fibrin, pus, and proteinaceous material .Slough 
can be found on the surface of a previously clean wound bed and it is thought to be 
associated with bacterial activity. The accumulation of necrotic tissue or slough in a 
chronic wound is of major clinical significant, because it is thought to promote bacterial 
colonization and prevent complete repair of the wound 
[50]
. 
 
Recently, the term necrotic burden has been proposed as an all-encompassing term to 
describe necrotic tissue, excess exudates, and high levels of bacteria present within dead 
tissue. Due to the underlying pathogenic abnormalities in chronic wounds and the 
altered biochemical and cellular environment, necrotic tissue tends to continually 
accumulate 
[36]
. However, it is not always feasible to fully remove the underlying 
pathogenic abnormality, making it even more essential to adequately prepare the wound 
bed. If the necrotic burden is allowed to accumulate in the chronic wound, it can 
prolong the inflammatory response, mechanically obstruct the process of wound 
contraction and impede re-epithelization
 [51]
. 
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2.1.7 Debridement 
Debridement is the process of removing necrotic tissue to diminish infection and 
promote healing. It is an essential component of any plan to prepare the chronic wound 
bed for healing. Chronic wounds are likely to require ongoing maintenance debridement 
rather than a single intervention. The underlying pathogenic abnormalities in chronic 
wounds cause a continual build-up of necrotic tissue, and regular debridement is 
necessary to reduce the necrotic burden and achieve healthy granulation tissue 
[52,53]
. 
 
There are several methods of debridement are applied in clinics, each with its own 
advantages and limitations. Those methods that are most efficient for removal of debris 
may, at the same time, be the most detrimental to fragile new growth, and more than 
one method may be appropriate 
[54]
:  
 
• Autolytic debridement 
• Surgical and sharp debridement 
• Enzymatic debridement 
• Mechanical debridement 
 
2.1.8 Enzymatic debridement 
Enzymatic debridement may be used as the primary technique for debridement in 
certain cases, when a surgical debridement is not feasible owing the bleeding disorders 
or other complications. Autolytic debridement occurs through the action of endogenous 
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enzymes including elastase, collagenase, myeloperoxidase, acid hydrolase, and 
lysosomes. Enzymatic methods use topical application of exogenous enzymes to the 
wound surface where they work synergistically with endogenous enzymes to debride 
the surface. This method appears to be most useful in the removal of eschar from large 
wounds where surgical techniques cannot be used. Cross-hatching or scoring of the 
eschar may be necessary prior to application of the enzyme. Excess exudates may be 
produced with these agents, and local irritation to the surrounding skin or infection 
sometimes occurs 
[55,56]
. 
 
Several agents are available, although not in all markets, including fibrinolysin, 
desoxyribonuclease (fibrinolysin/DNase), collagenase and papain/urea. 
Fibrinolysin/DNase breaks down fibrin, inactivates fibrinogen and several coagulation 
factors, and dilates blood vessels in the wound bed, all of which allow macrophages to 
enter the wound and degrade necrotic tissue. The products of fibrinolysin degradation 
are not resorbed and must be removed from the wound by irrigation.  DNase cleaves 
nucleic acids, leading to liquefaction of exudates and decreased viscosity. Bacterial 
collagenase isolated from Clostridium histolyticum displays great specificity for the 
major collagen types in the skin (type I and type II collagen) and has been successfully 
used as an enzymatic debrider. It cleaves glycine in native collagen and digests collagen, 
but is not active against keratin, fat, or fibrin. The wound healing process is promoted 
by the digestion of native collagen bundles which bind nonviable tissue to the wound 
surface, and by the dissolution of collagen debris within the wound. Papain is a 
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proteolytic enzyme derived from the papaya fruit. It is inactive against collagen and 
digests necrotic tissue by liquefying fibrinous debris. Papain requires the presence of 
activators in order to function: urea is used as an activator and it also denatures 
nonviable protein matter, making it more susceptible to proteolysis
 [57,58]
. 
 
Figure 2.1 shows the application of the enzymatic debriding agent for a 4-hour period. 
All burns in the Debrase group had evidence of the effective, complete debridement as 
indicated by a clean wound bed without any escher and the presence of a punctuate 
bleeding in the remaining wound bed. In contrast, there was no evidence of debridement 
or any changes in the control burns. Figure 2.2 shows the percentage of completely 
re-epithelialized burns was higher for Debrase than control burns at the 11
th
 day. 
 
 
 
Figure 2.1. Appearance of burns immediately after a 4-hour application of 
Debrase® (left) or control vehicle (right). Note the presence of punctate bleeding in 
Debrase-treated burns indicating viability of remaining wound surface [59] 
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Figure 2.2. Comb burns at day 11 treated with Debrase® (left) and control vehicle 
(right). The debrided wounds are reepithelialized, whereas the control burns are 
moist and glistening indicating little reepithelialization 
[59]
 
 
 
2.1.9 Collagenase debridement 
In the last 20 years, several enzymatic products for wound debridement have been 
developed [60]. The two most frequently used commercial products in this area are 
currently the combination of fibrinolysin and desoxyribonuclease (DNAse) and 
collagenase
 [61]
. Several studies revealed that the product of collagenase ointment was 
significantly more effective in removing necrosis than other products. The speed of 
wound surface epithelialization was significantly enhanced by collagenase gel. It is 
important to note that the newly formed epithelium at the wound margins was not 
damaged at all by this enzymetic product. Moreover, collagenase shows more 
selectively on denatured collagen in devitalized tissue. This selectivity is beneficial as it 
keeps the vital tissue and growth factors crucial to wound healing. The comparative 
results are presented in Figure 2.3. 
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A B  
C D  
E F  
Fig. 2.3. (A) Appearance of a necrotic wound just before treatment, 2 days after 
excision of the epidermis and the major part of the dermis, followed by application of 
trichloroacetic acid; (B) The same wound after 2 days of treatment with collagenase gel 
(2 U/cm2). During treatment, the necrotic layer is becoming gradually thinner; (C) 
Artificial necrotic ulcer, treated with fibrinolysin/desoxyribonuclease oleogel for 1 
week. The wound surface is still covered with necrotic tissue; (D) Identical necrotic 
ulcer treated with collagenase ointment for 1 week. The yellow necrotic material has 
been removed and red granulation tissue has become visible; (E) Necrotic ulcer, treated 
with placebo (gel only) for 1 week. The wound is still covered with necrotic tissue; (F) 
Identical necrotic ulcer treated with collagenase gel (2 U/cm2) for 1 week. The wound 
is entirely clean and epithelialization has started from the margins
 [62]
. 
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Currently, Collagenase Ointment (Healthpoint Biotherapeutics, Fort Worth, TX) is the 
only Food and Drug Administration (FDA)-approved biological enzymatic debridement 
agent in the United States. The enzyme used in this drug is a bacterially derived 
Collagenase from Clostridium histolyticum (C. collagenase) 
[15,63,64]
. 
 
2.1.10 Collagen 
Collagen is a major protein of the extracellular matrix and the most profuse protein in 
mammals, making up about 40% of the total. It makes up 75% of our skin 
[65]
. 
Collagens are proteins that assemble into fibrous aggregates surrounding cells made up 
of three polypeptide chains with the characteristic repetitive amino acid sequence 
Gly-X-Y which wind together to form into a triple helix structure 
[66]
.  
 
In its molecular structure, there is a high proportion (about 30%) of the simplest amino 
acid glycine which having virtually no side chain nestles well into the helix, and also an 
unusual amino acid proline - together with a modified version of it - hydroxyproline. 
This complex structure has been devised by nature to be invulnerable to the circulating 
enzymes and other materials in the body. Nature accomplished this purpose superbly 
which is why no other enzyme but a "collagenase" can break it into its component parts 
[66]
.  
Collagen itself confers th7 the way the collagen fibres aggregate. Collagens have many 
other functions including cell adhesion and migration. Collagen acts as a scaffold for 
our bodies, controls cell shape, cell growth, differentiation, broken bones regeneration; 
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wound healing. When the body needs to build any new cellular structure as in the 
healing process, collagen or collagen fragments play a central role 
[68]
.  
 
Common types of Collagen
 [67] 
There are 28 different types of collagen so far identified with type I being by far the 
most abundant: 
Type I– most widely occurring collagen found in skin, tendon, bone, cornea, lung, 
vasculature and is the component of scar tissue when a wound heals; 
Type II- major component of cartilage; 
Type III- Makes up elastic tissues such as embryonic skin, lungs, blood vessels; 
Type IV- Non fibrillar collagen type IV- also known as basement membrane 
collagen; is found at tissue boundaries; 
Type V- less abundant, found in the cornea; 
Type VI- minor component in cartilage. 
 
Procollagen 
Collagen is expressed with N- and c-terminal peptidases which are cleaved before 
collagen fibrils can assemble. 
 
Tropocollagen 
Tropocollagen is the product when procollagen is removed which assembles into fibrils. 
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Subunits 
Each polypeptide chain which makes up the triple helix can be the same or they can all 
be different. They may have different lengths or features 
 
Collagen Synthesis 
Stages: 
1. Transcription 
2. Translation into pre-pro-peptide 
3. Pre-pro-peptide modification 
4. Tropocollagen formation 
5. Collagen fibril 
6. Collagen fibre  
 
The process of the collagen synthesis is shown in Figures 2.4 and Figure 2.5 
Figure 2.4 indicates that genes encoding the collagen molecule must be turned on and 
transcribed firstly, then the mRNA transcript exits the nucleus and is translated by the 
ribosome into the signal sequence and pre-pro-peptide, the pre-pro-peptide is modified 
in the endoplasmic reticulum, and then the procollagen is modified by the addition of 
oligosaccharides and then packaged again into a secretory vesicle to be excreted into the 
extracellular matrix. 
24 
 
 
 
Figure 2.4. Pre-pro-peptide modification 
[67]
 
 
 
 
Figure 2.5. Collagen fibril formation
 [67]
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Figure 2.5 indicates that collagen peptidases in the extracellular matrix cleave the 
terminal N- and C- propeptides and spontaneous assembly of the collagen molecules 
into tropocollagen triple helices occurs, then the enzyme lysyl oxidase is responsible for 
this step where hydroxyl groups on lysines and hydroxyl-lysines are converted into 
aldehyde groups which covalently bond between tropocollagen molecules to form a 
collagen fibril. 
 
2.1.11 Collagenase 
Collagenase is a highly specific proteinase and is the only enzyme that can specifically 
cleave the triple helix of the fibrillar collagens
 [69,70]
. By nature, it is a water soluble 
proteinase that specially attacks and breaks down collagen into simple peptides and is 
most effective in a pH range of 6 to 8
 [71]
.  
 
Collagenases are members of the family of zinc-dependent enzymes known as the 
matrix metalloproteinases (MMPs). These enzymes have a similar domain structure: an 
N-terminal signal sequence to target for secretion, a pro-peptide domain to maintain 
latency, a catalytic domain containing the catalytic zinc, a linker region, and a 
C-terminal four-bladed propeller structure called the hemopexin domain. The MMPs are 
a family of approximately 27 Zn
2+
 ion-dependent endopeptidases acting at neutral pH 
which are involved in the proteolytic processing of several components of the 
extracellular matrix, such as collagens, proteoglycans and fibronectin. The extracellular 
matrix breakdown involved in a number of important biological processes such as cell 
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migration, angiogenesis and wound healing 
[69,74]
. 
 
MMPs are usually classified into five main groups, namely: 
1) Collagenases (i.e., MMP-1, MMP-8 and MMP-13), 
which are able to preferentially cleave fibrillar collagen, recognizing the substrate 
through the haemopexin-like domain. 
2) Gelatinases (i.e., MMP-2 and MMP-9), which are able to enzymatically process 
various substrates of the extracellular matrix (ECM), such as collagen I and 
collagen IV. Beside the haemopexin-like domain, these MMPs are characterized by 
the presence of an additional domain, called collagen binding domain (CBD) and 
located in their catalytic domain. CBD is made of three fibronectin II-like repeats 
and represents the preferential binding domain for fibrillar collagen I. 
3) Stromelysins (i.e., MMP-3, MMP-10 and MMP-11), 
which are able to hydrolyse collagen IV, but do not cleave fibrillar collagen I. 
4) Matrilysins (i.e., MMP-7 and MMP-26), which lack the haemopexin-like domain 
and are able to process collagen IV but not collagen I. 
5) Membrane-type (MT-MMPs) (i.e., MMP-14, MMP-15, MMP-16, MMP-17 and 
MMP-24), which contain at the C-terminal an additional domain, represented by an 
intermembrane region, completed by a short cytoplasmic tail. Only MMP-14 has 
been shown to be able to cleave fibrillar collagen I 
[72]
. 
 
The collagenases (MMP-1, MMP-8 and MMP-13) are the only proteinases that 
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specifically cleave the collagen triple helix, and are important in a large number of 
physiological and pathological processes. Structures are known for the N-terminal 
'catalytic' domain of collagenases MMPs 1, 8 and 13) are the only enzymes with 
significant activity against native triple-stranded collagen types I, II, III, VII and X, 
which they degrade by cleavage of a specific peptide bond in all three strands. The 
unique cleavage point is at bond 775-776 of mature triple-stranded collagen, producing 
fragments that are one-quarter and three-quarters the size of the whole collagen 
molecule.  
 
The collagenase, matrix metalloproteinase 1 (MMP-1), plays a pivotal role in 
degradation of interstitial collagen types I, II, and III. The structure of full-length 
MMP-1 (Figure 2.6) presented here provides a model for the structures of the other 
MMPs, all of which are highly homologous. The structure of human MMP-1 comprises 
of the N-terminal catalytic domain, the linker region and the C-terminal hemopexin 
domain. The catalytic domain of one monomer contacts the hemopexin domain of the 
other monomer 
[73]
. 
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Figure 2.6. Ribbon representation of the three-dimensional structure of human MMP-1. 
Helices have been coloured pink and the strands shown in green. There are four calcium 
ions and two zinc ions found in the structure that have been colored grey and orange, 
respectively. The secondary structural elements have been annotated: helices (hA-hC), 
strands (s1–s5) of the catalytic domain and blades (bI–bIV) of the hemopexin domain 
[73]
 
 
 
2.1.12 Collagenase biological implications: specific importance to this 
research study 
Collagen is the major structural protein of vertebrates. Collagenase is a highly specific 
proteinase and is the only enzyme that can specifically cleave the triple helix of the 
fibrillar collagens. Consequently an understanding of its mechanism of action is very 
important to the process of enzymatic debridement through the destruction of collagen. 
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Analysis of the enzymatic properties of collagenases, and of chimeras between them, 
demonstrates that features of the two folded domains (the N-terminal catalytic domain 
and the C-terminal haemopexin domain and the linker peptide that connects them are all 
essential for collagen binding and hydrolysis 
[75]
. 
 
An investigation of type I collagen reaction to collagenase solution using real-time 
atomic force microscope revealed that the collagenase degrades the entire fibrillar 
structure down to shorter and thinner fragments. Collagenase cleaves glycine in helical 
regions of native collagen containing the sequence x-proline-yglycine-proline-z. In vitro 
study investigating the digestive ability of collagenase on human collagen types I, III, 
IV, V and VI showed that these enzymes displayed proteolytic power to digest all these 
types of human collagen present in necrotic tissue, except type IV 
[76]
. 
 
There is considerable rationale for using Collagenase enzyme in wounds for the purpose 
of enhancing or accelerating re-epithelization 
[77]
. Clinical trials of Collagenase reported 
rapid cleansing and enhanced removal of necrotic debris. A conducted study suggested 
that Collagenase ointment is more effective than placebo (inactivated ointment or 
petrolatum ointment) for debridement of necrotic tissue. In vivo and in vitro studies 
have shown that collagenase promotes the cellular responses to injury and wound 
healing 
[15]
. 
 
Application of collagenase to a wound could help it heal faster. Collagenase is an 
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enzymatic debrider that specifically attack collagen in wound necrotic tissue which 
contains mostly the denatured collagens and cleans the wound of any dead tissue 
leaving the wound bed ready for healing 
[51]
. One of the exogeneous enzymes used for 
wound debridement is collagenase which is extracted from Clostridium hystolyticum by 
fermentation. With a few exceptions, different commercial collagenases are all made 
from C. histolyticum, or is recombinant versions where, Escherichia coli expresses a 
gene cloned from C. histolyticum 
[15,78]
. 
 
2.2 Wound-infections 
 
2.2.1 Infection 
If a microorganism either harms or lives at the expense of another organism, it is called 
a parasitic organism and the relationship is termed parasitism. Those organisms are 
capable of causing disease are called pathogens. Infection is the invasion of a host 
organism's bodily tissues by disease-causing organisms, their multiplication, and the 
reaction of host tissues to these organisms and the toxins they produce 
[79]
. 
 
2.2.2 Pathogen 
A pathogen is a biological agent that causes disease or illness to its host. The term is 
most often used for agents that disrupt the normal physiology of a multicellular animal 
or plant. However, pathogens can infect unicellular organisms from all of the biological 
kingdoms. There are several substrates and pathways whereby pathogens can invade a 
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host. The human body contains many natural defenses against some of common 
pathogens in the form of the human immune system and by some "helpful" bacteria 
present in the human body's normal flora. Some pathogens have been found to be 
responsible for massive amounts of casualties and have had numerous effects on 
afflicted groups. Today, while many medical advances have been made to safeguard 
against infection by pathogens, through the use of vaccination, antibiotics and fungicide, 
pathogens continue to threaten human life 
[80]
. 
Pathogens include: 
 Bacteria (example: bacterial meningitis or strep throat) 
 Viruses (example: hepatitis A, hepatitis B, and hepatitis C) 
 Fungi (example: athlete’s foot) 
 
2.2.3 Bacteria 
Bacteria are a category of microorganisms of Prokaryotes. There are many different 
types of bacteria which may be classified according to differences in their shape and 
cell wall. Cocci (spherical shaped cells), bacilli (rods) and sprirochaetes (spirals) can be 
arranged singly; however cocci and bacilli can also be found in pairs, chains and 
irregular clusters. The growth and survival of all bacteria is dependent upon 
environmental factors, for example strict aerobes require oxygen whereas anaerobes are 
rapidly killed by oxygen. It is important to note, however, that both aerobes and 
anaerobes can survive in close proximity to each other and that some can survive in 
both conditions by growing aerobically and then switching to anaerobic metabolism in 
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the absence of oxygen; these are known as facultative anaerobes
 [81]
. 
 
●Types of Bacteria According to Gram Staining 
Since bacterial organisms are so minute, it is impossible to view the organisms 
without compound microscope. In order to visualize the cellular components and to 
differentiate bacteria from other microbial agents, staining techniques are used to 
categorize different bacteria. 
 
Gram staining (or Gram's method) is a method of differentiating bacterial species into 
two large groups (gram-positive and gram-negative). The name comes from its inventor, 
Hans Christian Gram. Gram staining differentiates bacteria by the chemical and 
physical properties of their cell walls by detecting peptidoglycan, which is present in a 
thick layer in gram-positive bacteria
 [82]
.  
 
On the basis of gram staining, bacteria with the thick peptidoglycan layer in the cell 
wall are purple which are classified as gram positive (such as Staphylococcus aureus) 
and bacteria without a thick peptidoglycan layer in cell-wall are red which are classified 
as gram negative (such as Escherichia coli). Species that fail to stain with the Gram 
reaction due to presence of large spores, such as Clostridia, require specialized stains 
[83]
. 
From Figure 2.7 we can observe Gram positive (purple/blue colored cells) and Gram 
negative (pink/red colored cells) bacteria. 
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Figure 2.7. Gram staining primarily detects peptidoglycan, which is present in a thick 
layer in Gram positive bacteria  
http://www.microbiologyinpictures.com/morphology%20of%20bacterial%20cells
.html 
(Gram positive: purple/blue colored cells 
Gram negative: pink/red colored cells) 
 
2.2.4 Staphylococcus aureus  
Staphylococcal aureus bacterium, also called S. aureus is a spherical gram-positive 
bacteria based on their appearance under a microscope, which also means that the cell 
wall of this bacteria consists of a very thick peptidoglycan layer. It is also called 
golden staph. They may occur singly or grouped in pairs, short chains or grape-like 
clusters (Figure 2.8). They are usually facultative anaerobes, that is, they are capable of 
surviving at various levels of oxygenation, and are generally very hardy organisms. 
Staphylococcus aureus belongs to the family Staphylococcaceae 
[84]
. 
 
 
 
 
 
 
 
 
 
 
Figure2.8. Staphylococcus aureus Electron micrograph from  
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http://textbookofbacteriology.net/staph.html 
S. aureus is a common bacterium that frequently colonizes the human skin and is 
present in the nose. In most situations, S. aureus is harmless. It can exist in this 
form without harming its host or causing symptoms. However, if there is a break in 
someone's skin from a wound or surgery, or if there is a suppression of a person's 
immune system, then the colonizing S. aureus can cause a range of mild to severe 
infections, which may lead to death in some cases.  It affects all known 
mammalian species, including humans.  Further due to its ability to affect a wide 
range of species, S. aureus can be readily transmitted from one species to another. 
This includes transmission between humans and animals
 [79]
. 
 
S. aureus can cause: 
● Minor skin infections, such as pimples, impetigo etc. 
● It may cause boils (furuncles), cellulitis folliculitis, carbuncles 
● It is the cause of scalded skin syndrome and abscesses 
● It may lead to lung infections or pneumonia 
● Brain infections or meningitis 
● Bone infections or osteomyelitis 
● Heart infections or endocarditis 
●  Generalized life threatening blood infections or Toxic shock syndrome 
(TSS), bacteremia and septicaemia
 [79]
 
The growth and survival of S. aureus is dependent on a number of environmental 
factors such as the temperature range for growth of S. aureus is 7–48°C, with an 
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optimum of 37°C. It is resistant to freezing and survives well in temperature below 
-20°C, however, the viability is reduced at temperatures of -10 to 0°C; Growth of S. 
aureus occurs over the pH range of 4.0–10.0, with an optimum of 6–7; and it is a 
facultative anaerobe which can grow under both aerobic and anaerobic conditions. 
However, growth occurs at a much slower rate under anaerobic conditions 
[85]
. 
 
Pathology 
S. aureus is the most common cause of staphylococcal infections and is responsible for 
various diseases including: mild skin infections (impetigo, folliculitis, etc.), invasive 
diseases (wound infections, osteomyelitis, bacteremia with metastatic complications, 
etc.), and toxin mediated diseases (food poisoning, toxic shock syndrome or TSS, 
scaled skin syndrome, etc.). Infections are preceded by colonization. Common 
superficial infections include carbuncles, impetigo, cellulitis, folliculitis. 
Community-acquired infections include bacteremia, endocarditis, osteomylitis, 
pneumonia and wound infections are less common. S. aureus also causes economically 
important mastitis in cows, sheep and goats 
[85]
. 
 
As a pathogen, it is important to understand the virulence mechanisms of S. aureus 
especially the Methicillin-resistant (Figure 2.9).  
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Figure 2.9. The pathogenic capacity of a given strain of S.aureus is the 
combined effect of extracellular factors, virulence factors together with 
invasive properties of the strain. “Staphylococcus aureus : Lab Diagnosis and 
Diseases” 
http://medchrome.com/mbbs-exams/staphylococcus-aureus-lab-diagnosis-and-diseases/ 
 
Staphylococci are becoming increasingly resistant to many commonly used antibiotics 
including penicillins, macrolides such as erythromycin, tetracyclines and 
aminoglycosides. Penicillin resistance in S. aureus is due to production of an enzyme 
called beta-lactamase or penicillinase. Methicillin (meticillin) and flucloxacillin are 
lactamase-resistant penicillins so are the antibiotics of choice in most staphylococcal 
skin infections. Unfortunately there is now increasing methicillin resistance (MRSA). 
MRSA infection is caused by a strain of staph bacteria that's become resistant to the 
antibiotics commonly used to treat ordinary staph infections. This strain expressed a 
modified penicillin-binding protein encoded by mecA gene and is present in 4 forms of 
Staph. The MRSA, resistant to the antibiotic methicillin, was eventually isolated. 
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Consequently, vancomycin (the most powerful antibiotic in our arsenal) became the 
primary antibiotic used to combat staphylococcal infection. In 1997 a strain of S. 
aureus resistant to vancomycin was isolated, and people are once again exposed to the 
threat of untreatable staphylococcus infection 
[86]
. 
 
MRSA strains are currently a major pathogen worldwide and a very significant health 
care problem. MRSA infections are associated with increased morbidity and mortality, 
in comparison with other S. aureus infections. Over the past decade, the changing 
pattern of resistance in S. aureus has underscored the need for new antimicrobial 
agents. Increasing population of "super germs" and antibiotic resistant pathogens has 
increased pressure on researchers to find alternative, more effective ways of fighting 
these "super germs" 
[87,88]
. 
 
2.2.5 Escherichia coli  
 
Cell Structure  
E. coli is a Gram-negative rod-shaped bacteria, which possesses adhesive fimbriae and 
a cell wall that consists of an outer membrane containing lipopolysaccharides, a 
periplasmic space with only 1 to 2 layers of peptidoglycan, and an inner cytoplasmic 
membrane. Each bacterium measures approximately 0.5 μm in width by 2 μm in length 
(Figure 2.10). They can be commonly found in animal feces, lower intestines of 
mammals, and even on the edge of hot springs 
[89]
. 
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Some strains are piliated and capable of accepting and transferring plasmid to and from 
other bacteria. Such property enables E. coli under bad/stress conditions to survive. 
Even though it has extremely simple cell structure, with only one chromosomal DNA 
and a plasmid, it can perform complicated metabolism to maintain its cell growth and 
cell division. E. coli is a facultative anaerobe, which means it does not require oxygen, 
but grows better in the presence of oxygen. Optimal growth of E. coli occurs at 37 °C 
but some laboratory strains can multiply at temperatures of up to 49 °C. They prefer to 
live at a higher temperature rather than the cooler temperatures. E. coli is a 
Gram-negative organism that cannot sporulate. Therefore, it is easy to eradicate by 
simple boiling or basic sterilization 
[90]
. 
 
Figure 2.10, Ultrastructure of Gram-negative rod-shaped Esherichia coli cell 
http://ecdc.europa.eu/en/healthtopics/escherichia_coli/basic_facts/pages/basic_f
acts.aspx 
Most E. coli strains are harmless, but some serotypes can cause serious food poisoning 
in their hosts. However, E. coli strains are able to produce a toxin that could cause 
severe infections in many mammals, such as humans, sheep, horses, dogs, etc. The one 
that only found in humans is called enteroaggregative E. coli. Urinary tract infection, 
for example, can be caused by ascending infections of urethra. Such infections can be 
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found in both adult male and female, and some infants can be infected as well. E. coli 
consists of a diverse group of bacteria. Pathogenic E. coli strains are categorized into 
several pathotypes. Six pathotypes are associated with diarrhea and collectively are 
referred to as diarrheagenic E. coli 
[91,92]
.  
 
E. coli O157:H7 is one of the most infective strains that can cause food poisoning. It is 
an enterohemorrhagic strain and can lead to bloody diarrhea and kidney failure when 
one gets infected by contaminated ground beef, unpasteurized milk or contaminated 
water. The toxin that E. coli O157:H7 produces is called Shiga-like toxin which is a 
regulated toxin that catalytically inactivates the 60S ribosomal subunits of most 
eukaryotic cells, blocking mRNA translation and thus causing cell death. Some 
important symptoms are diarrhea that is acute and severe, either bloody or not bloody, 
stomach cramping, vomiting, loss of appetite, abdominal pain, and fever. E. coli 
O157:H7 is also notorious for causing serious and even life-threatening complications 
such as hemolytic-uremic syndrome. The O104:H4 strain is equally virulent. It is the 
strain behind the ongoing and deadly June 2011 E. coli outbreak in Europe 
[93,94]
.  
 
Shiga toxin-producing E. coli (STEC) is a group of pathogenic Escherichia coli strains 
capable of producing Shiga toxins, with the potential to cause severe enteric and 
systemic disease in humans. Transmission of STEC infection mainly occurs through 
contaminated food or water and contact with animals. Person-to-person transmission is 
also possible among close contacts 
[95]
. 
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Some studies revealed Escherichia coli strains are resistant to many of the commonly 
used antibiotics such as ampicillin, and some research showed that 74% of them are 
resistant to two or more antibiotics. E. coli isolates recovered from raw poultry meat 
are highly resistant to antimicrobials and carry antimicrobial resistance genes that 
could be transferred to other microbes in the food chain, even important human 
pathogens. Nowadays, E. coli accounts for 17.3% of clinical infections requiring 
hospitalization and is the second most common source of infections behind 
Staphylococcus aureus (18.8%). Scientists have warned that E. coli, as a frequent 
cause of infection, is becoming resistant to antibiotics and the resistance problem could 
become as big as MRSA 
[96,97]
. 
 
E. coli can cause: 
● Abdominal pain - typically, the first symptom is severe abdominal cramping 
that comes on suddenly. 
● Diarrhea - a few hours after the sudden abdominal pain, the patient typically 
has watery diarrhea. A day later there may be bright red bloody stools, caused 
by sores in the intestines. 
● Nausea 
● Vomiting - note that many patients who become ill may not vomit 
● Fever - note that many infected people may not have a fever 
●  Fatigue - diarrhea causes loss of fluids and electrolytes (dehydration), 
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making the patient feel sick and tired
 [98]
. 
 
2.2.6 Wound infection  
 
Wound infection presents the deposition and multiplication of microorganisms within a 
wound that cause an associated host reaction. When such wounds become infected, 
they are often colonized by multiple bacterial species. The most common pathogens 
are aerobic Gram-positive cocci such as: S. aureus, but complicated infections 
frequently involve Gram-negative bacilli like E. coli and anaerobic bacteria. These 
infections are often further characterized as being acute (present for days to at most a 
few weeks) or chronic (persisting for many weeks to months). Soft-tissue infections 
can be localized or focal (e.g. impetigo, abscess) or diffuse (e.g. cellulitis, fasciitis) 
[84]
. 
 
2.2.7 Antimicrobial Treatment for Wound Infection 
 
Antibiotics 
An antibiotic is an antibacterial agent that either destroys or suppressing the growth or 
reproduction of bacteria. Antibiotics are commonly classified based on their 
mechanism of action, chemical structure, or spectrum of activity 
[99]
. 
 
●Bactericidal  
The antibiotics have activities to target the bacterial cell wall (penicillins and 
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cephalosporins) or the cell membrane (polymyxins), or interfere with essential 
bacterial enzymes (rifamycins, lipiarmycins, quinolones, and sulfonamides) to kill 
bacteria.  
●Bacteriostatic 
The antibiotics have activities to target bacteria protein synthesis (macrolides, 
lincosamides and tetracyclines) to inhibit the growth of a microorganism
 [100,101]
. 
 
Antibacterial agents for the control of acute traumatic and chronic wounds 
[102,103]
 
1. Acute wounds 
Since S. aureus is considered to be the most problematic pathogen associated with 
infected traumatic wounds, flucloxacillin and oxacillin are often the choice of 
treatment. If methicillin-resistant strains are involved, the glycopeptide antibiotics 
vancomycin and teicoplanin are alternatives. 
2. Chronic wounds 
The majority of chronic wounds are characterized by polymicrobial aerobic and 
anaerobic bacteria. The use of broad-spectrum antimicrobial agents is likely to be the 
most successful treatment in the management of clinically infected chronic wounds. 
However, the probability of a successful outcome in chronic wounds may be 
compromised by the presence of ischemic and necrotic tissue which may impair tissue 
distribution and therapeutic efficacy of the drug.  Topical antibiotics are used as 
double antibiotic combinations to provide an appropriate spectrum of activity. 
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Complementary therapy 
Wound bed debridement may assist antibiotic treatment by reducing the microbial load, 
and hence the opportunity for infection, and enabling better penetration of antibiotics 
to where they are needed. 
 
Antiseptics 
Antiseptics are chemical agents that are potentially toxic to both microbial cells and 
host cells. Therefore, their use is limited to topical application to wounds and intact 
skin. Commonly used topical antiseptic agents are iodine-releasing agents, 
chlorine-releasing solutions, hydrogen peroxide, chlorhexidine, silver-releasing agents
 
[104]
. 
 
Alternative antimicrobial therapy: specific importance to this research study 
As the development of bacterial resistance to antibiotics continues, the need for 
identification and development of new antimicrobial agents become increasingly 
critical 
[105]
. In recent years, widespread interest has focused on a class of naturally 
occurring peptides that protect a variety of animals from infection. These peptides are 
found in a variety of cell types and operate by attaching to microbial cells, perforating 
the cell wall, and inducing leakage of cell contents. Such pore-forming antimicrobial 
peptides are widespread throughout nature such as human neutrophils produce 
defensins, magainins have been isolated from the skin of the African clawed frog, and 
cecropins have a similar function in the giant silkworm moth
 [106]
. 
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2.2.8 Antimicrobial peptides (AMP) 
 
Background 
The discovery of antibiotics has definitely been the major achievement in the treatment 
of infectious agents and it is one of the most important medical developments of the 
twentieth century. Up to date, the antibiotics are the common anti-infection drugs 
applied in clinic, but the rising antibiotics resistance making the currently applied 
standard anti-infection drugs losing effectiveness. The rise of resistant pathogens is 
posing increasing difficulties and the increasing severity of infections within hospital 
populations. Resistance to antibiotics is highly prevalent in bacterial isolates 
worldwide, particularly in developing countries as the excessive use of antibiotics 
which result the pathogenic bacteria diversified into resistant to the use of traditional 
antibiotics each year
 [107,108]
. 
 
Although effective new types of antibiotics against multidrug-resistant Gram-positive 
bacteria such as methicillin-resistant S. aureus (MRSA) have been introduced or are in 
clinical trials, the situation regarding new treatment options for infections produced by 
multidrug-resistant Gram-negative pathogens such as Acinetobacter baumannii, 
Pseudomonas aeruginosa, Klebsiella pneumoniae, and Stenotrophomonas maltophilia 
is still less encouraging 
[109,110]
. Due to increasing antibiotic resistance by pathogenic 
bacteria, it has become necessary to develop new antimicrobial molecules as 
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therapeutic agents to overcome this problem. Hence, there is an urgent need to find 
new types of alternative antimicrobial agents with activity against these 
microorganisms to eradicate the antibiotics resistance pathogens 
[111]
. 
 
For the development of next-generation antibiotics, in recent decades, it has been 
found that a new class of antimicrobial agents called antimicrobial peptides (AMPs) 
and proteins also known as “natural antibiotics” which have shown to represent 
promising alternative drugs for overcoming the problems of antibiotic resistance 
[112]
.  
 
AMPs represent a part of non-specific immune response and have been described as 
“evolutionary ancient weapons”. Currently, they have received much more attention 
due to their rapid and broad-spectrum antibiotic effect, and apart from their direct 
bactericidal effect they also have immunomodulatory properties, such as stimulating 
immune cells and enhancing the inflammatory response. These types of peptides 
constitute an important part of the immune defense and most of them act by disrupting 
the bacterial membrane
 [113,114]
.  
 
Diversity of AMPs 
Thousands of AMPs have been discovered and isolated from organisms as diverse as 
plants, insects, amphibians, humans and even bacteria. Since many AMPs exert rapid 
bactericidal activity against a broad range of microbes, and as the probability of 
pathogens acquiring resistance is low, AMPs open new avenues for antibacterial drug 
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development, especially against multidrug-resistant strains. These natural antimicrobial 
peptides or the host defenses peptides are generally positively charged and comprised 
of less than 100 amino acid residues with amphipathic properties. These peptides are 
conserved during evolutionary process in response to their innate immunity and serve 
as a first line of defense system. These peptides have been identified in virtually all 
forms of life from bacteria and animals to plants
 [112,115]
.  
The peptides have been classified into four groups on the basis of their structure
 [116]
: 
(i) α-helical  
(ii) β-sheet 
(iii) α-helical&β-sheet 
(iv) Non-α&β families( AMPs rich in specific amino-acids) 
 
In general, α-helical peptides are amphipathic, often with a bend around the central 
region disrupting an otherwise fairly perfect cylindrical structure. The β-sheet AMPs 
are usually formed by the presence of disulfide bonds with amphipathic patches 
scattered on the surface. The αβ-peptides consist of both α-helical and β-sheet 
structures, whereas non-αβ AMPs are free of α-helical and β-sheet structures, often 
unstructured, and rich in proline, arginine or histidine residues (Figure 2.11). 
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Figure 2.11. Structures of antimicrobial peptides  
http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.100
1067 
 
It has been found that AMPs possess approximately 50% hydrophobic residues and 
exhibit spatially separated hydrophobic and hydrophilic regions with amphipathic 
properties during interaction with biological membranes. In fact, the majority of AMPs 
present similar physicochemical properties with conventional antibiotics, including 
small molecular size and cationic and amphiphilic properties, that seem to be essential 
for activity. Their broad spectrum of action and the low number of observed 
phenomenon of resistance are advantages over conventional antibiotics, although their 
mode of action is not fully understood and not always studied yet 
[117]
. 
 
The mechanism of antibacterial activity of peptides 
Virtually every peptide sequence with a net positive charge and a few hydrophobic 
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residues will have antimicrobial activity. In general, the amphiphilic drugs often have 
targets that are associated with the cytoplasmic membrane, to which they bind and 
laterally diffuse within, until they come in contact with their target molecule. The 
fundamental function of the plasma membrane is to act as a barrier allowing cellular 
organisms to maintain a chemical gradient of ions and solutes, the loss of which 
inevitably leads to death
 [118,119]
. 
 
The cationic and amphiphilic nature of antimicrobial peptides is associated with 
positive charge and amphiphilic activity. The mechanism of antimicrobial activity of 
AMPs is to interact with microbe membranes and disrupt them. Some of the peptides 
may form pores or holes in the membrane, others may change the membrane structure 
by poking into it in many places. But the bottom line is these peptides damage 
membranes and makes them more permeable. When a microbe's membrane is too 
permeable, it will die. One reason is that it can lose important metabolites and ions, 
and molecules from the environment that the microbe would rather keep out can come 
right in. The bactericidal activities of AMPs are dependent on their ability to 
permeabilize membranes by creating pores or disrupting the organization of the lipid 
bilayer. The initial steps of membrane attack are thought to include electrostatic and 
receptor-mediated interactions 
[106-120]
.  
 
It has become increasingly clear that AMPs can also act through mechanisms involving 
interaction with membraneassociated protein targets or by penetration into the bacterial 
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cytoplasmand interacting with intracellular targets to reduce the activities of essential 
cellular processes including the synthesis of protein, DNA, RNA, and components of 
the bacterial cell envelope (Figure 2.12). Relying primarily on the physical 
membrane-lytic mechanisms, the AMPs kill bacteria with a low risk of triggering 
resistance
 [121,122]
. 
 
 
Figure 2.12. The proposed diverse mechanistic modes of action for 
antimicrobial peptides in microbial cells. 
(A) Disruption of cell membrane integrity: (1) random insertion into the 
membrane, (2) alignment of hydrophobic sequences, and (3) removal of 
membrane sections and formation of pores. (B) Inhibition of DNA synthesis. (C) 
Blocking of RNA synthesis. (D) Inhibition of enzymes necessary for linking of 
cell wall structural proteins. (E) Inhibition of ribosomal function and protein 
synthesis. (F) Blocking of chaperone proteins necessary for proper folding of 
proteins. (G) Targeting of mitochondria: (1) inhibition of cellular respiration and 
induction of ROS formation and (2) disruption of mitochondrial cell membrane 
integrity and efflux of ATP and NADH. 
http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.
1001067 
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Immunomodulation  
In addition to these direct antimicrobial effects, AMPs recently have been found to 
interact specifically with several membrane-bound or intracellular receptors with a 
profound ability to modulate the host response by enhancing protective immunity and 
suppressing inflammation
 [123,124]
. 
 
2.2.9 Neutrophils 
 
Neutrophils are the most common type of mature white blood cell and are normally 
exist in the bloodstream. It is the most abundant (40% to 75%) type of white blood 
cells in mammals and forms an essential part of the innate immune system. Neutrophils 
are spherical shape when they unactivated and circulate in the bloodstream. Once 
activated, they change shape and become more amorphous or amoeba-like and can 
extend pseudopods as they hunt for antigens 
[32]
. 
 
Neutrophils deal with defence against bacterial infection and other very small 
inflammatory processes and are usually the first responders of inflammatory cells to 
migrate towards the site of inflammation. They migrate through the blood vessels, then 
through interstitial tissue, following chemical signals such as Interleukin-8 (IL-8), C5a, 
fMLP and Leukotriene B4 in a process called chemotaxis. Neutrophils have an 
impressive range of toxic molecules that contribute to killing bacteria. Neutrophils 
capture and phagocytose bacteria and subsequently internalize them into 
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phagolysosomes, in which microbial killing takes place. The protein constituents of 
phagolysosomes include NADPH oxidase (which generates reactive oxygen species), 
myeloperoxidase, proteases (such as elastase and cathepsin G) and antimicrobial 
proteins (including defensins, azurocidin and actericidal/permeability increasing 
protein) 
[30,125]
. 
 
2.2.10 Azurocidin 
 
2.2.10.1 Biosynthesis and processing 
According to phylogenetics and evolution studies, the azurocidin belongs to sixth class 
of serine proteases containing subfamily of proteinases of the immune defense system. 
This family also includes neutrophil elastase, proteinase 3, cathepsin G, chymase and 
granzymes. A cluster of genes for neutrophil elastase, proteinase 3 and azurocidin is 
located in the terminal region of the short arm of human chromosome 19. The 
neutrophil elastase, proteinase 3 and azurocidin genes are constitutively expressed in a 
cell-specific manner during the promyelocyte stage of neutrophil differentiation and, 
after processing. All these proteins are localized inside granular structures of different 
immune effect or cells and contribute to the destruction of ingested microorganisms 
[126]
. 
 
Azurocidin is synthesized in the early stages of neutrophil maturation process as a 
precursor of 351 amino acids and processed to a glycosylated mature form of 222 
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amino acids, and stored in mature neutrophil azurofilic granules together with a set of 
glycosidases. It bears substantial similarities to serine proteases, especially neutrophil 
elastase (45% homology), but has no enzymatic activity. Azurocidin possesses some 
features that make it unique among the neutrophil granule proteins: It is the only 
neutrophil granule protein stored in two different compartments. As a result of its 
storage in secretory vesicles and primary granules, azurocidin is released at a very 
early stage of neutrophil extravasation as well as at a later stage when the neutrophil 
has reached the site of inflammation, thereby allowing it to target cells in the 
bloodstream, the endothelial lining, and the extravascular environment 
[127]
. 
 
2.2.10.2 Structure of Azurocidin 
Structurally, azurocidin is a member of the serine protease family that includes 
Cathepsin G, Neutrophil Elastase (NE), and Proteinase 3 (PR3). However, as a result 
of mutations in two of the three essential amino acids in the highly conserved catalytic 
triad seen in all serine proteases, azurocidin is devoid of protease activity. It is a single 
polypeptide glycoprotein synthesized as a 251 amino-acid precursor processed by 
removal of 26 amino-acid residues from the N-terminus and three residues from the 
C-terminus. Sequence analysis shows 45% homology to human neutrophil elastase, 42% 
homology to proteinase 3, and 32% homology to cathepsin G from human neutrophils 
[29]
.  
 
Azurocidin is an Azurophil granule antibiotic protein, with monocyte chemotactic and 
antibacterial activity. It possesses antibacterial activity through its binding to 
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Gram-negative bacterial lipid A. As a modulator of endothelial permeability, 
Azurocidin acts as Neutrophils arriving first at sites of inflammation release 
Azurocidin which acts in a paracrine fashion on endothelial cells causing the 
development of intercellular gaps and allowing leukocyte extravasation.  Azurocidin 
thus can be regarded as a reasonable therapeutic target for a variety of inflammatory 
disease conditions
 [128]
. 
 
2.2.10.3 Antimicrobial Activity 
The Azurocidin released extracellularly from neutrophil granules not only exerts 
antimicrobial activity to eliminate bacteria but also modulate immune response to 
direct monocytes and macrophages to the site of infection and activate their 
antimicrobial function
 [129-132]
. 
 
Direct antimicrobial effects 
Azurocidin exerts its antimicrobial activity by directly disrupting the microbial cell 
membrane, based on the combination of cationicity, amphipathicity and 
hydrophobicity appear to be unique to this antimicrobial peptides. The Azurocidin 
demonstrates direct antimicrobial activity through its binding capacity with 
lipopolysaccharide (LPS) and lipid A that was found on the surface of microbial cells, 
disrupting lipid bilayers through a variety of mechanisms and induce leakage of the 
bacterial membrane and to kill microorganisms 
[133-135]
. The capacity of Azurocidin to 
kill bacteria within phagolysosomes may be regulated by the intraphagosomal 
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hydrogen ion concentration. It has been generally appreciated that the intraphagosomal 
hydrogen ion concentration in time extends over a broad range, eventually becoming 
quite acidic. Thus, it would be advantageous to the O2-independent antimicrobial 
petides, such as Azurocidin, capable of bactericidal activity at various intraphagosomal 
hydrogen ion concentrations. Evidence presented shows the existence of Azurocidin 
that functions in vitro over a pH range similar to that of maturing phagolysosomes and 
is most active at or near pH 5.5. This pH is considered to be at or near the final pH of 
the mature phagolysosome. These results suggest that Azurocidin may contribute 
significantly to the capacity of polymorphonuclear granulocytes (PMN) to kill 
intraleukocytic bacteria by nonoxidative pro-cesses as the pH of the maturing 
phagolysosome declines after phagocytosis 
[128,136-138]
. 
 
Modulation of immune response 
Azurocidin has a broad spectrum of antimicrobial activity. In addition, it is also 
recognized as a multifunctional inflammatory mediator for its contracting effects on 
endothelial cells causing an increase of vascular permeability, capacity to bind 
endotoxin and ability to attract monocytes to inflammation sites. Monocytes and 
macrophages are multifunctional cells contributing to bacterial clearance by 
phagocytosis and killing of bacteria. Moreover, ingestion of bacteria by resident or 
newly recruited macrophages is an essential mechanism of host defense. Azurocidin, 
released from PMN secretory vesicles act as chemoattractant and activator for 
monocytes, T-cells, and K-cells and induces longevity and differentiation of monocytes 
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toward a macrophage phenotype.The consequence is enhancement of cytokine release 
and bacterial phagocytosis, allowing for a more efficient bacterial clearance
 [130,139]
. 
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CHAPTER 3 
 
Electromagnetic Radiation: Biological Effects and 
Therapeutic Applications 
 
 
3.1 Electromagnetic radiation  
 
Non-ionizing radiation is the radiation that has enough energy to move atoms in a 
molecule around or cause them to vibrate, but not enough to remove electrons from 
atoms. Sound waves, visible light, and microwaves are referred to as "non-ionizing” 
radiation. Non-ionizing radiation has found many different applications in everyday 
life: 
 Microwave radiation: telecommunication industry, microwave ovens (cooking 
and heating food), medical devices, and food technology. 
 Infrared radiation: infrared lamps, toasters, security etc. 
 Ultraviolet radiation: for microbial sterilization, photo-chemotherapy. 
 Radio waves: broadcasting 
 
Ionizing radiation has more energy than non-ionizing radiation; enough to cause 
chemical changes by breaking chemical bonds. This effect can cause damage to living 
tissue. Shorter wavelength ultraviolet radiation begins to have enough energy to break 
chemical bonds. X-ray and gamma ray radiation, which are at the upper end of 
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electromagnetic spectrum, have very high frequencies (in the range of 100 billion 
billion hertz) and very short wavelengths (1 million millionth of a metre). Radiation in 
this range has extremely high energy. It has enough energy to strip electrons from an 
atom or, in the case of very high-energy radiation, break up the nucleus of the atom. 
The process in which an electron is given enough energy to break away from an atom 
is called ionization. This process results in the formation of two charged particles or 
ions: the molecule with a net positive charge, and the free electron with a negative 
charge. Each ionization releases energy which is absorbed by material surrounding the 
ionized atom. Compared to other types of radiation that may be absorbed, ionizing 
radiation deposits a large amount of energy into a small area. In fact, the energy from 
one interaction with an atom is more than enough to disrupt the chemical bond 
between two carbon atoms. All ionizing radiation is capable, directly or indirectly, of 
removing electrons from most molecules.  
 
The examples of utilizing ionizing radiation in everyday life: 
 
 The main use of X-rays is in medicine (with a X-ray machine as a common 
application) 
 
 Gamma radiation is often used to kill living organisms. Applications of this 
include sterilizing medical equipment, removing decay-causing bacteria from 
many foods or preventing fruit and vegetables from sprouting to maintain 
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freshness and flavor. Gamma rays are also used to treat some types of cancer, 
in the procedure called gamma-knife surgery 
[148]
. 
 
Visible light  
Of particular interest to this PhD project are biological effects of visible light radiation 
on proteins and cells. The visible spectrum is the portion of the electromagnetic 
spectrum that can be detected by human eye. The electromagnetic radiation in this 
range of wavelengths is called visible light (Figure 3.4). A typical human eye can 
respond to wavelengths from about 390 to 700 nm. In terms of frequency, this 
corresponds to a band in the vicinity of 430–790 THz (Table 3.1) [149].  
 
The human eye is not capable of seeing radiation with wavelengths outside the visible 
spectrum. The visible colors from shortest to longest wavelength are: violet, blue, 
green, yellow, orange, and red. Ultraviolet radiation has a shorter wavelength than the 
visible violet light. Infrared radiation has a longer wavelength than visible red light. 
The white light is a mixture of the colors of the visible spectrum. Black is a total 
absence of light 
[150]
. 
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Figure 3.3 Wavelength image from Universe by Freedman and Kaufmann  
 
 
Energy with wavelengths too short for humans to see 
 Light with shorter wavelength than the violet light is called "Ultraviolet" light 
 
Energy with wavelengths too long for humans to see 
 Light with longer wavelength than red light is called "Infrared" light. 
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Table 3.1 Visible light wavelength and corresponding frequency 
[151]
 
 
 
 
 
3.2 Bioelectromagnetism 
 
There has been increasing concern about the harmful effects of exposure to ambient 
electromagnetic fields. However, electromagnetic energy is not a general toxin but a 
specific modality for transferring information to and from biological systems. Thus, 
there is great potential for beneficial use of electromagnetic field in different biological 
and medical applications. 
 
A human body produces its own very complex electrical activity. Wherever there is 
electrical activity, there is also a magnetic field. The natural internal electrical and 
magnetic fields of the body regulate all the body’s processes and interact with one 
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another 
[152]
. Groups of functional cells constitute higher organisms. There are narrow 
fluid channels between cells that take on special importance in signaling from cell to 
cell. These channels act as windows on the electrochemical world surrounding each 
cell. Hormones, antibodies, neurotransmitters and chemical cancer promoters, for 
example, move along them to reach binding sites on cell membrane receptors
 [153]
.  
 
The cell is the smallest unit of living organisms. It is believed that the cell membrane is 
an important site of interaction for electromagnetic fields. There are free ions that can 
move across the cell membrane, such as K
+
, Na
+
, Cl
-
and Ca
2+
, on both sides of every 
cell membrane, but in different concentrations. These ions control the cell volume, 
help the signaling process, and create a strong electric field between both sides of the 
cell membrane. The cell membrane contains ion channel proteins, the opening of 
which can be regulated by the transmembrane voltage, mechanical stress 
(mechanically gated channels gated by ion pressure) of chemical signals. The basic 
mechanism proposed is the forced vibration of all the free ions on the outer surface of a 
cell membrane, caused by an oscillating electric field. It is showed that this vibration of 
electric charge is able to irregularly gate voltage-gated channels in the plasma 
membrane, and thus disrupt the cell’s electrochemical balance and function [154,155]. 
 
Nothing in a living organism is static as there are movements of cells, tissues and 
organs. Thus in living tissue, it is mostly find alternating fields as well as a 
combination of EF and MF. Short-lived electrical events called action potentials occur 
62 
 
in several types of animal cells which are called excitable cells, a category of cell 
include neurons, muscle cells, and endocrine cells, as well as in some plant cells. These 
action potentials are used to facilitate inter-cellular communication and activate 
intracellular processes. The physiological phenomena of action potentials are possible 
because voltage-gated ion channels allow the resting potential caused by 
electrochemical gradient on either side of a cell membrane to resolve 
[156]
.  The EMF 
frequencies in human body are normally in the range of extremely low frequencies 
(ELF). This EMF includes the action potentials of nerves and heart tissue, skeletal 
muscle vibrations and frequencies elicited by rhythmic activities within other body 
tissues. The strength of human body’s magnetic fields in relation to the strength of the 
Earth’s magnetic field is shown in the table (Table 3.2) [152]. It can be seen that using 
the Earth’s magnetic field as a comparison, the body’s natural are incredibly tiny. 
 
Table 3. 2 Strengths of endogenous magnetic fields versus Earth’s field [152] 
Signal 
source 
Femto Tesla Gauss 
Earth’s field 
stronger by 
Skeletal 
Muscle 
~50,000 0.0000005 1 million times 
Heart ~500,000 0.000005 100,000 times 
Physiologic 
“noise” 
50,000-5,000,000 0.0000005-0.00000005 1–10 million times 
Earth’s field 50,000,000,000 0.5  
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3.3 Biological effects of electromagnetic fields 
 
Overview 
During the past two decades, it has become increasingly interesting for the biological 
effects of electromagnetic fields exert a wide range of athermal effects to alternate the 
specific physiological process, when energetic patterns and "biotargets" are properly 
matched. The interaction of electromagnetic fields with biological systems involves 
exposures ranging from continuous waves to short pulses and field magnitudes that 
range from “weak” to “strong” [157].  Electromagnetic waves in the frequency range 
3–300 GHz are often referred to as millimeter waves (MMWs) and are of interest 
because of health and safety concerns or diagnostic and therapeutic use 
[158]
. 
 
Currently, the interaction of EMF with biological systems involves 
[159]
: 
 
1) The passive effect (detection of endogenous magnetic fields) is in use for 
diagnostic purposes. It is possible to get valuable information about the 
functioning of various organs by analysis of the magnetic fields which they emit. 
2) The active effect of EMFs - its use for different therapeutic applications. 
 
The most biological molecules take place in the cells and in organisms are likely made 
of elements from C, O, H, N and S. When biological objects are exposed to EMF, 
changes occur in the energy levels of uncoupled EMF sensitive electrons of molecules, 
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which are in the cells of living organisms that are exposed to EMF. These changes 
affect the ratios of chemical reactions and thus, noticeable different chemical changes 
do occur at different EMF intensities. Since biological molecules are highly 
heterogeneous in structures, when they are exposed to electrical fields, important 
changes occur in their properties. The current that passes through the biological system, 
causes the positively and negatively charged molecules in the environment to drift 
towards opposite directions. In this way, the structural ingredient order of the 
environment changes and there is an increase in the concentration of certain loaded 
ions in different parts of the cell 
[160]
. 
 
3.3.1 Effects of low frequency EMF on cells 
 
1) Membrane changes 
The cell membrane is a biological membrane that separates the interior of all cells from 
the outside environment. The cell membrane is selectively permeable to ions and 
organic molecules and controls the movement of substances in and out of cells. It 
consists of the phospholipid bilayer with embedded proteins (Figure 3.5). Cell 
membranes are involved in a variety of cellular processes such as cell adhesion, ion 
conductivity and cell signaling and serve as the attachment surface for several 
extracellular structures, including the cell wall, glycocalyx, and intracellular 
cytoskeleton
 [161]
. 
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Figure 3.4 Cell membrane detailed diagram
 [162]
 
 
Cell membranes not only keep apart materials that not be allowed to mix, they also act 
as electrical insulators for the natural electric currents upon it. Natural electric currents 
are normally generated by molecular ion pumps in cell membranes. These are proteins 
that use metabolic energy to transport specific ions, usually one or two at a time, from 
one side of the membrane to the other. This, in turn, generates a voltage across the 
membrane (the membrane potential) and a chemical imbalance between the 
concentrations of ions on either side. Their combined effect gives an electrochemical 
gradient, which provides energy for other functions
 [163]
. 
 
The main signs of radiation-induced membrane perturbation are the changes in the 
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organization and/or composition of the glycocalyx, manifested as alterations in the 
amount and/or distribution of the negatively charged membrane components (i.e. sialic 
acid), lectin-, and calcium-binding sites. It is well known that the exposition to ionizing 
radiation is followed by reversible decrease of surface negative charges in several cell 
types 
[164]
. Electromagnetic field expositions (non-ionizing radiation) may also modify 
the amount of cell surface’s negative charges. However, the magnitude of this effect is 
dependent on the type of the field applied. Changes of lectin-binding capacity of cell 
membranes following ionizing and non-ionizing radiation have been observed by many 
authors 
[165-167]
.  
 
When the erythroleukemia series of K 562 cells were exposed to 2.5 mT EMF for 24 to 
72 h, and the cellular surfaces of the control and experiment groups were compared 
afterwards using the electron microscopy, it was observed that cellular surfaces with 
many microvillus and bubble-like structures were created quickly in cells that were 
reproduced in result to direct EMF exposures
 [168]
.
 
 
2) Ionic effects 
It was shown that Ca++ channel blockers, parathyroid hormone, and IGF-II, among 
others are affected by weak time-varying EMF
 [169]
. 
●Calcium 
It was found that low frequency (LF) EMF affects the concentrations of free 
intracellular Ca
2+
 concentrations when 50 Hz, 0.1 mT EMF was applied to Jurkat cells 
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[170]
. In this study, the researchers passed the cells through Helmholtz coil for periods 
between 15 and 200 s. During this exposure, the intracellular Ca
2+
 level increased two 
to four-fold, from its normal values of 50 to 100 nM to the values of 200 to 400 nM. 
Similar studies were carried out on peripheral lymphocytes and the response of the 
intracellular Ca
2+
 concentrations was found to be the same. It was reported that 10% of 
the lymphocytes responded to magnetic field. On the other hand, it was observed that 
85% of the Jurkat cells responded to EMF exposures, with an increase in the 
intracellular Ca
2+
 concentration.
  
 
Changes in calcium flux in lymphocytes exposed to electric and magnetic fields have 
also reported 
[171]
.
 
Experiments with rat thymocytes showed both an inhibition in 
uptake of Ca
2+
 due to magnetic field application, and a stimulation when the cells were 
simultaneously stimulated with a mitogen and an electric field 
[172]
. 
 
●Sodium and potassium 
As reported in study 
[173-175]
, the researchers observed an increase in the Rb
+
 
transportation which is potassium analog. Despite the concentration gradient, there was 
no change in the ATP hydrolysis. In view of this result, it was suggested that Na
+
-K
+
 
ATPase enzyme increases the Rb
+
 transportation by using the energy coming from the 
applied EMF. 
 
3) Nucleic acid and gene expression 
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DNA 
The effects of EMF on DNA replication was also studied and it was determined that 
EMF at a level of 0.1 to 0.4 mT inhibits the DNA synthesis in Jurkat cells
 [176]
. 
In another study, brain cells of the experimental rats were exposed to 0.01 mT of 
magnetic field at 60 Hz for 24 h by using applied electromagnetic field. It was 
observed that 24 h application of EMF increased the DNA single and double strand 
breaks in brain cells compared to that of the control
 [177]
. 
●RNA 
When 50 MHz radio frequency radiation with the low frequency modulation at 16 Hz 
was applied to Jurkat T-lenfoblast and Leydig TM3 cells, it was observed that 16 Hz 
frequency caused a high increase in the RNA synthesis rate of ets1 oncogenes
 [178]
. 
Proteins 
Along with the effects of EMF on RNA transcription, its effect on translation phase 
was also studied. A study 
[179]
 evaluated the changes in the translation level of 
Escherichia coli RNA polymerase enzyme that was irradiated at 72 Hz and magnetic 
flux density of 0.07 to 1.1mT (EMF strength) for different periods between 5 and 60 
min. It was observed that translation rate increased at the magnetic flux density 0.07 
mT. The decrease in the translation rate was also recorded at the high values of EMF 
strength/power. This was attributed to the instability of RNA in in vitro conditions.
 
 
 
Another study 
[180]
 showed that the effects of LF EMF at 50 Hz frequency 30 μT on the 
reproduction behaviors and the protein synthesis of E. coli and Saccharomyces 
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cerevisiae cells were obtained. EMF was generated with the Helmholtz coils and EMF 
parameters (50 Hz and 30 μT). There parameters were specifically selected as human 
beings are exposed to this type of exposures in their daily lives. According to the 
results of the study, the applied LF EMF decreased the total protein amount of the 
bacteria and yeast cells and also reduced the reproduction speed. 
 
In study 
[181]
 the researchers showed that the enzymatic activity of ornithine 
decarboxylase (ODC) enzyme was increased when it was exposed to EMF. It was 
suggested that there is a connection between EMF exposures and cancer risk as it is 
known that this particular enzyme is active especially in fast growing cells and can 
induce a tumor’s growth.  
 
Another enzyme, whose interaction with the applied EMF was also examined, is the 
acetylcholinesterase. When the acetylcholinesterase activity was examined in rat bone 
marrow cells, which were exposed to a strong 1.4 T static magnetic field for 30 min (at 
the temperature of 37 C), a decrease in the enzymatic activities of cells after 2 h of 
exposures was observed. At 27°C, an increase in the enzymatic activity was detected 
after 3.5 h of exposures with the same static magnetic field
 [182]
.
 
 
3.3.2 Effects of ultraviolet (UV) light radiation  
Ultraviolet B (UVB) irradiation has been studied as a source for the initiation of lipid 
peroxidation, and, in fact, a UVB-dependent generation of hydroxyl radicals and lipid 
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peroxides has been demonstrated in human keratinocytes and fibroblast cultures
 [183]
.
 
Ultraviolet (UV) is known to be able to induce the secretion of matrix degrading 
enzymes known as matrix metalloproteinases (MMPs) by various cells including 
keratinocytes, fibroblasts and inflammatory cells, thereby causing excessive 
collagenous connective tissue breakdown, and also known to decrease the level of 
collagen synthesis
 [184,185]
.
  
 
3.3.3 Effects of infrared light radiation  
A study showed that with 808 nm infrared light radiation induced a dose-dependent 
alteration in microglial polarization and resultant microglial induced neurite growth. 
The infrared radiation of photobiomodulation (PBM) has been found to improve 
recovery after tissue damage known to be associated with significant 
neuroinflammation, such as spinal cord injury and traumatic brain injury 
[186]
. 
 
In Vivo near-infrared mediated tumor destruction by photothermal effect of carbon 
nanotubes has been reported that near-infrared of photothermal effect of carbon 
nanotubes  may potentially serve as an effective photothermal agent and pave the way 
to future cancer therapeutics
 [187]
. 
 
It has been investigated that photobiomodulation effects of 1072 nm infrared light on 
the natural immune response involved in anti-bacterial and wound healing processes. It 
concluded that 1072 nm infrared light had a photobiomodulation effect which resulted 
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in an enhanced biological immune response to the bacterial infection by 
Methicillin-resistant Staphylococcus aureus (MRSA) and also increased the expression 
of Vascular endothelial growth factor (VEGF) to a significant level
 [188]
. 
 
Clinical studies have demonstrated beneficial outcomes for low-level laser therapy 
(LLLT) using near-infrared (NIR) wavelengths.  The result showed that Low-level 
exposure to 980 nm near-infrared laser light can accelerate wound healing in vitro 
without measurable temperature increases. However, these results also demonstrate the 
need for appropriate supervision of laser therapy sessions to prevent overexposure to 
NIR laser light that may inhibit cell growth rates observed in response to lower 
intensity laser exposure
 [189]
. 
 
3.3.4 Effects of visible light radiation  
Visible light irradiation of biological systems can be considered in terms of the 
wavelength, intensity and exposure duration. In the natural environment, light intensity 
fluctuates and, when in excess, can cause cellular damage. Photosynthetic organisms 
developed different mechanisms to cope with this fluctuation and to protect themselves 
from the effects of high UV and visible light, including the regulation of enzymatic 
activity
 [190,191]
.
 
 
Light has medical applications in two general categories: high intensity and low 
intensity light. Each category has therapeutic applications that are very different in 
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their concepts and applications. High intensity light therapy usually uses a different 
type of laser beam as its source of light. Due to its concentrated form of light, it is a 
very powerful and precise tool. These types of lasers are used to remove small tumors 
as a surgery tool, to apply heat to tumors to shrink them or as diagnostics tool in cancer. 
For instance, one application of laser in cancer therapy is known as laser therapy. This 
method utilizes high intensity laser light to shrink or destroy tumors due to the high 
energy transferred into and absorbed by a tumor. The major benefit of laser therapy is 
the fact that it causes less bleeding and damage to surrounding tissues
 [192,193]
. 
 
Low intensity light (laser or LED) therapy is widely believed as a benign treatment 
modality. Even though this method is not considered to impose any severe side effects, 
it is still at its early experimental stages 
[194,195]
. To firmly confirm that low intensity 
light exposure does not induce substantial side-effects, a number of research studies are 
being dedicated to this cause. For instance, 
[196]
 thoroughly investigates any possible 
DNA or protein damage in B14 cells after low intensity laser irradiation of near 
infrared range (810nm). This paper could not establish any cytotoxic or genotoxic 
effect as result of the exposures. The authors also showed that low level light 
exposures do not lead to direct damage in DNA. 
 
Several recent studies concluded that biological signaling processes correspond to 
electrical properties of radiation such as frequency (Hz), intensity of exposure or 
exposure power (mW), duration (s), and amplitude modulations 
[197-199]
. Effectiveness 
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of this treatment approach highly depends on their proposed energy transferred 
(measured by duration and intensity of exposure) and the wavelength of light 
irradiation. Any changes in these two crucial variables (energy transferred and 
wavelength) mitigate the therapeutic effect predicted by different research study. For 
instance, in 
[200–202]
, the authors found that the optimum therapeutic effect for 
bio-modulation is observed at the wavelengths between 630nm and 640nm. Any 
variation to the wavelengths or total transferred energy other than their specifically 
predicted parameters reverses the effect or results in a negative outcome 
[203,204]
. 
 
Studies have shown that low intensity (less than 100 mW/cm2 range) laser or light 
therapy is confirmed to have positive effect in pain reduction 
[205,206]
, promotion of 
wound healing
 [207]
, tissue growth and post-surgical healing
 [208]
. 
 
In wound healing applications, the investigations demonstrated that fibroblast activity 
could be regulated using light at low fluence/intensity. Using a variety of LED light 
sources with varying fluence and other parameters, pro-collagen synthesis could be 
up-regulated in human skin fibroblast culture. This was also found to correlate with the 
significant clinical changes in human skin
 [209,210]
.
 
 
The stimulatory effects of low energy lasers irradiation on cell activation have been 
demonstrated in vitro in a variety of cell lines. It was found that low level lasers 
stimulates the release of transforming growth factor (TGF) and platelet-derived growth 
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factor (PDGF) from cultured fibroblasts
 [211]
.
  
It’s reported a 50% faster healing of 
wounds treated with a LED array with 3 wavelengths combined into a single unit (670 
nm, 720 nm, 880 nm)
 [212]
. 
 
3.3.5 Effects of electromagnetic radiation on bacteria and cell growth 
A experimental study of Staphylococcus aureus both in Mueller-Hinton broth (MHB) 
and on Mueller-Hinton agar (MHA) exposed to (1) a low-frequency magnetic field 
(MF) 20 Hz, 5 mT; (2) a low-frequency MF combined with an additional alternating 
electric field (MF þ EF) 20 Hz, 5 mT, 470 mV/cm; (3) a sinusoidal alternating electric 
field (EF AC) 20 Hz, 470 mV/cm; and (4) a direct current electric field (EF DC) 588 
mV/cm, the results showed that No significant difference between samples and 
controls was detected on MHA. However, in MHB each of the four fields applied 
showed a significant growth reduction of planktonically grown Staphylococcus aureus 
in the presence of gentamicin between 32% and 91% within 24 h of the experiment. 
The best results were obtained by a direct current EF, decreasing colony-forming units 
(CFU)/ml more than 91%
 [213]
. 
 
Several in vitro studies have shown that high-energetic extracorporeal shock waves had 
a bactericidal effect on planktonic micro-organisms, such as Staphylococcus aureus, 
Streptococcus epidermidis, Pseudomonas aeruginosa and the MRSA 27065 strain
 
[214,215]
. 
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Effects on the treatment of muscle and articular injuries have been reported with the 
use of radiofrequency radiation. Radiofrequency has been used for aesthetic purposes 
and some authors have suggested a thermal action in deep tissues, promoting collagen 
denaturalisation and neocollagenogenesis
 [216].  
 
Electromagnetic radiation energy without breaking molecular bonds can cause the 
molecular dipoles to vibrate, inducing mechanical resonance of system. Bacterial 
effects of extremely high frequency EMR might be explained by EMR effects on 
charged particles containing structures and molecular chains
 [217]
.  
 
Studies investigating the effects of magnetic fields on microorganisms showed that the 
growth could be inhibited depending on the field strength (power/intensity) and 
frequency. Some studies observed a decrease in colony forming units of Escherichia 
coli, Leclercia adecarboxylata and Staphylococcus aureus at 50 Hz, 0.5 mT LF EMF 
[218]
. Strasak et al.
 [219]
 applied 5 – 21 mT ELF EMF to E. coli for 0 – 24 h and observed 
a decrease in bacteria cultures viability. A decrease in growth rate of E. coli subjected 
to 50 Hz, 2 mT for 6 h and static magnetic fields were also shown to be able to inhibit 
growth of bacteria
 [220]
.  
 
3.3.6 Effects of visible light radiation on bacteria and cells growth 
Sunlight is known to play an important role in determining the microbial quality of 
waste stabilization ponds (WSP) effluents and is a key factor affecting the fate of 
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pathogens in polluted waters 
[221]
.
 
Sunlight damage to inactive bacteria in pond systems 
has been described by previous researchers as involving three mechanisms 
[222]
:  
 
- direct damage by UVB wavelengths (280-320 nm) to DNA,  
- indirect endogenous damage caused mainly by UVB wavelengths, and  
- indirect exogenous damage involving UVB, UVA (320-400 nm) and visible 
wavelengths of up to 550 nm.
  
 
The use of light for environmental and food surface decontamination has generated 
much interest over many years. Ultraviolet (UV) light applications, although not 
largely utilized, have been demonstrated for decontamination of equipment in bakeries, 
and cheese and meat plants. However, despite the efficacy of this technology, due to 
the safety issues associated with UV light, its ability to degrade plastics and its limited 
transmissibility through various materials, overall applications have been limited 
[223]
.  
 
Visible light radiation, however, has provided a more recent alternative, specifically 
the visible light wavelength of 405 nm, which has displayed extensive bactericidal 
properties without the detrimental effects associated with UV light. The inactivation 
mechanism of 405 nm light is accredited to the excitation of intracellular 
photosensitive porphyrin molecules, which results in the production of reactive oxygen 
species, inducing oxidative damage and consequently cell death
 [224]
.  
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A recent study 
[225]
 showed that both P. gingivalis and F. nucleatum bacteria are more 
susceptible in vitro to violet/blue light radiation (wavelengths 400–495 nm) than the 
streptococci bacterium.
  
Although not as bactericidal as UV light, short-wave visible 
light in the blue wavelength range has been demonstrated to induce bactericidal effects 
in exposed bacteria, and has a number of potential advantages including improved 
safety due to the lower photon energy, and reduced photodegradation of materials
 
[226,227]
. 
 
3.3.7 Therapeutic applications of electromagnetic radiation 
Electromagnetic radiation has been successfully used in various therapeutic 
applications. For example, pulsed electromagnetic field (PEMF) therapy has been used 
successfully in the management of postsurgical pain and edema, the treatment of 
chronic wounds, and in facilitating vasodilatation and angiogenesis
 [228]
. Low-intensity 
ultrasound has been used to speed normal fracture healing and manage delayed unions
 
[229]
.
  
 
In another study, the possibility of low intensity PEMFs to kill breast cancer cells were 
investigated 
[230]
. It appears that PEMF-based anticancer strategies may represent a 
new therapeutic approach to treat breast cancer without affecting normal tissues in a 
manner that is non-invasive and can be potentially combined with the existing 
anti-cancer treatments.
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The effects of low level laser phototherapy (visible light) on hand and forearm 
fractures were investigated, and the results showed that the phototherapy is effective 
for human bone healing and pain relief
 [231]
. 
 
A study of the effects of light emitting diode (LED) phototherapy on bone defects 
grafted with MTA, bone morphogenetic proteins and guided bone regeneration was 
showed that infrared LED light irradiation improves the deposition of CHA in healing 
bone grafted
 [232]
. 
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CHAPTER 4  
 
METHODOLOGY 
 
 
4.1 Resonant Recognition Model (RRM) 
 
The Resonant Recognition Model (RRM) was employed in this project to: 
 design a bioactive peptide that can emulate the biological activity of a native 
anti-microbial protein Azurocidin; 
 determine an activation frequency/wavelength of the visible light radiation that 
can modulate the biological activity of Collagenase enzyme that plays a key role 
in would healing process. 
 
In Chapter 4 the concepts of the RRM approach and its particular applications are 
presented in details. 
 
4.1.1 Proteins, DNA and RRM 
Proteins are “the work horses” of biological systems at the cellular level. They are 
responsible for various biological activities including enzymatic analysis, transport and 
storage, immune protection, intracellular communication and many other tasks.  
Proteins are large, complex biological molecules, consisting of one or more long chains 
of amino acid residues that play many critical roles in our body. The primary structure 
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of a protein is made up of hundreds or thousands of smaller units called amino acids, 
which are attached to one another in long chains. It refers to the linear sequence of 
amino acids in the polypeptide chain. There are 20 different types of amino acids that 
can be combined to make a protein. The sequence of amino acids is unique to each 
protein, and defines the structure and function of the protein. Thus, proteins differ from 
one another primarily in their sequence of amino acids, which usually results in folding 
of the protein into a specific three dimensional structure that determines its activity. 
Proteins perform a vast array of functions within living organisms, including catalyzing 
metabolic reactions, replicating DNA, responding to stimuli, and transporting molecules 
from one location to another. Like other biological macromolecules such as 
polysaccharides and nucleic acids, proteins are essential parts of organisms and 
participate in virtually every process within cells. 
 
The protein’s molecular structures are connected with its biological functions. Its 
structure and function is determined by its linear information contained in the amino 
acid sequence. The more understanding the structure of proteins, the more benefit we 
will have to aid in identification of the proteins interactions and function. It used to be 
that the structure of proteins could only be determined using X-ray crystallography, 
fluorescence spectroscopy and NMR spectroscopy. Now, through bioinformatics tools, 
there are computer programs that can predict and model the structure of proteins. As 
mentioned above, the information contained in the amino acid sequence determines the 
protein's chemical properties, chain conformation, protein’s function and its specificity.  
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Although both function and structure of a large number of proteins are becoming known 
throughout projects like Human Genome Project and are available through a number of 
data bases 
[233]
, the crucial problem of understanding how the biological function is 
"written" within the protein sequence still remains 
[234]
. Once this understanding has 
been gained it should be possible to design peptides and even proteins de novo with the 
chosen biological function and thus to produce new and more efficient drugs and other 
biotechnological products 
[234-237]
. 
 
With the rapid accumulation of databases of proteins’ primary structures, there is an 
urgent need for theoretical approaches that are capable of analysing protein 
structure/function relationships. As described in the previous section, many attempts 
have been developed to predict the tertiary structure and biological function of protein 
from its sequence but only with limited success. These approaches have inherent 
limitations, i.e. they do not provide sufficient knowledge about the physical process for 
proteins folding and interacting. They also lack the informational, structural and 
physicochemical parameters crucial to the selectivity of protein interactions, which can 
be used for de novo design of peptide or protein analogous with the desired biological 
activity. 
 
The physico-mathematical approach, applied in this project, is called the Resonant 
Recognition Model (RRM) 
[236,237]
.  The RRM, developed by I. Cosic 
[236]
, is based on 
the representation of the protein primary structure as a numerical series by assigning to 
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each amino acid a physical parameter value relevant to the protein’s biological activity. 
A number of amino acid indices have been found to correlate in some way with the 
biological activity of the whole protein 
[238]
. Previous investigations 
[237,238,241]
 have 
shown that the best correlation can be achieved with parameters, which are related to 
the energy of delocalised electrons of each amino acid.  These findings can be 
explained by the fact that the electrons delocalised from the particular amino acid have 
the strongest impact on the electronic distribution of the whole protein.  In previous 
studies 
[239]
, the energy of delocalised electrons (calculated as the electron-ion 
interaction pseudopotential, EIIP) of each amino acid residue was employed in the 
RRM approach. The resulting numerical series then represented the distribution of the 
free electrons’ energies along the protein. This numerical series was then converted 
into a discrete Fourier spectrum, which carried the same information content about the 
arrangement of amino acids in the sequence as the original numerical sequence 
[242,243]
. 
 
4.1.2 Definition of Common Frequency Characteristics 
The RRM is a physicomathematical model. It interprets the protein's sequence linear 
information using signal analysis methods. It comprises two stages.  The first 
involves the transformation of the amino acid sequence into a numerical sequence. 
Each amino acid is represented by the value of the electron-ion interaction potential 
(EIIP) 
[239]
, which describes the average energy states of all valence electrons in 
particular amino acid. The EIIP values for each amino acid were calculated using the 
pseudopotentials general model
 [239,241]
: 
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                     
              k + q w k  =  0.25 Z sin ( 1.04Z)/(2 )               (4.1) 
where q is a change of momentum k of the delocalised electron in the interaction with 
potential w , while 
                    Z =  Zi  N                        (4.2) 
where Zi is the number of valence electrons of the i -th component of each amino acid 
and N  is the total number of atoms in the amino acid.  The EIIP values for 20 amino 
acids, as well as for five nucleotides (the whole procedure can be applied to the DNA 
and RNA), are shown in Table 4.1.  A unique number can thus represent each amino 
acid or nucleotide, irrespective of its position in a sequence. Numerical series obtained 
in this way are then analyzed by digital signal analysis methods in order to extract 
information pertinent to the biological function.  The original numerical sequence is 
transformed to the frequency domain using the discrete Fourier transform (DFT). As 
the average distance between amino acid residues in a polypeptide chain is about 3.8 Å, 
it can be assumed that the points in the numerical sequence derived are equidistant 
[236]
.  
For further numerical analysis, the distance between points in these numerical 
sequences is set at an arbitrary value d=1.  Then, the maximum frequency in the 
spectrum is F=1/2 d=0.5.  The total number of points in the sequence influences the 
resolution of the spectrum only.  Thus, for N-point sequence the resolution in the 
spectrum is equal to 1/N.  The n-th point in the spectral function corresponds to the 
frequency f = n/N
 [235,236]
. In order to extract common spectral characteristics of 
sequences having the same or similar biological function, the following cross-spectral 
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function was used: 
                       Sn = XnYn*       n = 1,2,...,N/2             (4.3) 
where Xn are the DFT coefficients of the series x(m) and Yn*  are complex conjugate 
DFT coefficients of the series y(m).  Peak frequencies in the amplitude cross-spectral 
function define common frequency components of the two sequences analyzed 
[235,236]
.  
The whole procedure: protein sequence  numerical series  amplitude spectra 
 cross-spectra is shown in Fig. 4.1a. Fig 4.1b presents: (i) sequences of  and  
human hemoglobins; (ii) graphical representation of the corresponding numerical 
sequences obtained by replacing every amino acid with its EIIP value; (iii) spectra of 
both  and  human hemoglobins; (iv) cross-spectral function of the spectra presented 
in (iii).  The prominent peaks denote common frequency components.  The abscissa 
represents RRM frequencies, and the ordinate is the normalized intensity. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1a The Resonant Recognition Model (RRM) procedure 
  
RRM
Protein sequence 1 protein sequence 2
 (EIIP)  (EIIP)
numerical sequence numerical sequence
 
Fourier spectrum Fourier spectrum
 
cross-spectrum

peaks in the cross-spectrum denote common
frequency components
 
85 
 
 
 
Figure 4.1b Graphical presentation of the RRM procedure
 [6]
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Nucleotide Nucleotide EIIP 
A A 0.1260 
G G 0.8606 
T T 0.1335 
C C 0.1340 
Amino Acid Amino Acid EIIP 
Leu L 0.0000 
Ile I 0.0000 
Asn N 0.0036 
Gly G 0.0050 
Val V 0.0057 
Glu E 0.0058 
Pro P 0.0198 
His H 0.0242 
Lys K 0.0371 
Ala A 0.0373 
Tyr Y 0.0516 
Trp W 0.0548 
Gln Q 0.0761 
Met M 0.0823 
Ser S 0.0829 
Cys C 0.0829 
Thr T 0.0941 
Phe F 0.0946 
Arg R 0.0959 
Asp D 0.1263 
   
 
Table 4.1 The Electron-Ion Interaction Potential (EIIP) Values for Nucleotides and 
Amino Acids [6] 
 
To determine the common frequency components for a group of protein sequences, the 
absolute values of multiple cross-spectral function coefficients M have been calculated 
as follows: 
             Mn = X1n X2n ...XMn     n = 1, 2,....,N/2        (4.4) 
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Peak frequencies in such a multiple cross-spectral function denote common frequency 
components for all sequences analyzed.  Signal-to-noise ratio (S/N) for each peak is 
defined as a measure of similarity between sequences analyzed 
[235,236]
.  S/N is 
calculated as the ratio between signal intensity at the particular peak frequency and the 
mean value over the whole spectrum.   
 
The extensive experience gained from previous research suggests that an S/N ratio of 
at least 20 
[234,240]
 can be considered significant.  The multiple cross-spectral function 
for a large group of sequences with the same biological function has been named 
“consensus spectrum”. The presence of a peak frequency with a significant S/N ratio in 
a consensus spectrum implies that all of the analyzed sequences within the group have 
one frequency component in common 
[235,236]
.  This frequency is related to the 
biological function provided the following RRM criteria are met: 
 
A: One peak only exists for a group of protein sequences sharing the same 
biological function 
B: No significant peak exists for biologically unrelated protein sequences 
C: Peak frequencies are different for different biological functions. 
 
In previous studies, the above criteria have been tested with over 1000 proteins from 
25 functional groups
 [234-236,240]
.  The regulatory DNA sequences were analyzed in the 
same way.  The following fundamental conclusion was drawn from these studies: 
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each specific biological function of protein or regulatory DNA sequence is 
characterised by a single frequency (Figure 4.2). 
 
Figure 4.2. presents multiple cross-spectral functions of six different functional groups 
of proteins. Each specific biological function of protein sequence is characterized by a 
single frequency. The abscissa represents RRM frequencies, and the ordinate is the 
normalized intensity. 
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The RRM also provides a method to identify the individual amino acids that contribute 
mostly to a protein’s specific biological function.  Since the characteristic frequency 
correlates with the biological function, the positions of the amino acids that are most 
affected by the change of amplitude at the frequencies and consequently to the 
corresponding biological function.  The inverse Fourier transform is used in this 
determining process.  This “hot spots” identification method has been applied already 
to a number of examples.  The previous studies with interleukin 2, SV40 enhancer, 
Ha-ras p21 oncogene product, glucagons, Cytochrome C, haemoglobins, myoglobins 
and lysozymes all have documented evidence that such predicted amino acids are 
found to be spatially clustered in the protein tertiary structure and to be positioned in 
and around the protein active site in some of those examples 
[234-236]
. 
 
4.1.3 Signal-Noise Ratio Normalization 
The frequency characteristic for an observed biological function is defined as the 
prominent peak frequency in the multiple cross-spectral function of the family of 
proteins having this function in common.  This prominent peak denotes a common 
frequency component for all the protein sequences analyzed. Any common frequency 
component can be considered as a characteristic of the observed function providing 
certain criteria are satisfied 
[236]
. To quantify those criteria it is important initially to 
define the index, which will be a measure of the level of commonality for any 
frequency component in the cross-spectral function. However, this definition of S/N is 
sensitive to the protein signal length and the number of sequences that computed in the 
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multiple cross-spectral function. Thus, it is not quite suitable for the development of 
the general criteria for a variety of protein families.  There was a need to define S/N 
as a general comparable index that could be consistent and universally applied to the 
system under examination.  This normalized S/N index has to be independent of the 
sequence length and the number of sequences analyzed.  This index should measure 
the confidence of determining the characteristic frequency of a biological function.  
After an empirical and statistical testing, a new normalized S/N ratio (NSN) has been 
introduced to avoid the problem discussed above 
[237]
.   
 
All these results show, the RRM represents a whole new view to protein activity, in 
particular protein-protein and protein-DNA interactions. The underlying hypothesis of 
this model is that certain periodicities in the distribution of energy of delocalised 
electrons along the protein molecule are critical parameters for protein biological 
function.  This model allows extract the linear information contained in amino acid 
sequence and also provides a physical explanation of macromolecule’s interaction 
processes. With a characteristic frequency identified by the RRM, it is possible then to 
design peptides of different length having desired periodicities in their distribution of 
energies of delocalised electrons along their sequence 
[235,236]
. Thus, the RRM can 
identify signals that characterize protein biological functions. Applications of the RRM 
are mostly in the area of biotechnology, drug design and pharmacology. The particular 
RRM applications will be explored in the following sections. 
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4.1.4 Interaction of electromagnetic fields with molecules and cells: RRM 
activation frequency 
 
Experimental investigations of the action of electromagnetic field (EMF) at the 
molecular level have shown mainly resonance effects, and these are in a very wide 
frequency range - from low to super-high. In recent years other new mechanisms of 
resonance absorption of EMF in biological media have been discovered 
[244,245]
. For 
instance, conformational vibrations of protein molecules consist of the formation of 
folds, twisting or compression of protein polypeptide chains. Conformational 
vibrations of protein molecule lead to the displacement of electric charges on their 
surface and thus, EMF of the particular frequency can interact with these vibrations 
[244,245]
. This mechanism might underlie the resonance absorption effects due to the 
action of audio frequency EMF on protein solutions. Another type of the resonance 
absorption is in the radiofrequency (RF) spectrum, the so-called “piezoelectric 
resonance”, was observed in some biopolymers. It was hypothesised that piezoelectric 
resonance is attributed to the interaction of an elastic wave produced by the EMF with 
defects and non-homogeneities on the surface and in the interior of the substance 
[244,245]
. Thus, if the effects observed in biopolymers are piezoelectric in nature then 
biological structures must contain regions consisting of many macromolecules with the 
piezoelectric properties. 
 
In general, the studies of interactions of EMF with biological media have been 
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separated by frequency – where some research concerns with extremely low frequency 
(ELF) effects and others with RF exposures. Much of the research on the effects of 
weak EMF on organisms was concentrated on possible interactions with cell 
membranes
 [153,246-250]
. It was proposed that cell membranes could act as non-linear 
resonators strongly amplified signals within a narrow range of frequencies. Interactions 
between EMF and bio-systems have been intensively studies for over a century and a 
quantitative understanding of many interaction mechanisms exists: effects arise from 
nerve excitations, electronically induced forces, the dielectric breakdown of cell 
membranes and other processes that directly involve electric fields 
[153,246-250]
.  
 
Each biological process involves a number of interactions between proteins and their 
targets (other proteins, DNA regulatory segments or small molecules). Each of these 
processes involves an energy transfer between the interacting molecules. These 
interactions are highly selective, and this selectivity is defined within the protein 
primary structure. However, the physical nature of these interactions is not yet well 
understood. The most acceptable existing model, the so-called key-and-lock model that 
incorporates a selectivity of interactions, is based on a spatial complementarity 
between the interacting molecules. With knowledge of more 3-D structures of proteins 
and their complexes with ligands it can be observed that the spatial complementarity is 
not selective enough to be considered as a sole parameter able to describe the nature of 
protein interactions occurred in living systems. 
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On the other hand, there is much evidence that biological processes can be induced or 
modulated by induction of light of particular characteristic frequencies 
[251-253]
. This is 
caused directly by the light-induced changes of energy states of macromolecules and in 
particular of proteins. The function of some proteins is directly connected with the 
absorption of visible light of defined wavelengths as in the case of rhodopsins. The 
strong light absorption is due to the presence of a colour prosthetic group bound to the 
protein, while the frequency selectivity of this absorption is defined by the amino acid 
sequence of the protein per se. In addition, there is evidence that light of a defined 
frequency can induce or enhance some biological processes, which are normally 
controlled by proteins only (i.e. cell growth and proliferation 
[253,254]
). 
 
All these frequency selective effects of light on biological processes of protein 
activation imply that protein activation involves energies of the same order and nature 
as the electromagnetic irradiation of light. Protein interactions can be considered as 
resonant energy transfer between the interacting molecules. This energy can be 
transferred through oscillations of a physical field, possibly electromagnetic in nature 
[234,255]
. Since there is evidence that proteins have certain conducting or 
semi-conducting properties, a charge, moving through the protein backbone and 
passing different energy stages caused by different amino acid side groups, can 
produce sufficient conditions for a specific electromagnetic radiation or absorption. 
The frequency range of this field depends on a charge velocity estimated to be 7.87 x 
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This estimated range includes IR, visible and UV light. These computational 
predictions were confirmed by comparison of:  
 
a) Absorption characteristics of light absorbing proteins and their characteristic 
frequencies,  
b) Frequency selective light effects on cell growth and characteristic frequencies of 
growth factors
 [253,255]
. 
 
All these results lead to the conclusion that the specificity of protein interactions is 
based on the resonant electromagnetic energy transfer at the frequency specific for 
each interaction observed. Taking into account all these and other possible resonant 
effects taking place in the human body and different other leaving systems, it becomes 
possible for such effects of low-intensity EM radiation to occur if the energy goes 
through the resonant path 
[234,240,256]
. Given the existence of these resonant effects, we 
consider here the possible interactions of the weak EM radiation and its influence on 
living systems. 
 
To grasp the meaning of the RRM characteristic frequency it is important, at first, to 
understand what is meant by the biological function of proteins. As was pointed out 
above, each biological process is driven by proteins that selectively interact with other 
proteins, DNA regulatory segment or small molecules. These interactive processes that 
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involve energy transfer between the interacting molecules are highly selective. How is 
this selectivity achieved? In the RRM it is postulated that the selectivity is defined 
within the amino acid sequence. It has been shown that proteins and their targets share 
the same characteristic frequency 
[234,240,256]
 but of opposite phase 
[257-260]
 for each pair 
of interacting macromolecules. Thus, we conceptualise that RRM characteristic 
frequencies represent proteins general functions as well as a mutual recognition 
between a particular protein and its target (receptor, ligand, etc). As this recognition 
arises from the matching of periodicities within the distribution of energies of free 
electrons along the interacting proteins, it can be regarded as the resonant recognition. 
The RRM model assumes that characteristic frequencies are responsible for the 
resonant recognition between macromolecules at a distance. Thus, these frequencies 
have to represent oscillations of some physical field which can propagate through 
water dipoles. One possibility is that this field is electromagnetic in nature
 [234,240,256]
. 
 
There is evidence that proteins and DNA have certain conducting properties 
[263-265]
. If 
so, then charges would be moving through the backbone of the macromolecule and 
passing through different energy stages caused by the different side groups of various 
amino acids or nucleotides. This process provides sufficient conditions for the 
emission of electromagnetic waves. Their frequency range depends on the charge 
velocity, which in turn depends on the nature of charge movement (superconductive, 
conductive, soliton transfer, etc.) and on the energy of the field that causes charge 
transfer. The nature of this physical process is still unknown; however, some models of 
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charge transfer through the backbone of macromolecules have been accepted 
[266-268]
. 
To simplify the calculations we assumed the electron transfer is attributed to the 
difference of the free Electron Ion Interaction Potentials (EIIP) at the N and C 
terminals of the protein molecule. According to the theory of pseudo-potentials
 [262]
 this 
potential difference is: 
 (COOH) (NH2)  0.13 W W W Ry    
This energy difference allows for a maximum velocity of the electrons of: 
meWV 2max   
where e is the electron charge, and m is electron mass. Therefore 
57.87 10 m secV    
As an inherent assumption is that amino acids in the protein sequence are equidistant 
at: 3.8 Ad   
Then, the maximum frequency that could be emitted during the electron transfer is 
dVF 2max  ; or 
15
max 10  HzF  ; while the corresponding wavelength is 
min 330 nmL  . 
 
The minimum frequency that could be emitted depends on the total length of the 
protein NFF /2 maxmin  , where N is the total number of amino acids in the protein.  
For example with proteins of 200 amino acids in length, the minimum frequency is 
13
min 10  HzF   and the corresponding wavelength is max 30 000 nmL  . 
The range from 30,000nm to 300nm is very wide, starting from the very low infrared 
through the visible to the ultraviolet regions 
[234,240]
. 
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To prove the possibility that macromolecular interactions are based on the resonant 
energy transfer between interacting molecules, we compared our computational 
predictions with the number of published experimental results. This assumption has 
been studied in a number of examples that include:  
• Laser light growth promotion of cells using the particular frequencies of light and 
producing the similar effect as it would be with the presence of growth factor proteins 
[253-255]
. 
• Chymotrypsin activation which was achieved by radiation of the laser light of 
850-860nm only
 [269,270]
. 
• Activation of highly homologous plant photoreceptors which although being very 
homologous absorb different wavelengths of light 
[251,261]
. 
• Proteins activated by light (eg rhodopsins, flavodoxins etc.) These proteins absorb 
light through the prosthetic group but frequency selectivity of this absorption and 
consequent activation is defined by the protein sequence 
[271,272]
. 
 
All these results lead to the conclusion that specificity of protein interactions is based 
on resonant electromagnetic energy transfer at the frequency specific for each observed 
interaction. The numerical frequencies obtained similarly by the RRM for various 
other groups of visible light-absorbing proteins are compared with their corresponding 
characteristic absorption frequencies in Table 4.2 and this linear correlation is shown 
in Figure 4.1.3. A result of considerable significance is that the scaling factor between 
these two sets of data is almost constant about the value of 200K   [234,240]. Thus, a 
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strong linear correlation would seem to exist between the numerical characteristic 
frequencies defined by the RRM and the experimentally determined frequencies 
corresponding to the electromagnetic radiation absorption of such proteins. From this 
correlation it can be observed that the full range of wavelengths, which can be related 
to RRM characteristic frequencies, is over 400 nm. 
 
 
 
 
 
 
 
 
 
 
 
Table 4.2 The RRM frequencies and characteristic absorption frequencies of different 
visible light-absorbing protein groups and their scaling factor, K
 [234,240]
 
protein nm rrm cm-1 K
cyt c 415 0.473 24096.39 196
blue 430 0.475 23255.81 204
green 540 0.355 18518.52 191
red 570 0.346 17543.86 197
hem. 14770 0.02 677.0481 295
purple 860 0.281 11627.91 241
flavodoxin 470 0.379 21276.6 178
igf 400 0.492 25000 196
fgf 441.6 0.453 22644.93 200
insulin 552 0.344 18115.94 189
growth f. 633 0.293 15797.79 185
650 0.293 15384.62 190
pdgf 830 0.242 12048.19 200
chymotr. 851 0.236 11750.88 200
calculative 400 0.5 25000 200
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Figure 4.3. Linear correlation between RRM frequencies and corresponding 
absorption frequencies of different visible light-absorbing protein groups 
[234,240]
 
 
This finding is in complete accord with the frequency range previously associated to 
the RRM spectra and calculated from the charge velocities through the protein 
backbone. It can be now inferred from both correlations that approximate 
wavelengths in real frequency space can be calculated from the RRM characteristic 
frequencies for each biologically related group of sequences. Furthermore, these 
calculations can be used to predict the wavelength of visible and near-infrared 
irradiation which may produce a biological effect
 [234,240]
. As described above, the 
selectivity achieved within the intermolecular protein interactions is still not 
completely understood. 
 
There are some indications that these interactions involve a certain resonant energy 
transfer but the physics and frequency range of this transfer is not yet identified. In a 
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recent work, oscillations of OH groups found on proteins and water molecules were 
proposed as an interaction medium for the transfer of vibrational energy from one 
protein to another
 [22,244,245]
. However, in the case of vibrations in the condensed 
phase, resonant energy transfer is limited with the time scale of vibrational 
relaxation 
[22,244,245]
. On the other hand, electronic excitations as the basis of transfer 
between macromolecules are more rapid. Thus, the vibrational energy transfer is an 
unlikely mechanism for the resonant energy transfer between the interacting 
macro-molecules proteins, RNA or DNA
 [245]
.  
 
In the RRM, it was hypothesized that the transfer between the interacting molecules 
presents an electromagnetic resonant energy rather than vibrational transfer. This 
possibility is based on the following findings within the RRM model 
[234,240]
:  
 
• The RRM frequencies are characteristic periodicities in the free electron energies 
along the protein or DNA molecule. 
• There is a possibility of the resonant energy transfer between proteins and their 
DNA and protein targets, which could be relevant for protein functional specificity.  
• This energy could be electromagnetic in nature. The frequency range is proposed 
to be from infra-red up to ultra-violet (10
13
 to 10
15
. 
• This energy transfer should be resonant as the frequencies in its spectrum are 
critical for biological function (selectivity of macromolecular interactions). 
• To further investigate the proposed resonant energy transfer between 
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macromolecules it is necessary to investigate the following aspects: 
• Time scale of the proposed interaction 
• Influence of water as a medium for electromagnetic radiation 
• Chemical energy supplied to the activated molecule and its sufficiency to produce 
proposed EM radiation. 
 
Time scale of the proposed interaction could be roughly estimated by taking into 
account the proposed velocity of charge along the protein backbone and the linear 
length of the protein. For an average protein of 200 amino acids the length of the 
backbone would be about 800Å. The velocity of the charge is estimated to be of the 
order of value of 10
6
 m/s which gives an estimated time for the reaction to be of the 
order of value of 10
-13
s.  For shorter proteins this time would be shorter (order of 
2x10
-14
s for proteins of 20 amino acids) and for longer proteins would be longer (up 
to 4x10
-13
s for proteins of 1000 amino acids). This time scale is of an order of value 
shorter than the proposed time needed for vibrational resonant energy transfer 
through the water dipoles
 [234,240,266-268]
. The vibrational relaxation time scale is of the 
order of a few picoseconds (10
-12 
s) 
[266-268]
 while the time scale proposed for 
resonant energy transfer through electromagnetic coupling is proposed here to be of 
the order of value of 10
-13
 s. Although the speed of selective recognition between 
large linear macromolecules is not experimentally measured, there is some 
indication that this process, which precedes the chemical bonding, is quite quick and 
could be in the proposed time scale 
[234,240]
. 
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All these protein interactions occur in an aqueous environment and thus, it is 
important to investigate the water absorption characteristics for the particular 
frequencies relevant to a particular biological function. This is based on the 
assumption that photons constitute the carrier of energy from one protein to another. 
The depth of water required to absorb 50% of the radiation was then calculated for 
each of the different RRM frequencies that correspond to proteins of different 
biological function. The 50% point was chosen as it notionally marks the point 
where the probability of the emitted photon is more likely to have been absorbed by 
water than by another protein. Assuming that the RRM mechanism expresses its 
energy interchange in terms of infra-red photons, the absorption properties of water 
should not impede the RRM mechanism for most proteins at distances that are 
biologically significant. However, a group of proteins have been identified where 
the IR absorption properties of water may play a role, limiting the impost of 
biological order by this proposed mechanism to distances less than 10m. [266-268]. In 
addition, the percentage of EM absorption in the water of 1m thickness, chosen at a 
reasonably far distance to encompass any biomolecular interaction, is presented in 
Table 2. It can be observed that the majority of biological functions (except 
Cytochrome C) are performed at frequencies which do not have high absorbances in 
water. Thus, it could be concluded that water does not represent a big obstacle for 
EM radiation in the proposed range to be transferred from one to the other 
interacting molecule
 [266-268]
. Further investigation was aimed to find out the 
energetics of the proposed mechanism. The energy contained in a single photon at 
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the RRM frequency was calculated using the relationship. Then the number of 
photons required to produce 2*ATP was calculated. Assuming that <50% absorption 
of the quanta by water in the boundaries calculated above, this would leave greater 
than 1*ATP worth of energy for a target protein for the resonance mechanism to 
proceed. It is assumed, that this energy is sufficient to activate the protein to perform 
its function
 [234,240]
. 
 
4.1.5. Applications of the RRM 
Once the characteristic frequency for a particular protein function/interaction is 
identified, it is possible then to utilize the RRM to predict the amino acids in the 
sequence predominantly contributed to this frequency and consequently to the 
observed function. Also it becomes possible to predict protein active sites using the 
CWT and design peptide analogous having only the desired periodicities and thus, 
the desired bioactivity 
[257-261]
.  
 
The RRM can be used to predict: 
1. "Hot spots" in terms of the RRM and 3-D protein structures 
2. Protein active and/or binding site(s) using the Continuous Wavelet 
Transform (CWT) 
3. Activation frequency for modulation of protein activity by applied 
electromagnetic radiation 
4. Design bioactive peptides 
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Of particular importance to this PhD project the RRM applications 3) and 4).  
 
The conducted previous studies revealed that biological activity of L-Lactate 
Dehydrogenase (LDH) enzyme can be modulated by the exposures of visible light 
radiation in the range of 550-850 nm and infrared light in the range of 1140 - 1200 
nm that was predicted computationally by the RRM approach
 [20-22]
. 
 
In other recent studies the RRM was employed to determine the 
frequency/wavelength of the applied electromagnetic radiation (far infrared light 
radiation in a range of 3500-6400nm) that can affect biological activity of oncogene 
proteins. The experimental evaluation conducted on different cancer and normal 
cells showed that the predicted wavelengths of far infrared light induce cytotoxic 
effects on studied cancer cells and produce no effect on normal cells 
[273,274]
.  
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4.2 Bioactive peptide design  
 
Small molecular weight peptides have been recently applied in developing cancer 
therapeutics, mostly for their ability to easily penetrate cellular membranes and to 
interfere with enzymatic functions or protein-protein interactions within cells
 [275]
. In 
the development of such therapies the focus is on small peptides with strong 
tumoricidal activity and low toxicity. This therapy aims at obtaining high therapeutic 
indices on cancer cells and to minimize undesirable side effects on normal cells 
[276]
. It 
is generally recognized that the relationship between the structure and biological 
function of a protein and its ability to bind to a specific ligand, can be enunciated in 
terms of a multistage process which involves specific biorecognition, chemical binding 
and energy transfer. The Resonant Recognition Model (RRM) 
[234,240]
 is one attempt to 
identify the selectivity of protein interactions within an amino acid sequence. 
 
The RRM represents a new view to protein activity, in particular protein-protein and 
protein-DNA interactions. The underlying hypothesis of this model is based on the 
finding that there is a significant correlation between spectra of the numerical 
presentation of amino acids and their biological activity. It has been found through 
extensive research that proteins with the same biological function have a common 
frequency in their numerical spectra. This frequency was found then to be a 
characteristic feature for protein biological function and interaction.  
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It is possible to determine the RRM characteristic frequency from analysis of the 
power spectra of proteins. In addition, from the analysis of their phase spectra we can 
identify the corresponding phase for a particular frequency. On the basis of determined 
RRM characteristic frequencies and phases for a particular group of protein sequences, 
we can design amino acid sequences (short peptides) having those specific 
characteristics related to a protein’s biological function. It is expected that the designed 
peptide will exhibit the desired biological activity.  
 
The strategy for design of such defined peptides is presented below: 
1. The RRM characteristic frequency is determined from the multiple cross-spectral 
function for a group of protein sequences that share a common biological function 
(interaction). 
2. The phases are calculated for the characteristic frequency or frequencies of a 
particular protein, which is selected as a parent for an agonist/antagonist.   
3. The minimal length of the designed peptide is defined by the appropriate 
frequency resolution. An Inverse Fourier Transformation (IFT) is used to calculate a 
numerical sequence of different lengths, which exhibits the same prominent 
characteristic frequency as a parent protein.   
4. To determine the amino acids that correspond to each element of the new 
numerical sequence defined above, the tabulated Electron Ion Interaction Potential 
(EIIP) parameter values are used. The resulting new amino acid sequence represents 
the anticipated designed peptide 
[234,241]
. 
107 
 
In previous studies the RRM approach was applied to structure-function analysis of 
basic fibroblast growth factor (bFGF) 
[277]
. Property-pattern characteristics for 
biological activity and receptor recognition for a group of FGF-related proteins were 
defined and then used to aid the design of a set of peptides which can act as bFGF 
antagonists. Molecular modelling techniques were then employed to identify the 
peptide within this set with the greatest conformational similarity to the putative 
receptor domain of bFGF. The 16 mer peptide, which exhibits no sequence homology 
to bFGF, antagonised the stimulatory effect of bFGF on fibroblast thymidine 
incorporation and cell proliferation, but exerted no effect itself in these in vitro 
bioassays
 [277]
.   
 
The RRM was also successfully applied for the analysis of HIV envelope proteins. The 
interaction between HIV virus envelope proteins and CD4 cell surface antigen has a 
central role in the process of virus entry into the host cell. Thus, blocking the 
interaction between the envelope glycoproteins and CD4 surface antigen, known to be 
the HIV receptor, should inhibit infection 
[278]
. For this purpose, six peptides, each of 
20 amino acids in length, were designed using the RRM methodology. To validate the 
RRM computational predictions, the activities of the designed peptides were evaluated 
experimentally. These investigations were performed initially by evaluating the 
reactivity and cross-reactivity of all designed peptides with their corresponding 
antibodies 
[278]
. The results obtained showed significant cross-reactivity to the 
polyclonal antibodies raised against peptides that share at least one characteristic 
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frequency and phase at this frequency. The results provided an experimental 
confirmation of the concept that RRM frequency characteristics present important 
parameters associated with bio-molecular recognition and in particular, the 
antibody-antigen recognition. 
 
More recently, the RRM analysis was used to find the characteristic frequency and the 
“hot spot” amino acids of Protoporphyrinogen oxidase (PpOI) proteins, and predicted 
the location of the proteins’ active site(s) [279]. In another study, the RRM 
computational approach was applied to the analysis of oncogene and proto-oncogene 
proteins. The results obtained showed that the RRM is capable of identifying the 
differences between the oncogenic and proto-oncogenic proteins with the possibility of 
identifying the "cancer-causing" features within their protein primary structure. In 
addition, the rational design of bioactive peptide analogues displaying oncogenic or 
proto-oncogenic-like activity
 [242]
.  
 
The RRM approach was also employed for structure-function analysis of anti-tumor 
cytokine, interleukin-12 (IL-12) and the design of a short therapeutic IL-12 analogue 
peptide having interleukin-like activity, with toxic anti-tumor effect which was 
experimentally validated on B16F0 mouse melanoma cell culture. The experimental 
results clearly indicated that the tested de-novo designed peptide analogue produced a 
toxic effect on the B16F0 melanoma mouse cancer cells. Importantly, it was found that 
its anti-tumor activity is dose and time dependent 
[237]
.  
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In the study 
[280]
 the authors applied the RRM approach to the structure-function 
analysis of selected myxoma virus (MV) proteins aiming to design a single short linear 
bioactive peptide that mimics MV protein activity. MV is a rabbit-specific poxvirus 
pathogen of the Leporipoxvirus genus. It was shown previously that MV is capable of 
targeting and destroying tumors, while causing no significant disease or collateral 
tissue infection in an immunocompetent host.  
 
The de novo designed peptide RRM-MV was assessed for its biological effects in 
mammalian tumor and normal cell lines. The efficacy of RRM-MV peptide as a 
candidate for cancer therapy was experimentally validated in vitro on tumor and on 
normal cell lines/primary cultures. The cellular cytotoxicity of this bioactive peptide on 
cancer and normal cell lines was qualitatively confirmed by the fluorescent 
apoptosis/necrosis assay with CLSM, in addition to the quantitative evaluation of 
cellular cytotoxicity by LDH assay, and cellular viability by the Prestoblue reagent. 
Cellular viability of peptide treated cancer cells was compared to cellular viability of 
peptide treated normal cells. The cytotoxic effects of the bioactive peptide RRM-MV 
by LDH assay were obvious and significant on the mouse melanoma cells (B16F0) and 
on the human squamous cell carcinoma (COLO 16), when compared with the effect of 
the negative control RRM-C on these cell lines and with the non-treated cultures 
incubated under similar conditions. Normal cell lines were not significantly affected by 
the RRM-MV treatment which resulted in negligible damage to normal skin cells, to 
macrophages and to CHO cells, revealing that this bioactive peptide analogue 
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(RRM-MV) has a selective cytotoxic effect on cancer cells only.  
 
In this PhD project, the RRM approach was employed to design a short bioactive 
peptide that can emulate the biological activity of the native anti-microbial protein 
Azurocidin. The computational design of the peptide analogue and experimental 
evaluation of its anti-microbial properties are presented in the Chapter 5.  
 
  
111 
 
4.3 Model systems under investigation 
 
As was presented earlier, this PhD study aims at developing a novel methodology for 
wound healing promotion via: 
(1) Experimental evaluation of visible light exposures on biological activity of 
Collagenase enzyme which plays a significant role in wound repair process; and  
(2) Experimental evaluation of anti-microbial properties of the synthetic 
computationally designed Azurocidin peptide analogue on selected Gram-positive and 
Gram-negative bacteria. Hence, it is important to describe the selected model systems 
in great details. 
 
Collagenase enzyme 
 
Collagenase is a highly specific proteinase and is the only enzyme that can specifically 
cleave the triple helix of the fibrillar collagens. It is described in 2.1.11 in this thesis. 
There is considerable rational for using Collagenase in wounds for the purpose of 
enhancing or accelerating reepithelization. Clinical trials of collagenase reported rapid 
cleansing and enhanced removal of necrotic debris. In this study, a computationally 
determined specific frequency of electromagnetic radiation is experimentally assessed 
in order to confirm that we can modulate collagenase enzymatic activity using EMR 
with a specific frequency, and thus to promote a wound healing process. 
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Azurocidin anti-microbial protein 
 
Azurocidin is an Azurophil granule antibiotic protein, with monocyte chemotactic and 
antibacterial activity. It is described in 2.2.10 in this thesis. Azurocidin exerts its 
antimicrobial activity by directly disrupting the microbial cell membrane, based on the 
combination of cationicity, amphipathicity and hydrophobicity appear to be unique to 
this antimicrobial peptides. Wound infection is one of the key factors addressed in 
wound healing. In this study, a computationally designed synthetic Azurocidin peptide 
analogue is assessed experimentally in order to find a new antimicrobial reagent which 
can exhibit an antimicrobial activity and thus, promote wound healing process. 
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4.4 Materials and Methods 
 
In this section, various materials and instruments utilized for 
characterization/evaluation of Collagenase enzymatic activity upon exposures to 
visible light radiation; and investigation of anti-microbial activity of synthetic 
Azurocidin peptide analogue are described. The experimental parameters for each 
technique are presented below. Please note, the specific experimental assays and 
procedures are presented in Chapter 5 (Results and Discussion). 
 
4.4.1 Visible light irradiation of Collagenase enzyme 
 
●Collagen Type I 
Collagen Type I was purchased from Sigma-Aldrich Australia, Prod. No. C-9879. 
Chemical Formula: C2H5NOC5H9NOC5H10NO2 
●Collagenase 
Collagenase was purchased from Sigma- Aldrich Australia and used as received. 
 
 
Figure 4.4. Mechanism of collagenolysis. 
www.worthington-biochem.com/cls/default.html 
 
114 
 
Collagenase is a protease with specificity for the X-Gly bond in the sequence 
Pro-X-Gly-Pro, where X is most frequently a neutral amino acid. Such sequences are 
often found in collagen, but only rarely in other proteins. Collagenases split collagen in 
its native triple-helical conformation at a specific site yielding fragments, TC A and 
TC B, representing 3/4 and 1/4 lengths of the tropocollagen molecule. 
http://www.advancedbiomatrix.com/wp-content/uploads/2012/03/DFU_Collagenase_5
030.pdf 
 
●Equipment 
In this study, as a source of visible light radiation a Monochromators SPEX 270M 
(Princeton Instruments, Trenton, NJ, USA) 1200 g/mm grating, focal length 270 mm, 
resolution 0.1 nm at 500 nm, dispersion 3.1 nm/mm, lamp Olympus 68v5A TP1 (35W), 
range 400 – 890 nm, RS232 connection with HP 34001A, controlled by LabView 6.1 
(National Instruments) was employed. 
 
A monochromator is an optical device that transmits a mechanically selectable narrow 
band of wavelengths of light or other radiation chosen from a wider range of 
wavelengths available at the input. Monochromators are used in many optical 
measuring instruments and in other applications where tunable monochromatic light is 
wanted. Sometimes the monochromatic light is directed at a sample and the reflected 
or transmitted light is measured. Sometimes white light is directed at a sample and the 
monochromator is used to analyze the reflected or transmitted light.  
The monochromator works by reflection of the wavelengths that obey Bragg's Law for 
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the particular d spacings of the monochromator. For a silicon crystal (which is cubic 
with a unit cell size equal to 5.4309 Å), the largest d spacing is 3.136 Å. Application of 
the Bragg equation (λ = 2 d sin θ) shows that for Cu Kα1, the diffraction condition will 
be satisfied for 2θ = 28.442°, while for Cu Kα2, it will be satisfied for 2θ = 28.514°, 
giving a difference in Bragg angle of only 0.072°. Hence only monochromator crystals 
with a narrow band pass, e.g. silicon, will be able to separate the K
α
1 and K
α
2 
wavelengths from a laboratory copper X-ray source. By contrast, pyrolytic graphite 
monochromators with their wide band pass will pass both K
α
 wavelengths, but not K
β 
  
for which the Bragg angle is considerably different. 
http://pd.chem.ucl.ac.uk/pdnn/inst1/monoc.htm 
In this study, the optical apparatus required to produce the monochromatic light 
suitable for irradiation is shown in Figure 4.5. The distance from the slit and an 
experimental sample was 50 mm. During the measurements, all other light’s sources in 
the laboratory were switched off. 
Figure 4.5. Laboratorial equipment. Source of light is a tungsten lamp beam directed to 
Monochromator SPEX 270. Beam was collimated and focused by lens (f=50 mm)
 [281] 
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In this study, to measure the changes in enzyme kinetics upon visible light exposures, a 
spectrophotometer (Ocean Optics, USA) was employed. A spectrophotometer is a 
photometer that can measure intensity as a function of the light source wavelength. 
Important features of spectrophotometers are spectral bandwidth and linear range of 
absorption or reflectance measurement. 
 
For measurement of absorbance of the analysed Collagenase enzyme solutions, we 
used Ocean Optics USB2000 spectrometer. The Spectrometer USB2000 has following 
characteristic: CCD detector with 2048 pixels; USB-2 connection with Pentium IV 
(Windows XP); controlled with OOIBase32 software. The software was set to 
automatically monitor and save the absorption coefficient at 570nm every 10sec. This 
spectrometer was connected with the light source USB-ISS-UV/VIS (Ocean Optics, 
Inc. FL, USA) of range 190nm-870nm (Figure 4.6). 
Figure 4.6. Typical setup of a Spectrometer with the light source and USB 
connections. A demonstration of a cuvette with experimental solution showing the 
absorption site and the location of cuvette placement for measuring absorption 
coefficients is also shown. 
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Absorption spectrophotometer measures the absorption of light by a sample as a 
function of wavelength. Sometimes the result is expressed as percent transmission and 
sometimes it is expressed as the inverse logarithm of the transmission. The 
Beer–Lambert law relates the absorption of light to the concentration of the 
light-absorbing material, the optical path length, and an intrinsic property of the 
material called molar absorptivity. According to this relation, the decrease in intensity 
is exponential in concentration and path length. The decrease is linear in these 
quantities when the inverse logarithm of transmission is used. The old nomenclature 
for this value was optical density (OD), current nomenclature is absorbance units (AU). 
One AU is a tenfold reduction in light intensity. Six AU is a millionfold reduction. 
 
4.4.2 Evaluation of anti-microbial activity of synthetic Azurocidin peptide 
analogue 
 
●Bacterial strains 
In this study, Gram-positive bacterial strains used for experimentation were 
Staphylococcus aureus ATCC 25923, and S. aureus344 (ampicillin resistant strain). 
We have also used Gram-negative bacterium E. coli ATCC 25922. The bacterial 
isolates were obtained from the Microbiology Laboratory, Department of 
Biotechnology & Environmental Biology, School of Applied Sciences, RMIT 
University. 
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●Reagents 
Mueller-Hinton Agar (MHA) and Mueller-Hinton Broth (MHB) were purchased from 
ThermoFisherScientific, Australia.  
The de novo designed bioactive Azu-RRM and control Azc-RRM peptides were 
commercially synthesized to 95% purity by GL Biochem, China. 
●Equipment 
Biophotometer 
Use of a spectrophotometer for measurement of the optical density of a bacterial 
culture at 600 nm (OD600) and monitoring bacterial growth has always been a central 
technique applied in microbiology. Three common applications where bacterial OD600 
is used are as follows:  
(a) Determination and standardization of the optimal time to induce a culture during 
bacterial protein expression protocols,  
(b) Determination and standardization of the inoculum concentration for minimum 
inhibitory concentration (MIC) experiments, and  
(c) Determination of the optimal time at which to harvest and prepare competent cells. 
In this study, measurement of initial bacterial cell density is important for monitoring 
the experiment and evaluating the anti-microbial activity of the synthetic Aza-RRM 
peptide.  
To determinate the initial bacterial inoculum concentration, the optical density (OD600) 
of bacterial suspensions in broth cultures was measured by Eppendorf Biophotometer 
(Figure 4.7) (Eppendorf, USA). 
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Figure 4.7. Eppendorf Biophotometer  
http://scientiis.com/laboratorium/catalog/popup_image.php?pID=14677&osCsid=47b7
467c0338da8b1132d6f0529e5ad6 
 
McFarland standards 
McFarland standards are used as a reference to adjust the turbidity of bacterial 
suspensions, so that a number of bacteria will be within a given range to standardize 
microbial testing. 
 
 
Table 4.3 McFarland Nephelometer Standards at wavelength of 600nm 
http://site.iugaza.edu.ps/yabdelal/files/05.14.01.pdf 
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Micro-plate spectrophotometer 
Multi-welled microtitre plates provide a convenient means of handling ‘large block’ 
multifactorial experiments with microbial cultures. Microplate Readers have been 
designed to detect microbial growth in each well, by transmitted light measurements. 
They are widely used in research, drug discovery, bioassay validation, quality control 
and manufacturing processes in the pharmaceutical and biotechnological industry and 
academic organizations. The most common microplate format used in academic 
research laboratories or clinical diagnostic laboratories is 96-well (8 by 12 matrix) with 
a typical reaction volume between 100 and 200 µL per well. Optional microcomputer 
control is employed to facilitate scanning of plates and data handling. 
 
Cell suspensions are turbid: they absorb or scatter some of the light letting the rest of it 
pass through. The higher the cell concentration is, the higher the turbidity. 
Spectrophotometers are electrical appliances that can measure intensity of light very 
accurately. The culture is placed in a transparent cuvette, the cuvette is placed in the 
machine, and the optical density can be measured immediately.  
 
Multiskan Ascent Reader 
To quantify studying the growth of gram-negative and gram-positive bacteria in the 
96-well plate, the microplate reader Thermo Multiskan Ascent Reader (Figure 4.8) 
from Thermo Electron Co. was used. The Multiskan Ascent Reader was connected 
with Dell Computer (Running Ascent Software). The software was set to automatically 
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monitor and save the absorption coefficient at wavelength of 600nm. 
 
 
Figure 4.8. Multiskan Ascent 96/384 Plate Reader 
http://www.labx.com/v2/adsearch/detail3.cfm?adnumb=513997#.U7YKOKiSxjY 
 
Viable cell counts 
The plate counting is used to estimate a number of cells present based on their ability 
to give rise to colonies under specific conditions of nutrient medium, temperature and 
time. In microbiology, colony-forming unit (CFU) is used to determine the number of 
viable bacterial cells in a sample per ml. Viable bacterial cell is defined as the ability 
of a cell to multiply via binary fission under the controlled conditions. In contrast, in a 
microscopic evaluation, all cells, dead and living are counted. In CFU 
analysis/assessment, the results are reported as CFU/mL (colony-forming units per 
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milliliter) for liquids. 
 
In general, the initial concentration of bacteria is too great, and the colonies will grow 
into each other and the plate will be uncountable. To insure a countable plate, a series 
of dilutions should be performed for CFU assessment. Procedure of a series of 
dilutions is shown in Figure 4.9. 
 
 
 
Figure 4.9. Calculation: Number of colonies on plate x reciprocal of dilution of 
sample = number of bacteria/ml 
 
http://classes.midlandstech.com/carterp/Courses/bio225/chap06/Microbial%20Grow
th%20ss5.htm 
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CHAPTER 5  
 
Results and Discussion 
As presented in earlier Chapters, this PhD project aims at developing an 
evidence-based methodology for wound healing promotion and thus, is focused in two 
directions:  
 
Study 5.1 - Evaluation of light radiation at the molecular and cellular levels for 
improvement of wound repair process  
5.1.1 - Visible light irradiation of Collagenase enzyme  
5.1.2 – Visible light irradiation of selected Gram-positive and Gram-negative 
bacteria 
5.1.3 – Infrared light irradiation of selected Gram-positive and Gram-negative 
bacteria 
 
Study 5.2 - Evaluation of anti-microbial properties of a novel de novo designed 
synthetic peptide on selected Gram-positive and Gram-negative bacteria. 
 
Both Study 5.1 and Study 5.2 include the computational and experimental components. 
The results of the conducted studies are presented in Chapter 5 in great details.  
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Study 5.1 - Evaluation of light radiation at the molecular and 
cellular levels for improvement of wound repair process 
 
5.1.1 - Visible light irradiation of Collagenase enzyme  
5.1.1.1 Overview  
Debridement is the process of removing necrotic burden or contaminated tissue from a 
wound bed until surrounding healthy tissue is exposed. Enzymatic debridement helps 
to remove non-viable tissue which can otherwise delay wound healing and lead to 
infection
 [36]
. Collagenase enzyme is known to be able to promote cellular responses to 
injury and wound healing in vivo. Collagenase shows more selectively on denatured 
collagen in devitalized tissue. This selectivity is beneficial as it keeps the vital tissue 
and growth factors crucial to wound healing intact. There are studies showing that 
applied electromagnetic radiation (EMR) in the visible light range can modulate 
protein and cellular activity. By increasing Collagenase activity via light irradiation, a 
wound repair process can be enhanced. 
 
Study 1.1 presents an experimental evaluation of the effects of applied visible light 
exposures on enzymatic activity of Collagenase. The RRM approach was employed for 
the computational analysis of 28 Collagenase primary sequences; and the activation 
frequency/wavelength range was determined to be within 450–460 nm. To evaluate the 
effects of light exposure in this range, the Collagenase enzyme solutions were 
irradiated by monochromatic light of 400 to 500 nm. The obtained results reveal that 
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Collagenase activity can be modulated at the particular wavelengths of 450nm, 456nm, 
and 460nm, which are within the activation wavelength range defined 
computationally. 
 
5.1.1.2 Introduction and problem definition 
Debridement is an essential treatment process used in wound bed preparation as part of 
wound healing procedure. Since devitalized tissue can obstruct healing of a wound, 
debridement offers a comprehensive approach to removing barriers to healing and 
creating a wound environment for healing promotion and thus, reducing risk of local 
infection 
[36]
. There are a number of methods currently used for debridement of wounds. 
These include surgical, chemical, enzymatic, mechanical and biological techniques 
[13,283]
. Although enzymatic debridement is a time consuming process, it is still a 
primary technique for wound debridement in certain cases when the surgery or 
conservative sharp wound debridement are not feasible due to bleeding disorders or 
other complication 
[13]
. Of particular interest to this study are the enzymatic 
debridement method and the possibility of accelerating/promoting this process aiming 
at its enhanced clinical practice in wound management. 
 
There is evidence that applied EMR in the visible light range can modulate protein and 
cellular activity 
[284,285]
. Reported studies show that endochondral bone formation can 
be regulated by exogenously applied biophysical stimuli that include EMR. Some 
studies revealed that exposures to pulsed electromagnetic fields (PEMF) enhance 
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chondrogenic differentiation and the synthesis of cartilage extracellular matrix proteins. 
Studies focused on investigating the effects of visible light on cell proliferation and 
their metabolisms were reported 
[286]
.  
 
In 
[21,282]
, it was shown show that activity of L-Lactate Dehydrogenase enzyme can be 
affected by external light of particular wavelengths, computed by the Resonant 
Recognition Model
 [21,282]
. The RRM theory states that an external EMR at a particular 
frequency would produce resonant effects on protein biological activity 
[240,282]
. The 
resonant absorption and resonant interactions have been proposed as an explanation for 
the marked sensitivity of living systems to EMR 
[245]
. Each biological process involves 
a number of interactions between proteins and their targets, which are based on energy 
transfer between the interacting molecules. The RRM is designed for analysis of 
protein (DNA) interactions and their interaction with EMR 
[21,240,282]
. Collagenase 
enzyme was irradiated here by visible light in the wavelength range of 400-500 nm 
defined computationally by the RRM.  
 
5.1.1.3. Materials and Methods 
The RRM is a physico-mathematical approach based on digital signal processing 
[240]
. 
The RRM concepts are presented in details in Chapter 4.  
The application of the RRM involves two stages of calculation. The first is the 
transformation of the amino acid sequence into a numerical sequence. Each amino acid 
is represented by its Electron-Ion Interaction Potential (EIIP) value which describes the 
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average energy states of all valence electrons in a given amino acid 
[240]
. A unique 
number can thus represent each amino acid or nucleotide, irrespective of its position in 
a sequence. Then the numerical series obtained are analyzed by digital signal analysis 
methods, Fourier and Wavelet transforms, in order to extract information pertinent to 
the biological function. A multiple cross-spectral function is defined and calculated to 
obtain the common frequency components from the spectra of a group of proteins. 
Peak frequencies in such a multiple cross-spectral function denote common frequency 
components for all sequences analyzed 
[243]
.  
 
As shown in the RRM previous studies, all protein sequences with a common 
biological function have a common frequency component in the free energy 
distribution of electrons along the protein backbone. This characteristic frequency was 
shown to be related to protein biological function 
[21,240,282]
. It was postulated that RRM 
frequencies characterize not only a general function but also a recognition/interaction 
between the particular proteins and their target at a distance. Thus, protein interactions 
can be viewed as a resonant energy transfer between the interacting molecules. This 
energy can be transferred through oscillations of a physical field, possibly 
electromagnetic in nature 
[240]
.  
 
Since there is evidence that proteins have certain conducting or semi-conducting 
properties, a charge moving through the protein backbone and passing different energy 
stages caused by different amino acid side groups can produce sufficient conditions for 
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a specific electromagnetic radiation or absorption
 [240]
. A strong linear correlation 
exists between the predicted and experimentally determined frequencies corresponding 
to the absorption of electromagnetic radiation of such proteins 
[240]
. It is inferred that 
approximate wavelengths in real frequency space can be calculated from the RRM 
characteristic frequencies for each biologically related group of sequences. These 
calculations can be used to predict the wavelength of the light irradiation, which might 
affect the biological activity of exposed proteins 
[20]
. A linear correlation between the 
absorption spectra of proteins and their RRM spectra with a regression coefficient of 
K=201 was established. Using RRM postulates, a computationally identified 
characteristic frequency for a protein functional group can be used to calculate the 
wavelength of applied irradiation, , defined as =201/fRRM, which could activate this 
protein sequence and modify its bioactivity 
[240,282]
. In this study, the above relationship 
was utilized to calculate the frequencies/wavelengths light that can modulate the 
bioactivity of the selected enzyme and investigate/evaluate their activation 
experimentally. 
 
Computational analysis of selected Collagenase enzymes using the RRM 
Here the RRM was used to compute the common characteristic frequency of 28 
vertebrate collagenase proteins that corresponds to their common biological activity. 
Collagenase primary protein sequences were collected from the NCBI protein database 
((http://www.ncbi.nlm.nih.gov/protein). A multiple cross-spectral analysis was 
performed resulting in one prominent RRM characteristic frequency identified at 
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f=0.4385 (Figure 5.1.1). This frequency is related to the biological activity of the 
analyzed Collagenase proteins.  
 
Figure 5.1.1 Multiple cross spectral function of 28 vertebrate collagenase sequences. 
The x axis represents the relative RRM frequency. The y axis represents the 
normalized intensity. 
 
This RRM frequency fRRM=0.4385 is used to calculate the wavelength of external 
irradiation, , which can activate Collagenase protein and modify its bioactivity, 
=201/fRRM. Thus, the wavelength of the EMR required for Collagenase enzyme 
activation will be at or near 456 nm. For the experimental validation of this 
computational prediction, the irradiating range was set between 400 – 500 nm. 
 
Experimental study of visible light irradiation of Collagenase enzyme 
In these experiments, the selected Collagenase enzyme solutions were irradiated by 
visible light (400-500nm). Changes in its activity upon radiation were evaluated and 
compared with control samples. 
fRRM 
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Equipment: As a source of visible light radiation we used Monochromators SPEX 
270M: (Princeton Instruments, Trenton, NJ, USA) 1200 g/mm grating, focal length 
270 mm, resolution 0.1 nm at 500 nm, dispersion 3.1 nm/mm, range 400 – 890 nm, 
RS232 connection with HP 34001A, controlled by LabView 6.1 (National Instruments). 
For measurement of absorbance of the analyzed enzyme solutions we used Ocean 
Optics USB2000 spectrometer coupled with USBISS-UV/VIS, (Ocean Optics, FL, 
USA) range 190 – 870 nm,  USB-2 connection with Pentium IV (Windows XP). 
Software automatically monitors and saves the absorption coefficient at 570 nm 
wavelength every 10 sec. 
 
Enzymatic Assay: Experimental solutions were prepared according to the standard 
enzymatic assay of collagenase from Sigma-Aldrich. The experiments were divided 
into two groups: (i) Group 1 (sham-exposure), collagenase sample not exposed to 
applied irradiation. This sample was used as a control for evaluating effects of 
irradiation on exposed vs. non-exposed samples; and (ii) Group 2, collagenase samples 
irradiated with light of different wavelengths (400—500nm, with 5nm steps) for 600 
sec. All experiments were performed at 37°C. 
The assay was chosen to satisfy following criteria: 
1. Time needed for catalyzing of 90% of the substrate should not be longer than 10 
min. 
2. Buffer does not include any substance that absorbs in visible/IR range and does not 
absorb at 570nm. 
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In accordance to the above mentioned prerequisites, the SIGMA Aldrich assay (c7521) 
was chosen. 
PRINCIPLE: Collagen + H2O
Collagenase
> Peptides 
CONDITIONS: T = 37° C, pH= 7.4, A570nm, Light path=1cm 
REAGENTS:   
Chemicals: TES free acis, Calcium Chloride with Dihydrate, Collagen Type 1, 
Collagenase were all obtained from Sigma.  
A. 50 mM TES Buffer with 0.36 mM Calcium Chloride, pH 7.4 at 37° C  
(Prepare 1000 ml in deionized water using TES Free Acid, Sigma Prod. No. 
T-1375, and Calcium Chloride, Dihydrate, Sigma Prod. No. C-3881. Adjust the pH 
to 7.4 at 37° C with 1 M NaOH.) 
B. Collagen Type I (Use Collagen, Type I, Sigma Prod. No. C-9879.) 
C. Collagenase Enzyme Solution ((Immediately before use, prepare a solution 
containing 0.1 mg/ml Collagenase, Sigma Prod. No. C-0130, in Buffer A.) 
 
Experimental protocol:  
1. The cuvette, filled with the collagenase solution, was irradiated with light of a 
particular wavelength in a range of 400-500 nm for 600 sec or incubated for 600 sec 
for the control enzyme sample. 
2. The irradiated (or control non-irradiated/sham-exposed samples) were added to the 
already prepared enzymatic substrate solution of Collagen Type I (pH 7.4).  
3. The optical density of digested Collagen solution was measured at 570 nm 
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(according to Sigma assay) for each selected irradiating wavelengths (400 - 500nm, 
with a step of 5 nm) using the spectrophotometer. The same experimental procedure 
was used for control samples.  
 
Method: 
Continuous Spectrophotometric Rate Determination: This method is widely used for 
qualitative analysis in chemistry, biochemistry and clinical applications. In this method, 
the course of a reaction is followed by monitoring how much light the assay solution 
absorbs by measuring the intensity of light as a beam of light passes through sample 
solution. This method is established on the fundamental principle that a compound 
either absorbs or transmits light over a certain range of wavelength.  
 
Measurement of Collagenase Enzyme Activity: 
The activity of the Collagenase enzyme is measured by determining the rate of 
substrate utilization during the collagen-collagenase reaction. The temperature was 
controlled during Collagenase irradiation as well as during the activity measurement 
procedure. Experiments were performed at the temperature of 37° C. 
 
With the aim at eliminating the effects of all possible artifacts (pH, temperature, and 
concentrations), the measurements were repeated three (3) times for each irradiating 
wavelength to evaluate changes in collagenase absorbance (changes in activity of 
collagenase solutions) before and after the light exposures. 
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Experimental Results: 
To validate the predicted activation wavelength, obtained within the computational 
analysis, the experiments were conducted according to the experimental protocol 
outlined above with the results presented in Fig.5.1.2 and Fig. 5.1.3.   
 
 
 
Figure 5.1.2 The effects of irradiating light on absorbance of Collagen 
 
 
Figure 5.1.3 Relative change in Collagen absorbance upon light irradiation, %. 
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Figure 5.1.2 shows that the selected light irradiation affected the enzymatic activity of 
Collagenase that resulted in the increase in Collagen’s absorbance. A significant effect 
(compared to the control sample) is seen at the wavelengths of 450, 456, and 460nm. 
Figure 5.1.3 presents relative changes in absorbance of Collagen. As can be seen from 
Figure 5.1.3, the increase of 30-32% in Collagen’s absorbance is achieved at these 
particular wavelengths. The maximum change in absorbance of digested Collagen is 
recorded at the wavelengths which are in the range predicted computationally by the 
RRM.  
 
An increase of 20% in Collagen’s absorbance can be observed at 500nm, and even 
smaller increases of 15-16% are seen at all other wavelengths (Figure 5.1.3). Clearly, 
these findings support the hypothesis that protein activity of Collagenase can be 
modulated by external light of the particular wavelengths predicted by the RRM 
approach. Modulated activity of irradiated Collagenase induced changes in this 
biochemical reaction via affecting the absorbance of Collagen. Interestingly, the results 
show that light exposures (400-500nm) affect the absorbance of digested collagen at 
different degrees, thus suggesting that these modulating effects are 
frequency-dependent. 
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Final remarks: 
The results presented reinforce the previously developed linear relationship between 
the calculated RRM frequencies and wavelengths of light radiation. With this 
correlation in mind, it is now possible to calculate wavelengths of light irradiation 
which will affect different biological processes. These findings suggest that EMR can 
be used as a non-invasive treatment to promote enzymatic debridement and thus assist 
wound healing. The possibility to computationally calculate the RRM frequencies, 
followed by the use of IR and visible light to produce the desired biological mutations 
and alterations in proteins will benefit the development of new biomaterials, and 
advanced technologies. 
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5.1.2 Visible Light Irradiation of selected Gram-positive and 
Gram-negative bacteria 
 
Overview: 
There are several theoretical and experimental studies published that evaluated the 
effects of visible light and infrared light exposures on bacterial growth 
[287,288,290,291]
. 
This study was aimed at investigating the phototoxic effects of visible and far infrared 
light on the selected bacterial strains. In this comprehensive experimental study, the 
biological effects induced by a LED-based exposure system on the selected 
gram-positive and gram-negative bacteria were evaluated using quantitative analyses. 
The LED-based exposure device was designed and developed to emit light at the 
selected wavelengths of 466nm, 585nm, 626nm (visible light) and at the selected far 
infrared wavelengths of 3400nm, 3600nm, 3800nm, 3900nm, 4100nm, 4300nm.  
 
LED-based exposure system 
The experimental setup and the exposure system were designed in a way to avoid any 
cross talk between different LEDs. To make sure that there are no heating effects on 
irradiated cells (from the heat generated by the LEDs), a heat-shielding gel 
(Inventables, USA) was used between the wells in order to prevent heat dissipation and 
absorption produced by other LEDs irradiating at the selected wavelengths 
[273,274]
. The 
gel was placed around the wells in the 96-well plate from outside and between the gaps. 
For a minimum dispersion, the device was designed to have the narrowest possible 
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irradiation angle and the gap between the device and an exposed sample was set at less 
than 1mm. For the consistency of the experimental exposure and power irradiated at 
each particular wavelength, all LEDs used in the experiments had the irradiation angle 
of less than 40
0
 (for minimum power dissipation from the energy source). More 
importantly, any cross-talk between the neighboring LEDs and the effect of two 
frequencies on the same well was eliminated by having the empty wells around each 
well that were used for running the experiments. 
 
 
 
Figure 5.1.4. The custom-build LED-based exposure device was designed and 
developed to emit light at the selected wavelengths. 
 
In this study, the selected bacterial cells were exposed and sham-exposed (control) 
using the custom-build LED-based exposure device. Its design and construction are 
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presented in details in 
[273,274]
. The main characteristics of the exposure systems are 
given below:  
1. Adaptor of 12v and 1A current has been fed into circuitry.  
2. The selected irradiating wavelengths: 3400nm, 3600nm, 3800nm, 3900nm, 
4100nm, 4300nm, 466nm, 585nm, 626nm, 810nm, 850nm and 950nm. 
3. To have these selected LEDs to operate in their optimal region, the input signal of 
250mA, 2 kHz and 50% duty cycle has been fed into the system.  
4. To have the minimum dispersion, the device was designed to have the narrowest 
possible irradiation angle and the gap between the device and an exposed sample was 
set at less than 1mm.  
5. All the LEDs used had the irradiation angle of less than 40o for minimum power 
dissipation from the energy source. 
6. The system was designed in a way to avoid any cross talk between different the 
LEDs. To make sure that there are no heating effects on irradiated cells, a heat-shield 
material was used between the wells in order to prevent heat dissipation and absorption 
produced by LEDs irradiating at the selected wavelengths. 
7.  The intensity of each frequency was constant (between 15µW to 30µW) and was 
not changed during the experiments. The relevance conversion factor between radiant 
intensity and luminous intensity can be calculated as follows: 
 
K () = Iv (Luminous Intensity)/ Ie (Radiant Intensity) 
In the experimental set up, the intensity of the exposure was kept constant for a better 
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comparison factor. All experiments were conducted three times in triplicates for the 
accuracy of the results. Three visible light wavelengths: 466nm, 585nm and 626nm 
were selected for the experimental evaluation of irradiation exposures. Six frequencies 
were selected for the experimental evaluation of far infrared exposures: 3400nm, 
3600nm, 3800nm, 3900nm, 4100nm, and 4300nm. 
 
Bacterial strains, inoculums preparation, and bacteria irradiation 
The selected Gram-positive bacterial strains, used in this experimentation, were 
Staphylococcus aureus ATCC 25923, and Staphylococcus aureus 344 (Ampicillin 
resistant strain). The selected Gram-negative bacterium used in this study was E. coli 
ATCC 25922. The bacterial isolates were obtained from the Microbiology Laboratory, 
Department of Biotechnology & Environmental Biology, School of Applied Sciences, 
RMIT University. 
 
The following exposure regimes were applied in this experimental study: 
(1) – 30 min of exposure and no post-exposure incubation 
(2) – 30 min of exposure followed by 1.5 hr of post-exposure incubation 
Regimes (1) and (2) were used to irradiated all three bacteria (S. aureus ATCC 25923, 
S. aureus 344 (ampicillin resistant strain) and E. coli ATCC 25922) 
(3) – 1.5 hr of exposure and no post-exposure incubation 
(4) – 1.5 hr of exposure followed by 1.5 hr of post-exposure incubation 
Regimes (3) and (4) were used to irradiate two Gram-positive bacteria (S. aureus 
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ATCC 25923 and S. aureus 344 (ampicillin resistant strain). 
(5) – 2 hr of exposure and no post-exposure incubation 
(6) – 2 hr of exposure followed by 1.5 hr of post-exposure incubation 
Regimes (5) and (6) were used to irradiate one bacterium (Gram-negative E. coli 
ATCC 25922) 
 
To assess the phototoxic effects of visible light and far infrared light radiation on 
gram-positive and gram-negative bacteria, a well isolated colony of either S. aureus 
ATCC 25923, S. aureus 344 (ampicillin resistant strain) or E. coli ATCC 25922 from 
the fresh MHA plate was inoculated into 2ml of Mueller-Hinton Broth (MHB) tube (to 
ensure a proper viability), and incubated at 37
0
 C overnight.  In order to attain the 
desired initial concentration of bacteria for the experiment, the initial concentration for 
inoculation was adjusted to 0.5 McFarland's turbidity standard
[293]
 while the density of 
the bacterial suspensions in following procedure were measured via optical density 
reading by Eppendorf BioPhotometer (to determine an approximate concentration of 
bacteria which is used as a basis for the experiment initial inoculation). Then, 
immediately after the optical density (OD600) of the bacterial suspension in MHB was 
adjusted, all bacteria, including gram-positive and gram-negative cells, were seeded in 
designated wells in 96-well plates.  
 
The experiments were divided into two groups:  
(i) Group 1 – control (sham-exposure/no irradiation): the bacterial samples were not 
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exposed by applied irradiation. These samples were used as a control group for 
evaluating effects of irradiation on exposed vs. non-exposed samples; and  
(ii) Group 2 – irradiated bacteria: bacterial samples were irradiated with light of 
different wavelengths (visible light: 466nm, 585nm, and 626nm; and far IR light: 
3400nm, 3600nm, 3800nm, 3900nm, 4100nm, and 4300nm).  
 
Different exposure regimes (presented above) were utilized. Irradiation of bacterial 
cells was conducted at room temperature. In the exposure regimes (2), (4) and (6), 
immediately after exposures the bacterial cells were then placed inside the incubator 
for 1.5 hr at the temperature of 37C. After incubation, the changes induced by light 
exposures in studied bacterial cells were evaluated by the OD reading and CFU 
techniques. All experiments were treated in triplicate in the same plate. Each 
combination of different exposure and incubation times was repeated three times in 
order to find the statistically significant results and reveal any specific effect on 
bacterial cell viability.  
 
Visible light LED radiation experimental results 
Cell viability assessment was performed on each type of bacteria in suspension, which 
were exposed to different wavelengths of light radiation under the above stated 
conditions. In particular, effects of applied exposures to visible light at the wavelengths 
466nm, 585nm, and 626nm were evaluated and expressed by optical density (OD) of 
bacteria in suspension and by live cell count of colony forming units (CFU). The 
experimental findings are is shown and discussed below. 
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Exposure regime (1) – 30 min of exposure with no post-exposure incubation 
 
Figure 5.1.5 OD reading for S. aureus ATCC25923 irradiated with visible light. 
 
 
 
Figure 5.1.6 CFU for S. aureus ATCC 25923 irradiated with visible light. 
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Figure 5.1.7 OD reading for S. aureus 344 (Ampicillin resistant strain) irradiated with 
visible light. 
 
 
 
Figure 5.1.8 CFU for S. aureus 344(Ampicillin resistant strain) irradiated with visible 
light. 
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Figure 5.1.9 OD reading for E. coli ATCC 25922 irradiated with visible light. 
 
 
 
Figure 5.1.10 CFU for E. coli ATCC 25922 irradiated with visible light. 
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Exposure regime (2) – 30 min of exposure followed by 1.5 hr of post-exposure 
incubation 
 
Figure 5.1.11 OD reading for S. aureus ATCC 25923 irradiated with visible light 
 
 
 
 
Figure 5.1.12 CFU for S. aureus ATCC 25923 irradiated with visible light. 
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Figure 5.1.13 OD reading for S. aureus 344 (Ampicillin resistant strain) irradiated with 
visible light 
 
 
 
Figure 5.1.14 CFU for S. aureus 344 (Ampicillin resistant strain) irradiated with 
visible light 
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Figure 5.1.15 OD reading for E. coli ATCC 25922 irradiated with visible light 
 
 
 
Figure 5.1.16 CFU for E. coli ATCC 25922 irradiated with visible light. 
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Exposure regime (3) – 1.5 hr of exposure and no post-exposure incubation 
 
Figure 5.1.17 OD reading for S. aureus ATCC 25923 irradiated with visible light 
 
 
 
Figure 5.1.18 CFU for S. aureus ATCC 25923 irradiated with visible light 
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Figure 5.1.19 OD reading for S. aureus 344 (Ampicillin resistant strain) irradiated with 
visible light. 
 
 
 
Figure 5.1.20 CFU for S. aureus 344 (Ampicillin resistant strain) irradiated with 
visible light 
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Exposure regime (4) – 1.5 hr of exposure followed by 1.5 hr of post-exposure 
incubation 
 
Figure 5.1.21 OD reading for S. aureus ATCC 25923 irradiated with visible light. 
 
 
 
Figure 5.1.22 CFU for S. aureus ATCC 25923 irradiated with visible light 
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Figure 5.1.23 OD reading for S. aureus 344 (Ampicillin resistant strain) irradiated with 
visible light. 
 
 
 
Figure 5.1.24 CFU for S. aureus 344 (Ampicillin resistant strain) irradiated with 
visible light 
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Exposure regime (5) – 2 hr of exposure and no post-exposure incubation 
 
Figure 5.1.25 OD reading for E. coli ATCC 25922 irradiated with visible light 
 
 
 
Figure 5.1.26 CFU for E. coli ATCC 25922 irradiated with visible light 
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Exposure regime (6) – 2 hr of exposure followed by 1.5 hr of post-exposure 
incubation 
 
Figure 5.1.27 OD reading for E. coli ATCC 25922 irradiated with visible light 
 
 
 
Figure 5.1.28 CFU for E.coli ATCC 25922 irradiated with visible light. 
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Discussion 
The obtained results show that the exposures of Gram-positive bacteria S. aureus 
ATCC 25923 and S. aureus 344 (ampicillin resistant strain) to blue light LED (466nm) 
produce  inhibitory effects on their population growth that in turn leads to an 
inactivation of pathogens present. From Figure 5.1.21 to Figure 5.1.24, it can be 
observed that both Gram-positive bacteria S. aureus ATCC 25923 and S. aureus 344 
(ampicillin resistant strain) irradiated for 1.5 hr and subjected to post-exposure 
incubated for 1.5 hrs at 37
0
C, ware affected the most (compared to the non irradiated 
control) by blue light exposures at 466nm. There is significant difference in OD 
reading/CFU data (Figures 5.1.21-5.1.24) between the control group and irradiated 
samples (p=6 x 10
-6
 <0.01) exposed at the wavelengths of 466nm. The same result was 
observed with Gram-negative bacteria E.coli ATCC25922 irradiated by blue light 
(466nm). As seen from Figure 5.1.27 to Figure 5.1.28, there is a significant difference 
(p=5x10
-7
<0.01) in OD reading/CFU data between the control groups and bacterial 
cultures irradiated by blue light LED (466nm) for 2 hours and post-exposure incubated 
for another 1.5hrs at 37C. Clearly, at the appropriate exposure duration, this exposure 
reduces the bacterial growth. These findings are in accordance with the published 
research
 [287,288]
.  
 
On the other hand, it can be also seen in (Figures 5.1.21-5.1.24 and Figure 5.1.27 to 
Figure 5.1.28) that there is no significant difference between samples irradiated by 
light exposures at 585 nm (yellow light) and 626nm (red light) and control groups. 
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Thus, it can be concluded that only light at wavelength 466nm induced changes on S. 
aureus ATCC 25923 and S. aureus 344 (ampicillin resistant strain) and suppress their 
growth.  
 
The experimental results also showed (from Figure 5.1.5 to Figure 5.1.16) that there 
are no significant effects induced by light exposures on Gram-positive bacterium S. 
aureus ATCC 25923, S. aureus 344 (ampicillin resistant strain) and Gram-negative 
bacterium E. coli ATCC 25922 , which were irradiated for 30 minutes. Clearly, the 
results demonstrate no significant difference between irradiated bacteria and control 
groups (Figures 5.1.5-5.1.16 respectively). Similar results were obtained for 
Gram-negative bacteria Ecoli. The findings reveal that there is no significant difference 
in Ecoli bacteria growth between the irradiated samples and the non irradiated control 
(Figures 5.1.9-5.1.10, 5.1.15-5.1.16 and 5.1.25-5.1.26). 
 
In summary, the experimental results of visible light exposures on the studied bacterial 
cultures revealed the following: 
 Light exposures by regime (1) – 30 min of exposure with no post-exposure 
incubation, regime (3) – 1.5 hr of exposure with no post-exposure incubation, 
and regime (5) – 2 hr of exposure and no post-exposure incubation (Figures 
5.1.5-5.1.10, 5.1.17-5.1.20 and 5.1.25-5.1.26 ) induce no changes on the growth 
rate of Gram-positive and Gram-negative bacteria irradiated for 30 min, 1.5hr 
and 2hr with no post-exposure incubation respectively.  
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 Light exposure with regime (2) - 30 min of exposure followed by 1.5 hr of 
post-exposure incubation (Figures 5.1.11-5.1.16) produced no significant 
effects on the studied bacteria. There is no statistically significant change 
between the irradiated bacterial cultures and control groups. However, by 
comparing the results of exposures of regimes (1), (3) and (5) and regime (2), 
we can observe that all values of OD reading and CFU are higher for regime (2) 
than for regimes (1), (3) and (5). This is interesting, as it shows that 1.5 hr of 
post-exposure incubation affects slightly the bacterial growth. 
 The results of visible light exposures with regime (4) – 1.5hr of exposure 
followed by 1.5 hr of post-exposure incubation and regime (6) – 2 hr of 
exposure followed by 1.5 hr of post-exposure incubation (Figures 5.1.21-5.1.24 
and 5.1.27-5.1.28) showed the significant inactivation/change in bacterial 
growth rate between the Gram-positive and Gram-negative bacteria irradiated 
by blue light (wavelength 466nm) and control samples.  
 The results also revealed that inactivation of Gram-positive bacteria S. aureus 
ATCC25923 and S. aureus 344 (ampicillin resistant strain) appeared to occur at 
a faster rate, within 30-60 min of experimentation compared to 60-90 min for 
the Gram-negative bacterium E.coli. Thus, Gram-positive bacteria are shown to 
be more responsive to visible light treatment than Gram-negative bacteria. This 
finding is similar to the results reported in other research studies 
[227,289]
.  
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5.1.3 Infrared Light Irradiation of Selected Gram-positive and 
Gram-negative Bacteria 
 
In this experimental sub-study, the anti-microbial effects of infrared (IR) light 
irradiation were evaluated on S. aureus ATCC 25923 and E. coli ATCC 25922 bacteria. 
Four different regimes of exposures were tested. The effects of different far IR 
wavelengths were examined.  
 
The following exposure regimes were applied: 
(1) – 30 min of exposure and no post-exposure incubation 
(2) – 30 min of exposure followed by 1.5 hr of post-exposure incubation 
(3) – 1.5 hr of exposure and no post-exposure incubation 
(4) – 1.5 hr of exposure followed by 1.5 hr of post-exposure incubation  
 
IR LED irradiation experimental results 
Cell viability assessment was performed on each type of bacteria in suspension, which 
were exposed to different wavelengths of far IR light radiation under the above stated 
conditions. In particular, effects of applied exposures at the wavelengths 3400nm, 
3600nm, 3800nm, 3900nm, 4100nm, and 4300nm were evaluated and expressed by 
optical density (OD reading) of bacteria in suspension (Figures 5.1.29-5.1.43) and live 
cell count (CFU) data is shown in (Figures 5.1.30-5.1.44).  
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Exposure regime (1) – 30 min of exposure with no post-exposure incubation 
 
 
Figure 5.1.29 OD reading for S. aureus ATCC 25923 
 
 
 
Figure 5.1.30 CFU for S. aureus ATCC 25923 
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Figure 5.1.31 OD reading for E. coli ATCC 25922 
 
 
 
Figure 5.1.32 CFU for E. coli ATCC 25922 
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Exposure regime (2) – 30 min of exposure followed by 1.5 hr of post-exposure 
incubation 
 
 
Figure 5.1.33 OD reading for S. aureus ATCC 25923 
 
 
 
Figure 5.1.34 CFU for S. aureus ATCC 25923 
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Figure 5.1.35 OD reading for E. coli ATCC 25922 
 
 
 
Figure 5.1.36 CFU for E. coli ATCC 25922 
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Exposure regime (3) – 1.5 hr of exposure and no post-exposure incubation 
 
 
Figure 5.1.37 OD reading for S. aureus ATCC 25923 
 
 
 
Figure 5.1.38 CFU for S. aureus ATCC 25923 
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Figure 5.1.39 OD reading for E. coli ATCC 25922 
 
 
Figure 5.1.40 CFU for E. coli ATCC 25922 
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Exposure regime (4) – 1.5 hr of exposure followed by 1.5 hr of post-exposure 
incubation 
 
 
Figure 5.1.41 OD reading for S. aureus ATCC 25923 
 
 
 
Figure 5.1.42 CFU for S. aureus ATCC 25923 
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Figure 5.1.43 OD reading for E. coli ATCC 25922 
 
 
 
Figure 5.1.44 CFU for E. coli ATCC 25922 
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Discussion 
The findings show that IR irradiation at the wavelength of 4300nm can accelerate S. 
aureus ATCC 25923 bacteria proliferation (Figure 5.1.41 and Figure 5.1.42). IR light 
at 4300 nm induces the changes in the bacterial growth, when these bacteria are 
irradiated for 1.5 hrs and post-exposure incubated for 1.5 hr. There is a significant 
difference in OD reading and CFU values between the irradiated bacteria and control 
group (p<0.01). There is no significant difference between bacteria exposed at all other 
far IR light wavelengths and control samples. The results also reveal that IR light 
exposures, in general, promote E. coli bacterial growth.  
The findings are summarized below: 
 
 For S. aureus ATCC 25923, findings obtained for Regime (1) – 30 min of 
exposure with no post-exposure incubation and regime (3) – 1.5hr of exposure 
with no post-exposure incubation (Figures 5.1.29-5.1.30 and Figures 
5.1.37-5.1.38) showed that there are no significant changes in the bacterial 
growth rate when compared to the control groups. However, irradiation by 
regime (1) - 30 min of exposure and no post-exposure incubation – slightly 
increases the bacterial growth of E. coli at the wavelengths 3400nm, 3800nm 
and 4100nm (Figures 5.1.31-5.1.32). 
 
 The results for irradiation of S. aureus ATCC 25923 by Regime (2) - 30 min of 
exposure followed by 1.5 hr of post-exposure incubation (Figure 5.1.33-5.1.34) 
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showed that there is no statistically significant change between the irradiated 
bacterial cultures and control groups. However, all values of OD reading and 
CFU induced by regime (2) exposures are slightly higher than the results 
obtained for regime (1) and regime (3). This is interesting, as the results 
suggest that 1.5 hr of post-exposure incubation is an important factor in 
promotion of bacterial growth.  
 
 For Gram-negative E. coli bacteria, irradiation by regime (2) – 30 min of 
exposure followed by 1.5 hr of post-exposure incubation – the results reveal the 
increase in bacterial growth by IR light at the wavelengths of 3600nm, 3800nm, 
4100nm and 4300nm. Irradiation by regime (3) – 1.5 hr of exposure and no 
post-exposure incubation – increased bacterial growth by exposures at 3400nm 
and 3800nm. 
 
 Irradiation of S. aureus ATCC 25923 by IR light in regime (4) – 1.5 hr of 
exposure followed by 1.5 hr of post-exposure incubation – induced a slight 
increase in bacterial growth at 4300nm (Figure 5.1.41-5.1.42).  
 
 In contrast, irradiation of E.coli by regime (4) induced a very significant 
increase in bacterial growth. This significant proliferation rate is observed at all 
studied wavelengths of far IR light. There is a significant difference between all 
radiated bacterial cultures and control groups (p<0.01).  
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It is important to note, the results demonstrate that the Gram-negative bacterium E.coli 
appeared to be more susceptible to the applied IR exposures than the Gram-positive 
bacteria S. aureus ATCC25923 (Figures 5.1.41-5.1.42 and Figure 5.1.43-5.1.44). 
Trushin 
[290]
 And Tsai 
[291]
 reported that the irradiation with visible red and infrared 
light can accelerate the rate of division and growth of E.coli.  Hence, the findings of 
this experimental evaluation are in agreement with the results of other studies. 
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5.2 Computational design of Azurocidin peptide analogue: a 
novel agent with anti-microbial activity 
 
Antimicrobial peptides (AMPs) are small (6 to 100 amino acids) amphipathic 
molecules of variable length, sequence, and structure with bioactivity against a wide 
range of microorganisms including bacteria, protozoa, yeast, fungi, viruses and even 
tumor cells. AMPs represent a new family of antibiotics that have stimulated research 
and clinical interest as new therapeutic options for treatment of infections caused by 
multidrug-resistant bacteria. This sub-study was aimed at designing a novel short 
bioactive peptide analogue that can emulate the biological activity of a native 
antimicrobial Azurocidin protein. The antimicrobial activity of the de novo designed 
Azurocidin peptide analogue was then evaluated in vitro on the selected Gram-positive 
and Gram-negative bacteria. Hence, this sub-study has two arms: computational and 
experimental in vitro.  
 
5.2.1 Computational analysis of Azurocidin proteins using the RRM approach 
The concepts of the RRM approach were presented in great details in Chapter 4 of this 
thesis. Azu-RRM peptide analogue was designed using the following strategy for the 
defined peptide design: 
1) The RRM characteristic frequency is determined from the multiple cross-spectral 
functions for a group of protein sequences that share a common biological function. 
2) The phases are calculated for the characteristic frequency or frequencies of a 
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particular protein, which is selected as a parent for an agonist/antagonist.   
3) The minimal length of the designed peptide is defined by the appropriate frequency 
resolution. An Inverse Fourier Transformation (IFT) is used to calculate a numerical 
sequence of different lengths, which exhibits the same prominent characteristic 
frequency as a parent protein.   
4) To determine the amino acids that correspond to each element of the new numerical 
sequence defined above, the tabulated Electron Ion Interaction Potential (EIIP) 
parameter values are used. The resulting new amino acid sequence represents the 
anticipated designed peptide. The de novo designed peptide has no homology to the 
original protein sequence but is expected to exhibit the same biological function as an 
original/parent protein. 
 
Peptide design procedure (graphical presentation) 
 
 
 
According to the RRM design procedure (shown above), on the basis of two 
frequencies and two phases determined within the computational analysis, it is possible 
to design six different peptide analogues for one parent protein. 
Peptide/frequency f1 f2 1 2
________________________________________
A * * - -
B * -
C * -
D * * + +
E * +
F * +
_______________________________________
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To utilize the RRM to design a novel bioactive peptide analogue, eight Azurocidin 
protein sequences were collected from the National Center for Biotechnology 
Information (NCBI) protein database (http://www.ncbi.nlm.nih.gov/protein). The 
RRM was used to compute the RRM characteristic frequency of the collected 
Azurocidin protein sequences.  
 
A multiple cross-spectral analysis was performed resulting in two prominent RRM 
characteristic frequencies identified at f1=0.1133 (prominent peak) and f2=0.0293 (less 
significant peak) shown in Figure 5.2.1. These frequencies are related to the biological 
activity of the analysed native Azu peptides. According to the RRM concepts, the 
prominent peak(s) characterizes the common biological activity of the analyzed Azu 
peptides. Less prominent peaks observed in Fig 5.2.1. indicate that these selected Azu 
peptides can be involved in a different biological process (interact with other proteins 
or small molecules).  
 
Figure 5.2.1. Multiple cross-spectral function of eight Azurocidin protein sequences. 
The abscissa represents RRM frequencies, and the ordinate - relative signal intensities. 
f1 
f2 
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When the common RRM was determined for all eight Azurocidin sequences, we then 
selected the particular sequence Azurocidin (179302 gb AAB59353.1 Homo sapiens) 
as a parent protein to design the synthetic peptide analogue that can mimic its 
anti-microbial activity.  
 
Selected original native Azurocidin amino acid sequence 
MTRLTVLALLAGLLASSRAGSSPLLDIVGGRKARPRQFPFLASIQNQGRH 
FCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDLRRRERQSRQTFSI 
SMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNATVEAGTRCQ 
VAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPNNVCTGVLTRRGGICNGD
GGTPLVCEGLAHGVASFSLGPCGRGPDFFTRVALFRDWIDGVLNNPGPGPA 
 
Then the phases were calculated at two frequencies f1=0.1133 (prominent peak) and 
f2=0.0293 (less significant peak). On the basis of the determined characteristic 
frequencies and phases f1=0.1133 and 1=-1.880; and f2=0.0293 and 2=-1.624, the 
short novel peptide analogue was designed, Azu-RRM 
(LPAQQQWAKAQRDDDRQWQCRDDTWAHHAWQWYPI).  
 
ProtParam (http://au.expasy.org/tools/protparam.html) was used as a tool to compute 
physical and chemical parameters of the synthetic Azu-RRM peptide analogue. This 
computationally designed peptide (35 amino acids) is 4.4358 kDa; theoretical pI: 6.00; 
estimated half-life in mammalian reticulocytes: 5.5 h; and instability index: 16.84 
which classifies the protein as stable. This peptide was further evaluated 
experimentally. 
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The control peptide Azc-RRM was also designed (with no active frequency)  
Azc-RRM: (GKMDDRQHLEACDDRWPL) 
Peptide length 18 amino acids, Molecular weight: 2283.4. The instability index (II) is 
computed to be 34.11. This classifies the protein as stable (used as control in 
experimental evaluation). 
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5.2.2 Evaluation of antimicrobial properties of the synthetic 
computationally designed Azurocidin peptide on growth of 
Gram-negative and Gram-positive bacteria 
 
In this experimental study a number of experiments were conducted to evaluate dose- 
and time-response of the selected bacteria to synthetic peptides treatment. These 
experiments are described below, with the findings being presented and discussed. 
 
5.2.2.1 Evaluation of antimicrobial activity of synthetic Azu-RRM and 
Azc-RRM analogues vs. native Azurocidin (Azu) against the Gram positve 
bacterium Staphylococcus aureus (ATCC25923) 
 
The computationally designed peptides Azu-RRM (bioactive analogue) and Azc-RRM 
(control) were commercially synthesized to 95% purity by GL Biochem (China). The 
native human neutrophil Azurocidin (Azu) protein was purchased from Sigma-Aldrich 
Pty Ltd, Australia. The gram-positive bacterium Staphylococcus aureus ATCC 25923 
was used here to assess the antimicrobial effects of the studied Azu-RRM, Azc-RRM 
peptide analogue and native Azu. Mueller-Hinton Agar (MHA) and Mueller-Hinton 
Broth (MHB) were obtained from ThermoFisher Scientific, Australia.  
 
To assess the antimicrobial activity of Azu-RRM and the native Azu peptide, a well 
isolated S. aureus colony from a fresh MHA plate was inoculated into 2ml of MHB 
and incubated at 37
0
 C overnight. Then, in order to attain the desired initial 
concentration of bacteria for the experiment, the initial concentration  
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for inoculation was adjusted to 0.5 McFarland's turbidity standard 
[293]
 while the 
density of the bacterial suspensions in following procedure were measured via optical 
density reading by Eppendorf BioPhotometer to determine an approximate 
concentration of bacteria which is used as a basis for the experiment starting 
inoculation. 
 
To examine the antimicrobial activity of Azu-RRM, Azc-RRM and native Azu peptide 
at different concentrations, the assay was conducted in a 96-well microtitre-plate as 
explained below: 
1. First, 100μl of MHB were added to each well from column 1 to column 12 in all 
rows of A, B, C, F, G, and H 
2. Then, 100μl of Azu or Azu-RRM, Azc-RRM working solution with an initial 
dose of 0.6 μM for Azu, Azu-RRM, Azc-RRM were added to the first well in rows 
A, B and C. Serial dilutions of the peptides were then created in wells (2-10). 
3. In the next step, all wells of rows F, G, and H were used for halving the 
concentration of the peptide in each consecutive well. 
4. The extra 100μl solution in the last column well of rows F, G, and H was 
discarded. 
5. 100μl of bacterial suspension was added to all wells in column 1 to 10. 
6. Negative growth controls of sterile MHB (100μl) were added in all wells in 
column 11. And 100μl of bacterial suspensions were added to wells in column 12 as 
full positive growth controls. 
176 
 
7. The seeded plate was then incubated at 37°C overnight. 
The antimicrobial experiments were repeated three times. The growth of S. aureus 
ATCC 25923 was measured with the microplate reader Thermo Multiskan Ascent 
Reader. The software was set to automatically monitor and save the absorption 
coefficient at wavelength of 600nm.  The average of the three times OD600 reading 
was taken for the data analysis. 
 
The anti-microbial effects of the designed synthetic Azu-RRM peptide analogue and 
native Azurocidin (Azu) were evaluated against bacterial growth of S. aureus as 
shown in Figures 5.2.2, 5.2.3. Different concentrations of native and synthetic 
peptides have been used in order to find the optimal concentrations that can induce 
the maximum suppressing effects on bacterial growth. For Azu-RRM, Azc-RRM 
and Azu, we started from a concentration of 3x10
-1 μM, then reduced it in half until 
it reached 5x10
-6 μM.  
The negative control is added all with MHB solution. The positive control is added 
all with bacterial suspensions (without the peptide). 
Figure 5.2.2 demonstrates the effects of the native Azu protein on the bacterial 
growth of S. aureus. The results show that the anti-microbial activity of Azu is 
noticeably strong at the concentrations ranging from 3x10
-1 μM to 5x10-3 μM when 
compared to the positive control (p<0.01). However, the anti-microbial effects of 
Azu are significantly reduced at the lower concentrations in a range of 2.5x10
-3 μM - 
5x10
-6
 μM.  
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As can be seen from Fig. 5.2.2, no significant effects are observed when compared 
to the positive control. 
 
 
Figure 5.2.2. Effect of native Azurocidin on the growth of Gram-positive bacteria S. 
aureus. 
 
 
Figure 5.2.3. Effect of bioactive peptide analogue Azu-RRM on the bacterial growth 
of S. aureus.  
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Figure 5.2.3 demonstrates the effects of the synthetic peptide analogue Azu-RRM on 
the bacterial growth of S. aureus. As it can be observed from Figure 5.2.2, 
Azu-RRM at the concentrations range of 0.3 μM to 5x10-3 μM shows a significant 
anti-microbial activity against Gram-positive bacteria S. aureus. However, the 
anti-microbial effects of Azu-RRM are reduced at the lower concentrations: ranging 
from 5x10
-3 μM to 5x10-6 μM, at which no significant effects can be seen, when 
compared to the positive control (p<0.01).  
 
The experimental results reveal that the in vitro inhibitory effect of the synthetic 
Azu-RRM peptide analogue on Staphylococcus aureus is comparable to the 
inhibitory effect of the native Azurocidin against this pathogenic bacterium (Figure 
5.2.4). 
 
 
Figure 5.2.4. Staphylococcus aureus ATCC25923 treated with Azu-RRM and native 
Azu. 
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The findings show that dose-dependent activity of the synthetic Azu-RRM was 
comparable to that of the native Azurocidin. The designed Azu-RRM peptide 
analogue exhibited a potent activity against the bacteria. The peptide’s treatments at 
the particular concentrations lead to the reduced bacterial growth.  
 
The results showed that the survival level of bacterial cells treated by Azu-RRM and 
native Azu at the concentrations range of 0.3µM - 0.005µM was significantly lower 
(p<0.05) when compared to the positive control. The statistical analysis was 
performed using the Microsoft Office 2003 Excel and MATLAB software. The 
statistical significance of the differences between the Azu-RRM and native Azu 
treatments of bacteria and the positive control group were analysed by one-way 
ANOVA. These findings reveal that the computationally designed Azu-RRM 
exhibits the inhibitory activity (similarly to the native antimicrobial protein Azu) 
against pathogenic bacteria. 
 
The results of experimental evaluation of anti-microbial activities of the synthetic 
Azu-RRM (bioactive), Azc-RRM (control) peptides and the native Azurocidin (Azu) 
against S. aureus (ATCC25923) are shown in Figure 5.2.5. The obtained results 
demonstrate that the designed native control peptide analogue Azc-RRM does not 
exhibited any potent activity against the studied bacteria.  
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Figure 5.2.5. Comparison of the effects on Staphylococcus aureus ATCC25923 
treated with Azu-RRM (bioactive), Azc-RRM (control) and native Azurocidin 
(Azu).  
 
 
Final Remarks: 
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show that the anti-microbial effects, induced by Azu-RRM treatment on the 
bacterium S. aureus, are comparable to the effects of the native Azu in the 
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can significantly affect the bacterial growth. Moreover, the results showed that their 
activities against S. aureus are rather bacteriostatic than bactericidal.
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5.2.2.2 Time- and dose-dependency of anti-microbial effects of synthetic 
Azu-RRM and Azc-RRM peptides: evaluation study on Gram-positive and 
Gram-negative bacteria  
 
Materials 
Gram-positive bacterial strains used in this sub-study were S. aureus ATCC 25923, 
and S. aureus344 (Ampicillin resistant strain). The Gram-negative bacterium, used 
in this study, was E. coli ATCC 25922. The bacterial isolates were obtained from 
the Microbiology Laboratory, School of Applied Sciences. The bacterial isolates 
were cultures in Mueller-Hinton Agar (MHA) and Mueller-Hinton Broth (MHB) 
(ThermoFisherScientific, Australia). The optical density (OD600) of bacterial 
suspensions in broth cultures was measured by Eppendorf OD600 reader 
(Biophotometer). Ascent software for Multiskan Ascent Reader for OD600 was 
from Thermo Electron Co. The de novo designed peptide Azu-RRM was 
commercially synthesized to 95% purity by GL Biochem, China. 
 
Antimicrobial Assay  
To assess the anti-microbial activities of the synthetic peptides Azu-RRM and 
Azc-RRM, well isolated colonies of Staphylococcus aureus ATCC25923; 
Staphylococcus aureus 344; and E. coli ATCC25922 from a fresh MHA plate were 
inoculated into 2ml of MHB (to ensure a proper viability), and incubated at 37
0
C 
overnight.  
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In order to attain the desired initial concentration of bacteria for the experiments, the 
starting concentration for inoculation was adjusted to 0.5 McFarland's turbidity 
standard 
[293]
 while the density of the bacterial suspensions in following procedure 
were measured via optical density reading by Eppendorf BioPhotometer to 
determine an approximate concentration of bacteria which is used as a basis for the 
experiment starting inoculation. 
 
To examine the antimicrobial activity of Azu-RRM (bioactive) and Azc-RRM 
(control) peptides at different concentrations and incubation times, the assay was 
conducted in a 96-well microlitre-plate as presented below:  
 
1. Firstly, 100μl of MHB were added to each well from column 1 to column 12 in all 
rows of A, B, C, F, G, and H.  
2. Then, 100μl of Azu-RRM working solution with an initial dose of 1000 μM was 
added to the first well in rows A, B and C. Serial dilutions of the peptides were then 
created in wells (2-10).  
3. In the next steps, all wells of rows F, G, and H were used for halving the 
concentration of the peptide in each consecutive well. Then the extra 100μl solution 
in each well from the last column of rows F, G, and H were discarded. This was 
followed by adding 100μl of the bacterial suspension to all wells in column 1 to 10. 
Negative growth controls of sterile MHB (100μl) were added in all wells in column 
11. And 100μl of bacterial suspensions were added to wells in column 12 as full 
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growth positive controls.  
4. Then the seeded plates were incubated at 37°C for 8 hours and overnight. 
 
Antibiotics susceptibility testing 
In order to measure the activity of Azu-RRM against the studied bacterium, Multiskan 
Ascent Reader for OD600 reading was carried out with Ascent software. The 
antimicrobial activity was assessed by measuring the optical density of the seeded 
plates, which were, as previously indicated, incubated at 37
0 
C for 8 hours and 
overnight. The experiments were performed in triplicates with three repeats for each 
experiment. The average of the three times OD600 reading was taken for the data 
analysis. 
 
Viable cell counts 
The colony-forming unit (CFU) count is an estimate of viable bacterial numbers. 
Unlike direct optical density counts, where all bacterial cells, dead and living, are 
counted, CFU estimates viable cells only. This method is employed here to assess the 
effects induced by the synthetic peptide treatment on the selected Gram-negative and 
Gram-positive bacteria. 
 
1. Firstly, 10ul samples of bacterial suspensions were collected from wells with 8h 
incubation, treated with Azu-RRM at the concentration of 2 uM and 4 uM, and positive 
control after OD600 reading. Secondly, the collected samples were diluted to final 
concentrations of 10
-2
, 10
-4
, 10
-5
, 10
-6
, and 10
-7 
uM.  
185 
 
2. Then, 100 ul from the last 3 dilutions (10
-5
, 10
-6
, and 10
-7
) were spread as lawn 
culture on MHA plates and incubated overnight at 37
0 
C. The next day, the data of CFU 
was conducted according to the standard methods of surface plate dilution and cell 
counting in a similar way to Roszak 
[292]
.  
 
Data analysis 
The statistical analysis was performed using the Microsoft Office 2003 Excel and 
MATLAB software. The statistical significance of the differences between the 
Azu-RRM treatments of bacteria and the positive control group were analyzed by 
one-way ANOVA. 
 
Results 
The anti-microbial effects of Azu-RRM and Azc-RRM peptide analogues on the 
growth of Gram-positive S. aureus ATCC25923, S. aureus 344 (ampicillin resistant 
strain) and Gram-negative E. coli bacteria are shown in Figures 5.2.6-5.2.14.  
Different concentrations of Azu-RRM at 8h and overnight incubations were used in 
order to determine the optimal treatment concentrations and time that can induce the 
maximum suppressing effects on bacterial growth. 
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Figure 5.2.6. Effects of Azu-RRM (bioactive) peptide analogue on the growth of S. 
aureus ATCC 25923 at 8 hours incubation 
 
Figure 5.2.6 demonstrates the effects of different concentrations of Azu-RRM peptide 
analogue on S. aureus ATCC25923 at 8 hour incubation. Its antimicrobial activity is 
noticeably most effective at the concentration of 2μM, when compared to the positive 
control (p<0.01). At this concentration the synthetic peptide Azu-RRM treatment of S. 
aureus induces a relative change of 48% in absorbance (OD reading) as can be seen 
from Fig. 5.2.6. 
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Figure 5.2.7. Effects of Azu-RRM (bioactive) and Azc-RRM (control) peptides on the 
growth of S. aureus ATCC 25923 at 8 hours incubation 
 
The obtained results clearly show that the designed synthetic control peptide 
Azc-RRM does not exhibit any potent activity against the studied S. aureus bacteria, 
when compared with the anti-microbial effects induced on bacterial growth by 
treatment with the designed bioactive peptide Azu-RRM.  
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Figure 5.2.8. Effects of Azu-RRM on the growth of S. aureus ATCC 25923 at 
overnight incubation 
 
Figure 5.2.8 demonstrates the effects of different concentrations of Azu-RRM peptide 
on Gram-positive S. aureus ATCC25923 bacteria at overnight incubation. Its 
antimicrobial activity is significant at the concentration of 4μM, when compared to the 
positive control (p<0.01). A change of 40% in absorbance (OD reading) in bacterial 
growth can be seen with the synthetic peptide treatment at the concentration of 4μM. 
 
The above experimental results (Figure 5.2.6, 5.2.8) reveal that the in vitro inhibitory 
effects of the synthetic Azu-RRM peptide analogue on bacterial growth of S. aureus 
ATCC25923 are time- and dose-dependent. The noticeably strong antimicrobial 
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activity of Azu-RRM is demonstrated at the concentration of 2uM and 8hours 
incubation, and at the concentration of 4uM and overnight incubation.  
 
 
 
Figure 5.2.9. Effects of Azu-RRM on the growth of Gram-negative E. coli 
ATCC25922 bacterium at 8 hours incubation 
 
Figure 5.2.9 demonstrates the effects of different concentrations of the bioactive 
Azu-RRM peptide on Gram-negative E.coli ATCC25922 bacteria at 8 hours 
incubation. Its anti-microbial activity is noticeably strong at the concentration of 
0.5μM, when compared to the positive control (p<0.01). A change of 26% in 
absorbance (OD reading) can be seen at 0.5 μM concentration of the synthetic peptide 
treatment. 
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Figure 5.2.10. Effects of Azu-RRM (bioactive) and Azc-RRM (control) peptides on the 
growth of Gram-negative E.coli ATCC 25922 at 8 hours incubation 
 
Figure 5.2.10 shows that treatment with the designed Azc-RRM control peptide 
analogue does not exhibit any potent anti-microbial activity against E.coli bacteria 
when compared to the anti-microbial activity of designed synthetic Azu-RRM peptide 
analogue.  
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Figure 5.2.11. Effects of bioactive Azu-RRM peptide on the growth of Gram-negative 
E. coli ATCC25922 bacterium at overnight incubation 
 
As can be observed from Figure 5.2.11, there are no noticeable effects of the synthetic 
Azu-RRM peptide analogue treatment on Gram-negative E. coli ATCC25922 at 
overnight incubation. 
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Figure 5.2.12. Effects of Azu-RRM on the growth of S. aureus 344 (ampicillin 
resistant bacterium) at 8 hours incubation 
 
Figure 5.2.12 demonstrates the effects of different concentrations of bioactive 
Az-RRM peptide on Gram-positive S. aureus 344 (ampicillin resistant strain) at 8 hour 
incubation. Its anti-microbial activity is noticeably strong at the concentration of 0.5 
µM, when compared to the positive control (p<0.01). The significant anti-microbial 
effect is observed at this concentration, which leads to a change of 40% in absorbance 
OD reading. 
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Figure 5.2.13. Effects of Azu-RRM on the growth of S. aureus 344 (ampicillin 
resistant bacterium) at overnight incubation 
 
Figure 5.2.13 demonstrates the effects of different concentrations of the bioactive 
Azu-RRM peptide on Gram-positive S. aureus 344 (ampicillin resistant strain) at the 
overnight incubation. Its anti-microbial activity is noticeably most effective at the 
concentration of 2 μM when compared to the positive control (p<0.01). A change of 44% 
in absorbance (OD reading) can be seen at this concentration of the synthetic peptide 
treatment. 
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In essence, the results shown in Figures 5.2.6-5.2.13 indicate that the synthetic 
computationally designed Azu-RRM peptide analogue has a broad range of 
antimicrobial activity against the studied Gram-positive and Gram-negative bacteria at 
the particular concentrations and incubation times. It should be noted, that the studied 
Gram-positive bacteria are well susceptible to the Azu-RRM treatment at the 
concentrations ranging from 62.5 µM to 0.5 µm at 8 hours incubation. It can be also 
noted that Gram-negative bacteria E. coli 25922 are susceptible (the effects vary 
depending on Azu-RRM concentration) to Azu-RRM treatment at the concentrations of 
62.5 µM - 2 µM at 8 hours incubation; with the maximum suppressing effect achieved 
at 0.5 µM (Figure 5.2.9). However, there are no noticeable effects of Azu-RRM 
treatment on Gram-negative Ecoli 25922 bacteria at overnight incubation (Figure 
5.2.11).   
 
Viable cell counts: Azu-RRM treatment at 8 hours incubation 
 
The viable cell count (CFU) results from plates inoculated with the 10
-6
 bacterial 
suspension dilutions are shown in Figure 5.2.14. The viable count of bacterial cultures 
(Figure 5.2.14) shows that both Gram-positive bacteria S. aureus ATCC 25923 and S. 
aureus 344 ampicillin resistant strain are more susceptible to Azu-RRM treatment than 
the Gram-negative bacterium E. coli 25922 at 8 hours incubation. 
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Figure 5.2.14. Viable cell counts (CFU) of S.aureus ATCC25923, S. aureus 344 and E. 
coli ATCC25922 cultures following treatment with Azu-RRM at 8h incubation 
 
It also can be seen that:  
(i) there is a significant reduction of 44% in viable cell counts of S. aureus 
ATCC25923 induced by Azu-RRM treatment at the concentrations of 2 µM and 4 µM, 
when compared to CFU of positive control at 8h incubation;  
(ii) a reduction of 36% in viable cell counts of S.aureus 344 induced by Azu-RRM 
treatment at the concentrations of 2 µM and 4 µM, when compared to CFU of the non 
treated control at 8h incubation; and  
(iii) a reduction of 25% in viable cell counts of Ecoli ATCC25922 induced by 
Azu-RRM treatment at the concentrations of 2 µM and 4 µM, when compared to CFU 
of the non treated control at 8h incubation.  
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The findings reveal that the growth rates of these three selected bacterial species were 
significantly affected by Azu-RRM treatment at the concentrations in a range of 62.5 
µM to 0.5 µM at 8h incubation, when compared to the non-treated positive control. 
The statistical analysis of the experimental data shows that the survival rates of 
bacterial cultures of S. aureus ATCC 25923, S. aureus344 and E. coli 25922 treated 
with Azu-RRM (62.5µM-0.5µM) at 37
0
C, 8 hour incubation were significantly lower 
(p<0.01), when compared to the non-treated cultures (positive control). Hence, these 
findings allow summarizing that the computationally designed Azu-RRM peptide 
analogue exhibits an inhibitory activity against the studied pathogenic bacteria.  
 
Discussion 
Wound infection could prolong the time of wound healing, obstruct the effective 
treatment and increase patient morbidity. Currently, the rising antibiotics resistance is a 
major problem to limit the use of traditional antibiotics. Hence, there is a growing need 
to develop new antimicrobial drugs as therapeutic agents to overcome this problem. 
Antimicrobial peptides (AMP) from different organisms can serve as the natural defense 
molecules to combat these pathogenic microorganisms. Azurocidin is an Azurophil 
granule antibiotic protein that possesses some features whick make it unique among 
other neutrophil granule proteins. As one of the defense key players of the immune 
system, it has attracted much interest from medical scientists. Azurocidin is described in 
details in Chapter 2.2.10.  
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In this study, the RRM approach was used to design computationally Azurocidin 
synthetic peptide analogue (Azu-RRM) having native Azurocidin-like anti-microbial 
activity. The experimental results clearly showed that the anti-microbial activity of 
Azu-RRM is very comparable to the activity of the native Azurocidin (Figure 
5.2.2-5.2.4). The RRM approach has been previously utilized in computational analysis 
of oncogene and proto-oncogene proteins and the results showed that the RRM is 
capable of to identify  the differences between oncogenic and proto-oncogenic proteins 
with the possibility of identifying the ‘‘cancer-causing’’ features within their protein 
primary structure
 [242]
. 
 
The activity of anti-microbial peptides is diverse. Due to their high effectiveness against 
the disease causing organisms, Gram-positive and Gram-negative bacteria, viruses, 
fungi and protozoa are susceptible to anti-microbial peptide’ treatments at their very 
low concentration (in micro-molar concentration or below)
 [29,139]
. The findings of this 
experimental evaluation are in accord with the results reported in other studies. 
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Chapter 6  
 
Conclusion 
 
Based on the findings presented and discussed in Chapter 5, the following conclusive 
remarks are made: 
 
1. The results of electromagnetic radiation (visible light) of the computationally 
determined frequency reinforce the previously developed linear relationship 
between the calculated RRM frequencies and wavelengths of light radiation. With 
this correlation in mind, it is now possible to calculate wavelengths of light 
irradiation which will affect different biological processes. To evaluate the effects 
of visible light exposures, Collagenase enzyme solutions were irradiated by 
monochromatic light of 400 to 500 nm. The obtained results reveal that 
Collagenase activity can be modulated at the particular wavelengths of 450nm, 
456nm, and 460nm, which are within the activation wavelength range defined 
computationally. These findings suggest that EMR can be used as a non-invasive 
treatment to promote enzymatic debridement and thus, assist wound healing.  
 
2. In the experimental in vitro study evaluating the antimicrobial activity of the 
synthetic computationally design peptide analogue Azu-RRM, its efficacy was 
compared with the native Azurocidin (Azu) proteins against the Gram-positive 
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bacterium S. aureus ATCC25923. The results showed that the antimicrobial 
activity of Azu-RRM was strong and comparable to the activity of the native Azu 
in the concentration range of 0.3μM to 0.005μM. It was previously reported by 
Watorek
 [29]
 that Azu induces significant anti-microbial effects (the most effective 
dosage) at the concentrations range of 10
-5
-10
-6
(M). These results are in accord 
with the experimental findings of this PhD project. The results obtained reveal that 
both native and synthetic peptides induce suppressing effects on Staphylococcus 
aureus, their treatments at the particular concentrations do affect significantly the 
bacterial growth of S. aureus. 
 
3. In the experimental evaluation (Chapter 5), the efficacy of the synthetic Azu-RRM 
peptide analogue, as a candidate for anti-infection therapy, was studied on 
Gram-positive bacteria (S.aureus ATCC 25923, and S.aureus344) and the 
Gram-negative bacterium (E. coli 25922). According to our results, the activity of 
Azu-RRM peptide against Gram-positive bacterium (S. aureus ATCC 25923, S. 
aureus 344) and Gram-negative bacterium (Ecoli ATCC 25922) is dose-dependent. 
It is important to note, that at 8 hours incubation the most significant antimicrobial, 
supressing effects of Azu-RRM against S.aureus ATCC25922 was recorded at the 
concentration of 2 µM. While for the penicillin resistant strain S. aureus344, the 
killing effect is most noticeable at the concentration of 0.5 µM. For E. coli ATCC 
25922 bacterium, the most significant effect of Azu-RRM treatment is observed at 
the concentration of 0.5 µM.  
 
200 
 
4. Furthermore, the results also showed that the effects of Azu-RRM peptide against 
Gram-positive and Gram-negative bacteria are time-dependent, when compared to 
the same concentration treatment of Azu-RRM (0.5 µM, 2 µM and 4 µM) on these 
bacteria at 8 hours and overnight incubations. Interestingly, the test results of 
Gram-negative bacterium E.coli ATCC25922 treatment by Azu-RRM at 8 hours 
incubation clearly demonstrate the antimicrobial effects. In contrary, the Azu-RRM 
treatment at overnight incubation induces no effects on the bacterial growth of 
E.coli ATCC25922.  
 
5. The results also showed that the activity of Azu-RRM against the Gram-positive 
bacterial strains is stronger than against Gram-negative bacterium. The 
antimicrobial activity data from the live cells count revealed that Azu-RRM 
activity against the studied bacteria was rather bacteria-static than bacteria-cidal 
as the viable cell count (CFU) results showed that there were still live bacterial 
cells that survived the peptide treatment.  
 
6. As was shown through the experimental evaluation, the RRM is capable of 
identifying the key amino acids in the native Azurocine peptide sequence, which 
predominantly contributes to its characteristic frequency and thus, to the desired 
function, and design of the de novo peptide analogue. Since this de novo peptide 
carries the common characteristic of Azurocidin, specifically in terms of its 
antimicrobial activity, the peptide analogue will exhibit the same biological activity 
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as the native Azurocidin. The experimental findings corroborate our previous 
results of using the RRM approach to de novo design of different peptide analogues
 
[237,242,243,280]
. The novel Azu-RRM peptide analogue emulates the activity of the 
native anti-microbial Protein Azu and presents itself as a potent therapeutic agent 
against the studies bacteria. It can be successfully used to treat infections caused by 
these particular pathogens and thus, promote wound healing process.  
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Chapter 7  
 
Future work 
 
 
This research project was focused on improvement of wound bed preparation and 
development of a novel anti-infection treatment for wound healing promotion. Within 
the study two hypotheses have been tested: 
1. Electromagnetic radiation of the computationally determined frequency can 
modulate the enzymatic activity and thus, promote a wound healing process. 
2. The computationally designed synthetic peptide can exhibit an antimicrobial 
activity and thus, promote wound healing process. 
 
Upon completion of the project, the above hypotheses and identified research questions 
have been successfully addressed through the conducted computational and 
experimental studies. However, there are still some experiments can be performed to 
continue with this particular research topic: 
 
1. Firstly, it will be interesting to study the synergetic effects of the combined treatment 
(visible light and synthetic peptide analogue Azu-RRM) on selected bacterial cultures. 
 
2. Secondly, it will be also impotant to investigate the synergetic effects of the 
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combined treatment (synthetic peptide analogue Azu-RRM and traditional antibiotics, 
i.e. penicillin, ampicillin) on selected bacterial cultures. 
 
3. Third, to study and evaluate the effects of the synthetic peptide analogue RRM-Azu 
on infected tissue cultures. 
 
4. Fnally, to study the effects of the synthetic peptide analogue Azu-RRM on 
experimental animals (treatment of acute wounds).  
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Appendix I 
 
 
Primary amino acid sequences of collagenase used in thesis: 
PRT>P1; 
ATFFLLSWTHCWSLPLPYGDDDDDDLSEEDLEFAEHYLKSYYHPVTLAGILKKSTVTSTV 
DRLREMQSFFGLDVTGKLDDPTLDIMRKPRCGVPDVGVYNVFPRTLKWSQTNLTYRIVNY 
TPDISHSEVEKAFRKAFKVWSDVTPLNFTRIHDGTADIMISFGTKEHGDFYPFDGPSGLL 
AHAFPPGPNLGGDAHFDDDETWTSSSKGYNLFIVAAHELGHSLGLDHSKDPGALMFPIYT 
YTGKSHFMLPDDDVQGIQSLYGPGDEDPNPKHPKTPEKCDPALSLDAITSLRGETMIFKD 
RFFWRLHPQQVEPELFLTKSFWPELPNHVDAAYEHPSRDLMFIFRGRKFWALNGYDIMEG 
YPRKISDLGFPKEVKRLSAAVHFEDTGKTLFFSGNHVWSYDDANQTMDKDYPRLIEEEFP 
GIGDKVDAVYEKNGYIYFFNGPIQFEYSIWSNRIVRVMPTNSLLWC 
PRT>P2; 
MLSGLWSSILALLGVFLQSVGEFRAETQEQDVEIVQKYLKNYYNSDKRNSGLVVEILKQF 
FGLKVTGKPDAETLVMKQSTCGVPDVGEYVLTPGNPRWENTHLTYRIENYTPDLVSPLTF 
TKVSEGQADIMISFVRGDHRDKYPFDGPGGNLAHASQPGPGIGGDAHFDEYERWTKNFQD 
YNLYRVAAHELGHSLGLSHSTDIGALMYPTYLRGDVQLSQDDIDGPSGNPVQPRGPQTPQ 
VCDSKLTFDAITTVRGELMFFKMRTNRFYPEVELGLQAAYEMADRDEVRFFKGNKYWAVS 
GQDVLYGYPKDIHSSFGFPTGVAHECWSYDEYKQSMDTGYADEFPGDAVFQKFFHGTRQY 
QFDLKTKRILTLQKANSWFNCRKN 
PRT>P3; 
MHSFPPLLLLLFWGVVSHSFPATLETQEQDVDLVQKYLEKYYNLKNDGRQVEKRRNSGPV 
VEKLKQMQEFFGLKVTGKPDAETLKVMKQPRCGVPDVAQFVLTEGNPRWEQTHLTYRIEN 
YTPDLPRADVDHAIEKAFQLWSNVTPLTFTKVSEGQADIMISFVRGDHRDNSPFDGPGGN 
LAHAFQPGPGIGGDAHFDEDERWTNNFREYNLHRVAAHELGHSLGLSHSTDIGALMYPSY 
TFSGDVQLAQDDIDGIQAIYGRSQNPVQPIGPQTPKACDSKLTFDAITTIRGEVMFFKDR 
FYMRTNPFYPEVELNFISVFWPQLPNGLEAAYEFADRDEVRFFKGNKYWAVQGQNVLHGY 
PKDIYSSFGFPRTVKHIDAALSEENTGKTYFFVANKYWRYDEYKRSMDPGYPKMIAHDFP 
GIGHKVDAVFMKDGFFYFFHGTRQYKFDPKTKRILTLQKANSWFNCRKN 
PRT>P4; 
MRTVCALLGLLAAVHCMPVSQETMEEQRFAQSYLKNFFNLTEEAGPAVRRGFSQVTSKLI 
EMQTFFGLQITGTLDAETLAMMKKPRCGVSDSRVARFSTFGNNLKWEKNSLTYRITNYTP 
DMSKEEVDESIEKALQVWARVTPLRFTKIYSSTADIMVSFGQRAHGDYYPFDGPDGTLAH 
AFAPAPGIGGDAHFDDDETFTFRSNTGYVLFMVAAHEFGHSLGLSHSDDPGALMYPIYSY 
RNPETFVLPRDDVRGIQSLYGPNLDPAQPEPTAPPTPDACDSTMVLDAVATLRGEMFFFK 
DSFFWRVHPQSYTPQQTFITNFWPDAPLSVDAAYENQQSDRIFLFKGRQVWAFRGYDLVQ 
GYPQAISSFGLPKRIEKVDAALYDAQSGKTLFFVGRNYYSYDEAKGTMDAGFPKAVDQKF 
SGMSGRVTAALQYRGFAYLYSGPYMFEYSLRTGQLLRLLRNSYFLPCTSY 
PRT>P5; 
MQSLLCLLLLCAASSRAFPAASDPDSEESDIQRAEAYLKRFYGLDTEKKHFTRKNGSPFS 
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EKLREMQEFFGLEVTGRLDSETLEVMEKPRCGVSDVARYSITPGNPVWKHTEITYRILNY 
TPDMAKADVDAAIQRALNVWADVTPLTFTRLYEGTADIQISFAAGDHRDNSPFDGPDGLL 
AHAFEPGRGIGGDAHFDEDERWTKGSERYNLFLMAAHEFGHSLGLSHSNDPGALMYPTYS 
STDPDEFRLPQDDINGIQSLYGESKNPVQPTGPTTPSICDTKVIFDAVATLRGEMLFLKE 
RFFWRRHAQYPEAELHFIKSFWPSLPSDIEAAYENPEQDEVLIFKGSKYWALNGYDIVQG 
YPKNIHTLGFPTTVKKIDAAVYNEETGKTFFFVGNQYWSYDESTRTMDQGFPKETINDFP 
GIGQKVHAVFQSNGFLYFFSGKYQFEFSMKSKRVMRVLRNNSWLGCQEA 
PRT>6; 
MFSLLLLLLLLCNTGSHGFPAATSETQEQDVEIVQKYLKNYYNLNSDGVPVEKKRNSGLV 
VEKLKQMQQFFGLKVTGKPDAETLNVMKQPRCGVPDVAEFVLTPGNPRWENTHLTYRIEN 
YTPDLSREDVDRAIEKAFQLWSNVSPLTFTKVSEGQADIMISFVRGDHRDNSPFDGPGGN 
LAHAFQPGPGIGGDAHFDEDERWTKNFRDYNLYRVAAHELGHSLGLSHSTDIGALMYPNY 
IYTGDVQLSQDDIDGIQAIYGPSENPVQPSGPQTPQVCDSKLTFDAITTLRGELMFFKDR 
FYMRTNSFYPEVELNFISVFWPQVPNGLQAAYEIADRDEVRFFKGNKYWAVRGQDVLYGY 
PKDIHRSFGFPSTVKNIDAAVFEEDTGKTYFFVAHECWRYDEYKQSMDTGYPKMIAEEFP 
GIGNKVDAVFQKDGFLYFFHGTRQYQFDFKTKRILTLQKANSWFNCRKN 
PRT>P7; 
MPGLPLLLLLLWGVGSHGFPAASETQEQDVEMVQKYLENYYNLKDDWRKIPKQRGNGLAV 
EKLKQMQEFFGLKVTGKPDAETLKMMKQPRCGVPDVAQFVLTPGNPRWEQTHLTYRIENY 
TPDLSRADVDNAIEKAFQLWSNVTPLTFTKVSKGQADIMISFVRGDHRDNSPFDGPEGQL 
AHAFQPGLGIGGDVHFDEDDRWTKDFRNYNLYRVAAHELGHSLGLSHSTDIGALMYPNYM 
FSGDVQLAQDDIDGIQAIYGPSQNPSQPVGPQTPKVCDSKLTFDAITTIRGEIMFFKDRF 
YMRANPYYSEVELNFISVFWPHLPNGLQAAYEVAHRDEILFFKGNKYWTVQGQNELPGYP 
KDIHSSFGFPRSVNHIDAAVSEEDTGKTYFFVANKYWRYDEYKRSMDAGYPKMIEYDFPG 
IGNKVDAVFKKDGFFYFFHGTRQYKFDPKTKRILTLQKANSWFNCRKN 
PRT>P8; 
MHSAILATFF LLSWTHCWSL PLPYGDDDDD DLSEEDLEFA EHYLKSYYHP VTLAGILKKS 
TVTSTVDRLR EMQSFFGLDV TGKLDDPTLD IMRKPRCGVP DVGEYNVFPR TLKWSQTNLT 
YRIVNYTPDI SHSEVEKAFR KAFKVWSDVT PLNFTRIHDG TADIMISFGT KEHGDFYPFD 
GPSGLLAHAF PPGPNLGGDA HFDDDETWTS SSKGYNLFIV AAHELGHSLG LDHSKDPGAL 
MFPIYTYTGK SHFMLPDDDV QGIQSLYGPG DEDPNPKHPK TPEKCDPALS LDAITSLRGE 
TMIFKDRFFW RLHPQQVEPE LFLTKSFWPE LPNHVDAAYE HPSRDLMFIF RGRKFWALNG 
YDIMEGYPRK ISDLGFPKEV KRLSAAVHFE DTGKTLFFSG NHVWSYDDAN QTMDKDYPRL 
IEEEFPGIGD KVDAVYEKNG YIYFFNGPIQ FEYSIWSNRI VRVMPTNSLLWC 
PRT>P9; 
SSLSVLVLSLSFAYCLSAPVPQDEDSELTPGDLQLAEHYLNRLYSSSSNPVGMLRMKNVN 
SIETKLKEMQSFFGLEVTGKLNEDTLDIMKQPRCGVPDVGQYNFFPRKLKWPRNNLTYRI 
VNYTPDLSTSEVDRAIKKALKVWSDVTPLNFTRLRTGTADIMVSFGKKEHGDYYPFDGPD 
GLLAHAFPPGEKLGGDTHFDDDEMFSTDNKGYNLFVVAAHEFGHALGLDHSRDPGSLMFP 
VYTYTETSRFVLPDDDVQGIQVLYGPGNRDPHPKHPKTPEKCDPDLSIDAITELRGEKMI 
FKDRFFWRVHPQMTDAELVLIKSFWPELPNKLDAAYEHPAKDLSYLFRGKKFWALNGYDI 
VEDYPKKLHELGFPKTLKAIDAAVYNKDTGKTFFFTEDSYWSFDEEARTLDKGFPRLISE 
DFPGIGEKVDAAYQRNGYLYFFNGALQFEYSIWSQRITRILKTNFVLMC 
PRT>P10; 
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MFSLKTLPFLLLLHVQISKAFPVSSKEKNTKTVQDYLEKFYQLPSNQYQSTRKNGTNVIV 
EKLKEMQRFFGLNVTGKPNEETLDMMKKPRCGVPDSGGFMLTPGNPKWERTNLTYRIRNY 
TPQLSEAEVERAIKDAFELWSVASPLIFTRISQGEADINIAFYQRDHGDNSPFDGPNGIL 
AHAFQPGQGIGGDAHFDAEETWTNTSANYNLFLVAAHEFGHSLGLAHSSDPGALMYPNYA 
FRETSNYSLPQDDIDGIQAIYGLSSNPIQPTGPSTPKPCDPSLTFDAITTLRGEILFFKD 
RYFWRRHPQLQRVEMNFISLFWPSLPTGIQAAYEDFDRDLIFLFKGNQYWALSGYDILQG 
YPKDISNYGFPSSVQAIDAAVFYRSKTYFFVNDQFWRYDNQRQFMEPGYPKSISGAFPGI 
ESKVDAVFQQEHFFHVFSGPRYYAFDLIAQRVTRVARGNKWLNCRYG 
PRT>P11; 
MHPRALAGFL FFSWTACWSL PLPSDGDSED LSEEDFQFAE SYLKSYYYPQ NPAGILKKSA 
ASSVIDRLKE MQSFFGLEVT GRLDDNTLDI MKKPRCGVPD VGEYNVFPRT LKWSKMNLTY 
RIVNYTPDLT HSEVEKAFRK AFKVWSDVTP LNFTRIHNGT ADIMISFGTK EHGDFYPFDG 
PSGLLAHAFP PGPNYGGDAH FDDDETWTSS SKGYNLFLVA AHEFGHSLGL DHSKDPGALM 
FPIYTYTGKS HFMLPDDDVQ GIQSLYGPGD EDPNSKHPKT PDKCDPSLSL DAITSLRGET 
LIFKDRFFWR LHPQQVEAEL FLTKSFWPEL PNRIDAAYEH PSHDLIFIFR GRKFWALSGY 
DILEDYPKKI SELGFPKDVK KISAALHFED SGKTLFFSEN QVWSYDDTNH VMDKGYPRFI 
EEVFPGIGDK VDAVYQKNGY IYFFNGPIQF EYSIWSNRIV RVMPTNSLLW C 
PRT>P12; 
MFRLKTLPLL IFLHTQLANA FPVPEHLEEK NIKTAENYLR KFYNLPSNQF RSSRNATMVA 
EKLKEMQRFF SLAETGKLDA ATMGIMEMPR CGVPDSGDFL LTPGSPKWTH TNLTYRIINH 
TPQLSRAEVK TAIEKAFHVW SVASPLTFTE ILQGEADINI AFVSRDHGDN SPFDGPNGIL 
AHAFQPGQGI GGDAHFDSEE TWTQDSKNYN LFLVAAHEFG HSLGLSHSTD PGALMYPNYA 
YREPSTYSLP QDDINGIQTI YGPSDNPIQP TGPSTPKACD PHLRFDATTT LRGEIYFFKD 
KYFWRRHPQL RTVDLNFISL FWPFLPNGLQ AAYEDFDRDL VFLFKGRQYW ALSGYDLQQG 
YPRDISNYGF PRSVQAIDAA VSYNGKTYFF INNQCWRYDN QRRSMDPGYP KSIPSMFPGV 
NCRVDAVFLQ DSFFLFFSGP QYFAFNFVSH RVTRVARSNL WLNCS 
PRT>P13; 
MLHLKTLPFL FFFHTQLATA LPVPPEHLEE KNMKTAENYL RKFYHLPSNQ FRSARNATMI 
AEKLKEMQRF FGLPETGKPD AATIEIMEKP RCGVPDSGDF LLTPGSPKWT HTNLTYRIIN 
HTPQMSKAEV KTEIEKAFKI WSVPSTLTFT ETLEGEADIN IAFVSRDHGD NSPFDGPNGI 
LAHAFQPGRG IGGDAHFDSE ETWTQDSKNY NLFLVAAHEF GHSLGLSHST DPGALMYPNY 
AYREPSTYSL PQDDINGIQT IYGPSDNPVQ PTGPSTPTAC DPHLRFDAAT TLRGEIYFFK 
DKYFWRRHPQ LRTVDLNFIS LFWPFLPNGL QAAYEDFDRD LVFLFKGRQY WALSAYDLQQ 
GYPRDISNYG FPRSVQAIDA AVSYNGKTYF FVNNQCWRYD NQRRSMDPGY PTSIASVFPG 
INCRIDAVFQ QDSFFLFFSG PQYFAFNLVS RRVTRVARSN LWLNCP 
PRT>P14; 
MEALMARGAL TGPLRALCLL GCLLSHAAAA PSPIIKFPGD VAPKTDKELA VQYLNTFYGC 
PKESCNLFVL KDTLKKMQKF FGLPQTGDLD QNTIETMRKP RCGNPDVANY NFFPRKPKWD 
KNQITYRIIG YTPDLDPETV DDAFARAFQV WSDVTPLRFS RIHDGEADIM INFGRWEHGD 
GYPFDGKDGL LAHAFAPGTG VGGDSHFDDD ELWTLGEGQV VRVKYGNADG EYCKFPFLFN 
GKEYNSCTDT GRSDGFLWCS TTYNFEKDGK YGFCPHEALF TMGGNAEGQP CKFPFRFQGT 
SYDSCTTEGR TDGYRWCGTT EDYDRDKKYG FCPETAMSTV GGNSEGAPCV FPFTFLGNKY 
ESCTSAGRSD GKMWCATTAN YDDDRKWGFC PDQGYSLFLV AAHEFGHAMG LEHSQDPGAL 
MAPIYTYTKN FRLSQDDIKG IQELYGASPD IDLGTGPTPT LGPVTPEICK QDIVFDGIAQ 
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IRGEIFFFKD RFIWRTVTPR DKPMGPLLVA TFWPELPEKI DAVYEAPQEE KAVFFAGNEY 
WIYSASTLER GYPKPLTSLG LPPDVQRVDA AFNWSKNKKT YIFAGDKFWR YNEVKKKMDP 
GFPKLIADAW NAIPDNLDAV VDLQGGGHSY FFKGAYYLKL ENQSLKSVKF GSIKSDWLGC 
 
PRT>P15; 
MSPWQPLLLA LLAFGCSSAC PYQRHATFVV FPKDLKTSNL TDTQLAEAYL YRYGYTRAAQ 
MMGEKQSLRP ALLMLQKQLS LPQTGELDSQ TLKAIRTPRC GVPDVGRFQT FKGLKWDHHN 
ITYWIQNYSE DLPRDMIDDA FARAFAVWGE VAPLTFTRVY GPEADIVIQF GVAEHGDGYP 
FDGKDGLLAH AFPPGAGVQG DAHFDDDELW SLGKGVVIPT YYGNSNGAPC HFPFTFEGRS 
YSACTTDGRN DGTPWCSTTA DYDKDGKFGF CPSERLYTEH GNGEGKPCVF PFIFEGRSYS 
ACTTKGRSDG YRWCATTANY DQDKLYGFCP TRVDATVVGG NSAGELCVFP FVFLGKQYSS 
CTSDGRRDGR LWCATTSNFD TDKKWGFCPD QGYSLFLVAA HEFGHALGLD HSSVPEALMY 
PLYSYLEGFP LNKDDIDGIQ YLYGRGSKPD PRPPATTTTE PQPTAPPTMC PTIPPTAYPT 
VGPTVGPTGA PSPGPTSSPS PGPTGAPSPG PTAAPTAGSS EASTESLSPA DNPCNVDVFD 
AIAEIQGALH FFKDGWYWKF LNHRGSPLQG PFLTARTWPA LPATLDSAFE DPQTKRVFFF 
SGRQMWVYTG KTVLGPRSLD KLGLGPEVTH VSGLLPRRPG KALLFSKGRV WRFDLKSQKV 
DPQSVIRVDK EFSGVPWNSH DIFQYQDKAY FCHGKFFWRV SFQNEVNKVD PEVNQVDDVG 
YVTYDLLQCP 
PRT>P16; 
MAPSSLSVFV LSLSFTYCLS APVSQDEDSE LTPGALQLAE HYLNRLYSSS SNPAGMLRMK 
DVNSVETKLK EMQSFFGLEV TGKLNEDTLD IMKQPRCGVP DVGQYNFFPR KLKWPRNNLT 
YRIVNYTPDL STSDVDRAIK KALKVWSDVT PLNFTRLRTG TADIMVAFGK KEHGDYYPFD 
GPDGLLAHAF PPGEKIGGDT HFDDDEMFST DNKGYNLFVV AAHEFGHALG LDHSRDPGSL 
MFPVYTYTET SRFVLPDDDV QGIQALYGSG NRDPHPKHPK TPEKCDPDLT IDAITELRGE 
KMIFKDRFFW RVHPQMTDAE LVLIKSFWPE LPNKIDAAYE HPAKDLIYIF RGKKFWALNG 
YDFVEDYPKK LHELGFPKTL KAIDAAVYNK AIGKTLFFAE DSYWSFDEEA RTMDKGFPRL 
ISEDFPGIGE KVDAAYQRNG YIYFFNGALQ FEYSIWSKRI TRILKTNFVL MC 
PRT>P17; 
MEARLVWGVL VGPLRVLCVL CCLLGHAIAA PSPIIKFPGD VAPKTDKELA VQYLNTFYGC 
PKESCNLFVL KDTLKKMQKF FGLPQTGDLD QNTIETMRKP RCGNPDVANY NFFPRKPKWD 
KNQITYRIIG YTPDLDPETV DDAFARALKV WSDVTPLRFS RIHDGEADIM INFGRWEHGD 
GYPFDGKDGL LAHAFAPGTG VGGDSHFDDD ELWTLGEGQV VRVKYGNADG EYCKFPFLFN 
GREYSSCTDT GRSDGFLWCS TTYNFEKDGK YGFCPHEALF TMGGNADGQP CKFPFRFQGT 
SYNSCTTEGR TDGYRWCGTT EDYDRDKKYG FCPETAMSTV GGNSEGAPCV FPFTFLGNKY 
ESCTSAGRND GKVWCATTTN YDDDRKWGFC PDQGYSLFLV AAHEFGHAMG LEHSQDPGAL 
MAPIYTYTKN FRLSHDDIKG IQELYGPSPD ADTDTGTGPT PTLGPVTPEI CKQDIVFDGI 
AQIRGEIFFF KDRFIWRTVT PRDKPTGPLL VATFWPELPE KIDAVYEAPQ EEKAVFFAGN 
EYWVYSASTL ERGYPKPLTS LGLPPDVQQV DAAFNWSKNK KTYIFAGDKF WRYNEVKKKM 
DPGFPKLIAD SWNAIPDNLD AVVDLQGGGH SYFFKGAYYL KLENQSLKSV KFGSIKSDWL 
GC 
PRT>P18; 
MHPGVLAAFL FLSWTHCRAL PLPSGGDEDD LSEEDLQFAE RYLRSYYHPT NLAGILKENA 
ASSMTERLRE MQSFFGLEVT GKLDDNTLDV MKKPRCGVPD VGEYNVFPRT LKWSKMNLTY 
RIVNYTPDMT HSEVEKAFKK AFKVWSDVTP LNFTRLHDGI ADIMISFGIK EHGDFYPFDG 
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PSGLLAHAFP PGPNYGGDAH FDDDETWTSS SKGYNLFLVA AHEFGHSLGL DHSKDPGALM 
FPIYTYTGKS HFMLPDDDVQ GIQSLYGPGD EDPNPKHPKT PDKCDPSLSL DAITSLRGET 
MIFKDRFFWR LHPQQVDAEL FLTKSFWPEL PNRIDAAYEH PSHDLIFIFR GRKFWALNGY 
DILEGYPKKI SELGLPKEVK KISAAVHFED TGKTLLFSGN QVWRYDDTNH IMDKDYPRLI 
EEDFPGIGDK VDAVYEKNGY IYFFNGPIQF EYSIWSNRIV RVMPANSILW C 
PRT>P19; 
MMPSVLSAAI FFLSLAFGLP VPVPHERDSD VTEQELRLAE KYLKTFYVAS DHAGIMTKKG 
GNALASKLRE MQSFFDLEVT GKLDEDTLEV MKQPRCGVPD VGEYNVFPRS LKWPRFNLTY 
RIENYTPDMT HAEVDRAIKK AFRVWSEVTP LNFTRLRSGT ADIMISFGTK EHGDFYPFDG 
PNGLLAHAFP PGQRIGGDTH FDDDETFTSG SNGYNLFIVA AHEFGHALGL DHSRDPGSLM 
YPVYSYTEPS RFLLPDDDVQ GIQSLYGPGN RDPNPKHPKT PEKCDPELSL DAITEMRGEK 
LIFKDRFFWR QHPQMTDVEL VLIRNFWPEL PSKIDAAYEY PEKDLIYIFR GRKFWALNGY 
DILADYPKKI QELGFPKSLR TIDAAVYNRA MGKTLFFTGE KYWSFDEEKQ TVEKGYPRFI 
ADDFPGIGET VDAAYQRNGY IYFFSGSLQF EYSTWSNKVI RVLKTNSILW C 
PRT>P20; 
MLLAPLTLAL LALCRAAPLH SKPQAVITFP GELLSAPSDV ELAENYLLRF GYIQEAEVRR 
SSKHVSLAKA LRRMQKQLGL EETGELDAST LEAMRAPRCG VPDVGGFLTF EGELKWDHMD 
LTYRVMNYSP DLDRAVIDDA FRRAFKVWSD VTPLTFTQIY SGEADIMIMF GSQEHGDGYP 
FDGKDGLLAH AFPPGSGIQG DAHFDDDEFW TLGTGLEVKT RYGNANGASC HFPFIFEGRS 
YSRCITEGRT DGMLWCATTA SYDADKTYGF CPSELLYTNG GNSDGSPCVF PFIFDGASYD 
TCTTDGRSDG YRWCATTANF DQDKKYGFCP NRDTAAIGGN SQGDPCVFPF TFLGQSYSAR 
TSQGRQDGKL WCATTSNYDT DKKWGFCPDR GYSIFLVAAH EFGHSLGLDH SSVREALMYP 
MYSYVQDFQL HEDDVQGIQY LYGRGSGPEP TPPAPLPTEE PQSIPTEAGS ASTTEEEEEE 
TPEPTAEPSP VDPSRDACME KNFDAITEIN GELHFFKNGK YWTHSSFWKS GTQGAFSIAD 
TWPGLPAVID AAFQDVLTKR VFFFAGRQFW VFSGKNAVGP RRIEKLGIGK EAGRITGALQ 
RGRGKVLLFS GEHYWRLDVK VQTVDKGYPR DTDDVFTGVP LDARNVFLYQ DKYHFCRDSF 
YWRMTPRYQV DRVGYIRYDL LQCPQH 
PRT>P21; 
MKTYYQFLTT SILIGLVFRA HSGPVAPSET DDHEFAKNYL KKLYNMEEDN TPSFGRKVNE 
MSLKLGEMQE FFGLKVTGTL DAETMEMMKK PRCGVPDVAA LKARALTYKW TTNSLTYRIE 
NYTPDMSVAE VDDSIQRALQ VWARVTPLKF KRIYSGIADI MISFVVGDHR DGSPFDGPNG 
FLAHAFFPGV GIGGDAHFDD DETFSFRSTR GYNLFLVAAH EFGHSLGLEH SNVPGALMYP 
TYSYTNPDTF VLPRDDVKRI QALYGSNRDK PVNPDKPEPT PPVNPDACDP NLALDAVTTL 
RGEKLFFKNR FFWRIHPQLT ETDQYLIKFF WPELPDNIDA AFENPSTDLV YIIKGQKVWA 
LSGYDVVQRL SLSSFGLPDT VKKIDAAVYD VDTEKALFFL GKSYYSYDVN GKVMDRGFPK 
PVEQSFPGMT TKVTAAFQEN GNTYLFSGPD VFQYNSGRLV NVLKSNSFLR C 
PRT>22; 
MAPSSLSVFV LSLSFTYCLS APVSQDEDSE LTPGALQLAE HYLNRLYSSS SNPAGMLRMK 
DVNSVETKLK EMQSFFGLEV TGKLNEDTLD IMKQPRCGVP DVGQYNFFPR KLKWPRNNLT 
YRIVNYTPDL STSDVDRAIK KALKVWSDVT PLNFTRLRTG TADIMVAFGK KEHGDYYPFD 
GPDGLLAHAF PPGEKIGGDT HFDDDEMFST DNKGYNLFVV AAHEFGHALG LDHSRDPGSL 
MFPVYTYTET SRFVLPDDDV QGIQALYGSG NRDPHPKHPK TPEKCDPDLT IDAITELRGE 
KMIFKDRFFW RVHPQMTDAE LVLIKSFWPE LPNKIDAAYE HPAKDLIYIF RGKKFWALNG 
YDFVEDYPKK LHELGFPKTL KAIDAAVYNK AIGKTLFFAE DSYWSFDEEA RTMDKGFPRL 
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ISEDFPGIGE KVDAAYQRNG YIYFFNGALQ FEYSIWSKRI TRILKTNFVL MC 
PRT>23; 
MHPRVLAGFL FFSWTACWSL PLPSDGDSED LSEEDFQFAE SYLKSYYYPQ NPAGILKKTA 
ASSVIDRLRE MQSFFGLEVT GRLDDNTLDI MKKPRCGVPD VGEYNVFPRT LKWSKMNLTY 
RIVNYTPDLT HSEVEKAFRK AFKVWSDVTP LNFTRIHNGT ADIMISFGTK EHGDFYPFDG 
PSGLLAHAFP PGPNYGGDAH FDDDETWTSS SKGYNLFLVA AHEFGHSLGL DHSKDPGALM 
FPIYTYTGKS HFMLPDDDVQ GIQSLYGPGD EDPYSKHPKT PDKCDPSLSL DAITSLRGET 
LIFKDRFFWR LHPQQVEAEL FLTKSFGPEL PNRIDAAYEH PSHDLIFIFR GRKFWALSGY 
DILEDYPKKI SELGFPKHVK KISAALHFED SGKTLFFSEN QVWSYDDTNH VMDKDYPRLI 
EEVFPGIGDK VDAVYQKNGY IYFFNGPIQF EYSIWSNRIV RVMTTNSLLW C 
PRT>P24; 
MELTAVVLLV IAAHALAKPI SSEEKDKVLF AEKYLRRYYG MPAGLQGKEK TSDVMYKKKI 
QEMQEFFKLN VTGKLDDDTL ELMEMARCGV PDVAEYNHFP NDLKWKTTEV TFRILNYTPD 
LRKADVDRAV RNGLNVWSSV TPLKFKKLYE GNADIMISFG AREHGDFNPF DGPDGLLAHA 
YPPGNGIGGD THFDEDETWT KDFHEFNLFL VAAHEFGHAL GMAHSSDPGS LMYPVYSYGK 
GYPLSEDDIK GIQSLYGENP NHRRIKPKPD APSKCDPELS FDAVTELRGE TIIFKDRFYW 
RLHSQIPEPE QTLIKSTWPE IPNKVDAAYE NPEKDVVIIF SGIKMWALNG YNLVDGYPKY 
IHKLGLPKTV RKIDAAVNIR DTGKTLLFVE EEYWSYDERT GTMDSGYPRS IEEDFPGIGD 
EVDAAAYHFG YLYFYHEHIQ FEYSYNSRKV MRIMRANSIL NC 
PRT>P25; 
MKTCFRLCVFITLLFSGHSSPIAPPAGGDQDTLAENYLTRLYGLPKPAQNPSPSGGEKRS 
SDVSLRLKEMQQFFKLKVSGKLDQETLEVMKKPRCGVPDIKAYSTFAGDYKWKKHQLTYR 
IGNYTPDMSVAEVDDSISKALKVWADVTPLRFTRIYSGTADIMISFATGDHRDGYPFDGP 
NGFLAHAFPPFEGIGGDAHFDDDETFSYRSPQYYNLFLVAAHEFGHSLGLEHSQDPGALM 
YPTYVYRDVDRFVLPRDDVNGIQSLYGPNTDVNTDDSKPTPPVTPNTCDPNLVLDAVTML 
RGEIMFFKNSFFWRSYPQSADVEQQLIKSFWPEAPDNIDAAFESVMQDKVFLIKGEKVWA 
LYGYDMVQGYPKSLSMFRLPKNVRKIDAVLYKEDSNSILFFANNQVYSYNEGIRQMDKGF 
PKPVEEVFPGMTGKVTAAFQYRGLNYLFSGSKMLEFGSNNRLFRVLNNNYFLPCK 
PRT>P26; 
MHPGVLAAFLFLSWTRCWSLPVPNDDDDDDDMSEEDFQLAERYLKSYYYPLNPAGILKKT 
AANSVVDRLREMQSFFGLEVTGKLDDNTLDIMKKPRCGVPDVGEYNVFPRTLKWPKMNLT 
YRIVNYTPDLTHSEVEKAFKKAFKVWSDVTPLNFTRLYNGTADIMISFGTKEHGDFYPFD 
GPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGAL 
MFPIYTYTGKSHFVLPDDDVQGIQYLYGPGDEDPNPKHPKTPDKCDPSLSLDAITSLRGE 
TMVFKDRFFWRLHPQLVDAELFLTKSFWPELPNRIDAAYEHPSKDLIFIFRGRKFWALNG 
YDILEGYPQKISELGFPKDVKKISAAVHFEDTGKTLFFSGNQVWRYDDTNRMMDKDYPRL 
IEEDFPGIGDKVDAVYEKNGYIYFFNGPIQFEYSIWSNRIVRVMPTNSLLWC 
PRT>P27; 
MHSAILATFFLLSWTHCWSLPLPYGDDDDDDLSEEDLEFAEHYLKSYYHPVTLAGILKKS 
TSTVDRLREMQSFFGLDVTGKLDDPTLDIMRKPRCGVPDVGEYNVFPRTLKWSQTNLT 
YRIVNYTPDISHSEVEKAFRKAFKVWSDVTPLNFTRIHDGTADIMISFGTKEHGDFYPFD 
GPSGLLAHAFPPGPNLGGDAHFDDDETWTSSSKGYNLFIVAAHELGHSLGLDHSKDPGAL 
MFPIYTYTGKSHFMLPDDDVQGIQSLYGPGDEDPNPKHPKTPEKCDPALSLDAITSLRGE 
TMIFKDRFFWRLHPQQVEPELFLTKSFWPELPNHVDAAYEHPSRDLMFIFRGRKFWALNG 
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YDIMEGYPRKISDLGFPKEVKRLSAAVHFEDTGKTLFFSGNHVWSYDDANQTMDKDYPRL 
IEEEFPGIGDKVDAVYEKNGYIYFFNGPIQFEYSIWSNRIVRVMPTNSLLWC 
PRT>P28; 
MHPGVLAAFLFLSWTHCRALPLPSGGDEDDLSEEDLQFAERYLRSYYHPTNLAGILKENA 
ASSMTERLREMQSFFGLEVTGKLDDNTLDVMKKPRCGVPDVGEYNVFPRTLKWSKMNLTY 
RIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDG 
PSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALM 
FPIYTYTGKSHFMLPDDDVQGIQSLYGPGDEDPNPKHPKTPDKCDPSLSLDAITSLRGET 
MIFKDRFFWRLHPQQVDAELFLTKSFWPELPNRIDAAYEHPSHDLIFIFRGRKFWALNGY 
DILEGYPKKISELGLPKEVKKISAAVHFEDTGKTLLFSGNQVWRYDDTNHIMDKDYPRLI 
EEDFPGIGDKVDAVYEKNGYIYFFNGPIQFEYSIWSNRIVRVMPANSILWC 
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Appendix II 
 
 
Primary amino acid sequences of Azurocidin used in thesis: 
PRT>P1; 
MTRLTVLALLAGLLASSRAGSSPLLDIVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQS
QNPGVSTVVLGAYDLRRRERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNAT
VEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPNNVCTGVLTRRGGICNGDGGTPLVCEGLA
HGVASFSLGPCGRGPDFFTRVALFRDWIDGVLNNPGPGPA 
PRT>P2; 
MFKYAAVFVLAVATVSAATLKNPVSSENRQGRIAGGEVANPNQFPYHAALQTADGLTFCGAAIVNQRWV
ITAGSCAQGKATTDVLVIVGTNRVDALAVPRHTVDRIVIHPNFDVNVYANDVAVLRVLRPFIFSESIQPITLG
SDNVEAESNAVATGFGRTAISDSTPASYLRYVNVDVITNEECQEAFDDSYQERLHGNTVCTRSAEGSGICL
GDAGGPLVIDDTLVGVISWGIPCGMGMPDVYARVSAHRAWVLVHTMI 
PRT>P3; 
IVGGRRAQPQEFPFLASIQKQGRPFCAGALVHPRFVLTAASCFRGKNSGSASVVLGAYDLRQQEQSRQTFSI
RSISQNGYDPRQNLNDVLLLQLDREARLTPSVALVPLPPQNATVEAGTNCQVAGWGTQRLRRLFSRFPRVL
NVTVTSNPCLPRDMCIGVFSRRGRISQGDRGTPLVCNGLAQGVASFLRRRFRRSSGFFTRVALFRNWIDSVL
NNPP 
PRT>P4; 
MVVSKSVPKPKSHKPALKKKQALKFSICCSPGVIDEDIISPGILEKYLKEHIKVNKKLNNLGKDIHIERDKSTI
NITANIPFSKRYLKYLTKNSSKDTNFGIFSESLQSLKILTNYDSSTLRMRTRMMKKRADHFP 
PRT>P5; 
MTRLTVLALLAGLLVSSRAGSSPLADIVGGRKARPRQFPFLASIQNQGRHFCGGALIHPRFVMSAASCFRN
QNPGTVTVVLGAYDLRRRERRSRQMFSISSMSENRYDPQQNLNDLVLLQLDREANITSSVAILALPLQNAM
VEAGTRCQVAGWGTRRSGGRLSRFPRFVNVTVTPEDQCRPNNVCTGVLARRAGICNGDGGTPLICDGLGH
GVASFSMGPCGRGPDFFTRVSVFRDWIDGVLNGGPVPA 
PRT>P6; 
MGTMKTQRDSPSLGRWSLVLLLLGLVMPLAIVAQVLSYQEAVLRAIDGINQRSSDANLYRLLDLDPRPTM
DGDPDTPKPVSFTVKETVCPRTTQKSPEDCDFKEDGLVKRCVGTVILNQARDSFDISCDKDNRRSARLGNF
FRKVKEKIGGGLKKVGQKIKDFLGNLVPRTAS 
PRT>P7; 
MTALRLLAMLASLLATSRAGSAPLVDIVGGRKARPQELPFLASIQNQGRHFCGGALIHPNFVLTAASCFQS
RNTGIATVVLGAYDLRRRERSRQTFFIRSVSENGYDPQQNLNDVLLLQLDRQANLTSSVALVPLPEQNATV
EAGTGCQVAGWGTRRRRGRLSRVPRVLNVTVTPANQCRPNNVCTGVLTRRGGICQGDGGTPLVCNGLAH
GVASWSRGPCGRGTDFFARVALFRNWIDSVINQPA 
PRT>P8; 
MEKIVCLLLIALYGCSAAPAELEIRETPTLDNVTTVAIHLVANDGQFPFMVSIQQRFEPGQLGHTCGGTLISL
QHVLTAASCLYQTTSGSPVLINPQFYRVFGGHRSLGNNMNDPDRVRMIENFTIHPDFVGNNQHLNDIAIITL
DSPFVAGQYLQPLPLPEQDEQPSEQEGDCTICGWGKKTADTSLMQNSLTYAPKTVLNQTECIAEYYTKFNI
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PTAMDENMVCAASTRSLTYGCPGDEGGPLVCNKRLAGVLFTSVRCGISTDPLLYTRVSPYANWAKGVVG
EPLSTSSSATFQPGVALVFMLAVKQFVATFSF 
 
 
 
 
 
 
 
